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                                                SUMMARY 
      Educational institutions have been suspected of being foci for transmission 
of influenza. University population provides an advantage to study local 
epidemiology of influenza as well as imported cases, as university students 
have a good mix of both local and overseas students. Viral etiology of 
influenza-like illness (ILI) has been determined previously in military 
populations or hospitalized patients with not many studies in university 
cohorts. A prospective surveillance study was conducted at the University 
health and wellness centre (UHC), National University of Singapore (NUS), to 
characterize influenza viruses circulating on campus from 2007-09 with initial 
phase of the influenza A/H1N1 2009 pandemic (pH1N1/09) being captured. 
Nasopharyngeal swabs, clinical information and demographic data were 
collected from 510 students and staff presenting to UHC with ILIs. Influenza 
virus (32.8%; that comes form 18% in 2007, 24% in 2008 and 59% in 2009) 
was identified as the main causative agent followed closely by adenovirus 
(32.4%), rhinovirus (10.6%), enterovirus (7%), coronavirus (3.4%), 
parainfluenza virus (1.4%), respiratory syncytial virus (1.4%) and human 
metapneumovirus (1%).  
       Of the seven symptoms elicited, five had significant association with 
laboratory-confirmed influenza: fever (OR 2.36, 95%CI 1.74-3.20), cough 
(OR 1.43, 95%CI 1.10-1.84), chills (OR 1.51, 95%CI 1.18-1.94), running nose 
(OR 1.33, 95%CI 1.02-1.73) and aches (OR 1.61, 95%CI 1.24-2.09). Fever 
(p<0.0001), chills (p<0.0001), aches (p<0.0002), running nose (p<0.0009) and 
cough (p<0.0062) were predictive of influenza. Pandemic H1N1 had fever as 
IX 
 
the most common presentation and H3N2 infections were the most 
symptomatic of all influenza subtypes. 
       PCR was found to be superior to culture in detecting both seasonal and 
pandemic 2009 influenza A virus. Additionally, an inverse relationship 
between cycle threshold (ct) value and successful viral isolation was found in 
case of pandemic H1N1 2009 viruses. 
       Genetic characterization using molecular sequencing data found that the 
seasonal IAVs were genetically diverse from the contemporary vaccine strain 
for the same season but matched well with the vaccine strain of upcoming 
influenza season. No neuraminidase inhibitor resistance was detected but a 
very high level of adamantane resistance was detected (98%).  
       Molecular epidemiological analysis based on hemagglutinin gene 
sequences identified residence at hostel (OR 4.2, 95%CI 1.2-14.9, p<0.05) as a 
potential risk factor for contracting any influenza A subtype seasonal or 
pandemic. Phylogenetic analysis conducted on concatenated whole genomes 
of pH1N1/09 viruses showed 5 well-supported clusters of highly-similar 
sequences with the majority from students staying on-campus suggesting intra-
campus transmission. Phylogeographic analysis provided a stronger evidence 
of geographical clustering based on faculty, Life-Sciences versus Non-life 
Sciences (AI P=0.02; PS P=0.05); residence, on-campus versus off-campus 
(AI P=0.009; PS P=0.04). This phylogeographic analysis was clearer than the 
conventional epidemiologic analysis which only identified residence on-
campus (OR 1.517, 95%CI 1.037-2.217) as a significant risk factor for 
laboratory-confirmed pandemic H1N1 2009 infection. Integration of 
X 
 
molecular, epidemiological and statistical methods for influenza surveillance 
can guide public authorities to identify foci of transmission in localized 
communities. Targeted intervention strategies including possibly closures of 
the university or campus-based quarantine may be implemented in cases of 
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at the bottom indicates the number of amino acid 
substitutions per site. The strain name is followed by date 
and month of isolation. 
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Figure 9-3         Maximun-Likelihood phylogenetic tree of 34 
concatenated genomes of pH1N1/09 viruses from NUS 
campus. Strain name is followed by residence status and 
week of isolation. On campus sequences are in red and 
Off campus sequences are in black font. Clusters were 
identified with strong bootstrap support (70%). Clusters 
with exclusively On- campus sequences are highlighted 
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Chapter 1:  Introduction 
1.1 Influenza infection  
         Influenza (commonly called ‘flu’) is an acute, febrile, contagious 
infection of respiratory tract caused by influenza viruses. The symptoms range 
from mild to severe. The common symptoms of influenza include fever or 
feeling feverish, chills, sore throat, cough, muscle aches, headache, and 
weakness/fatigue. Although it is self-limited illness, complications such as 
pneumonia, sinus infections and ear infections may occur in 
immunocompromised individuals, young children, pregnant women or 
individuals with serious underlying medical conditions (CDC 2014a).  
 
1.2 Influenza virology 
          Influenza virus belongs to family Orthomyxoviridae (Pringle 1996). 
Currently, this family is constituted by 6 genera: influenza virus A, influenza 
virus B, influenza virus C, Thogotavirus (Pringle 1996), Isavirus (Palese & 
Shaw 2007; Wright et al. 2007) and Quarjavirus (Presti et al. 2009). Antigenic 
differences in matrix (M) proteins and nucleoproteins (NP) form the basis of 
classification of influenza viruses into three types: A, B, and C. Although 
these 3 types cause human infections only influenza A virus (IAV) possesses 
the remarkable capacity to cause pandemics (Klenk et al. 2008) because only 
IAV has animal reservoirs: pigs, birds, sea mammals (Webster et al. 1992; 
Alexander & Brown 2000) and birds (CDC 2014b) which provide HA and NA 
capable of adaptation and transmission in humans.    
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        IAVs encode 8 negative stranded RNA segments (Figure 1-1 and Table 
1.1) ranging from 890 to 2341 nucleotide (nt) in length for a total of about 
13,588 nts depending on the subtype (Lamb & Choppin 1983) and 16 
polypeptides (Schrauwen et al. 2014) that perform specific functions (Table 
1.1). IAV subtypes are based on HA and NA. There are 18 HA subtypes 
known so far with H17 discovered in fruit bats (Tong et al. 2012) and H18 in 
Peruvian bats (Tong et al. 2013) and 11 NA subtypes. Influenza B virus (IBV) 
has antigenically diversified into Victoria and Yamagata lineages since 1970s 
(Kanegae et al.1990). 
                                       
                                                                Adapted from Schrauwen et al. 2013      
Figure 1-1: Schematic representation of influenza virus segments and 
proteins. The Non-structural (NS) proteins and newly discovered proteins are 
shown in rectangles 
  Table 1.1: Influenza A virus RNA segments and proteins encoded  (Adapted 
from Lamb et al. 2001) 
Segment Length 
(nucleotides) 
Encoded polypeptides (length) 
1 2,341 PB2(759) 
2 2,341 PB1(757), PB1-F2(87),PB1N40 
3 2,233 PA(716), PA-X, PA-N155, PA-N182 
4 1778 HA(566) 
5 1565 NP(498) 
6 1413 NA(454) 
7 1,027 M1(252), M2(97), M42 
8 890 NS1(230), NS2/NEP(121) 
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1.3. Influenza proteins 
1.3.1 Polymerase proteins 
           Polymerase proteins comprise of Polymerase Basic protein-1 (PB-1), 
Polymerase Basic protein-2 (PB-2), Polymerase Acidic protein (PA) and together 
with Nucleoprotein (NP) and viral RNA they form ribonucleoprotein (RNP) 
complex (Figure 1-2). These proteins are required for transcription and replication 
of genome (Huang et al. 1990). Chen et al., identified 52 host-associated 
signatures and 35 of these signatures are located in the RNP (Chen et al. 2006). 
 
                                                                    Adapted from Naffakh et al. 2008  
Figure 1-2: Schematic representation of Ribonucleoprotein complex(RNP). RNP 
is composed of four viral proteins(PB-2, PB-1, PA, NP) and viral RNA 
1.3.1.1 PB-2  
       PB-2 possesses host range restriction markers (Shi et al. 1995; Chen et al. 
2006; Naffakh et al. 2008) the most remarkable being PB2 residue 627 (Subbarao 
et al. 1993) which in avian host generally encodes Glutamic acid (E) while in 
human host encodes Lysine (K) and rarely Arginine (R). PB-2 residue 701 is 
another host range restriction marker with Aspartate (701D) encoded in avian host 
while asparagine (701N) encoded in human host (Gabriel et al. 2005; Li et al. 
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2005). Additionally residues 701–702 direct nuclear localization (Gabriel et al. 
2008; Tarendeau et al. 2007). Notably, 2009 H1N1 virus (pH1N1/09) does not 
possess mammalian adaptation residues 627K and 701N (Schrauwen et al. 2014). 
Of the 10 amino acid (aa) changes in PB2 proposed to be human host markers, 
pH1N1/09 only carries T271A (Finkelstein et al. 2007). Alternative strategies 
such as SR polymorphism have been proposed for human adaptation (Mehle & 
Doudna 2009).  
1.3.1.2 PB-1 & PB1-F2  
         PB1 also determines host range restriction with human viruses encoding  
Serine (S) at residue 375 and Asparagine (N) in most avian viruses (Taubenberger 
et al. 2005; Naffakh et al. 2008). PB1-F2 induces apoptosis (Gibbs et al. 2003)   
and is a determinant of virulence in IAVs (Chen et al. 2001; McAuley et al. 2007; 
Chakrabarti & Pasricha 2013; McAuley et al. 2010; Conenello et al. 2007). 
Asparagine (N) to Serine (S), substitution at residue 66 (N66S) reduces interferon 
(IFN) production (Varga et al. 2012). Notably, pandemic H1N1 2009 (pH1N1/09) 
does not encode PB1-F2 because of the premature stop codon (Schrauwen et al. 
2014). 
1.3.1.3 PA 
       PA is a phosphoprotein and induces proteolytic cleavage (Sanz-Ezquerro et 
al. 1995). PA-X modulates host response to infection (Jagger et al. 2012) and is a 




           HA is the major surface glycoprotein comprising a globular head and a 
stem and possesses three important sites: antigenic site and receptor binding site 
(RBS) in head region and cleavage site in stem (Figure 1-3). The RBS is a 
grooved pocket and is formed of 3 elements: 130 loop, 190 helix and 220 loop 
with following residues (Tyrosine-98, Tryptophan-153, Histidine-183, Glutamic 
acid-190, Leucine-194) (Skehel et al. 1982; Shangguan et al. 1998; Skehel & 
Wiley 2000). Although conserved in avian viruses, the HA receptor binding 
domain (RBD) has mutations in several residues, including sites 138, 190, 194, 
225, 226 and 228 in H3 subtype and residues 190 and 222 in H1 subtype (H3 
numbering) (Wright et al. 2007). The mutations at these sites have been thought to 
increase attachment from alpha (α) 2-3 sialic acid (avian) to α2–6 sialic acid 
(human).  
        The cleavage of HA0 into a signal peptide, HA1 and HA2 protein is a 
prerequisite for infectivity. HA1 binds to the receptor and thus is targeted by host 
immune defences by production of neutralizing antibodies while HA2 serves as an 
anchor protein (Sriwilaijaroen & Suzuki 2012). One of the well-known virulence 
markers of IAVs is the multibasic cleavage site (MBCS) which is thought to be 
cleaved by ubiquitously expressed proteases facilitating systemic spread 
(Schrauwen et al. 2014) while cleavage of human HA0 is mainly by trypsin-like 





                                                                      Adapted from Stevens et al. 2004 
Figure 1-3: X-Ray crystallographic structure of HA protein monomer of the 1918 
H1N1 virus. The HA protein possesses two domains: the globular head with 
receptor binding and antigenic sites and the stem with cleavage site. 
 
1.3.3 NP 
        NP is an RNA binding protein and is conserved among influenza types and 
subtypes (Tarus et al. 2012). The primary function of NP is in encapsidation of 
the virus genome during viral replication cycle (Portela & Digard 2002) but also 
plays a role in host range restriction (Ruigrok et al. 2010; Snyder et al. 1987). The 
NP contains molecular markers of enhanced transmission such as L136M and 








           NA is a surface glycoprotein with major role in the detachment of the 
influenza virus by cleavage of sialic acid from the host cell though its role in the 
early stages of viral replication has also been postulated (Matrosovich et al. 2004; 
Xu et al. 2012). The NA also consists of a head and a stalk region like HA. The 
tetrameric head bears the four catalytic sites (Colman et al. 1983). Stalk deletion 
has been shown to be potential virulence factor in pathogenesis of disease 
(Munier et al. 2010; Sorrell et al. 2010). Another well-established feature of  NA 
is its association with drug resistance (Zambon & Hayden 2001). 
1.3.5 M1 & M2  
         M1 is the most abundant protein in influenza virion (Schmitt & Lamb 2005) 
and M2 possesses ion channel activity. The M protein harbors molecular markers 
of adamantane resistance (Hay et al. 1986; Belshe et al. 1988; Deyde et al. 2010; 
Wang et al. 2013; Arango et al. 2014). Mutations A16G and C55F are associated 
with enhanced transmission (Byarugaba et al. 2011).  
1.3.6 NS1 & NS2 
        NS1 protein is a molecular determinant of virulence. It is an IFN antagonist 
(Hayman et al. 2007; Hale et al. 2008) and thus helps the virus to circumvent host 
immune responses. Glutamic acid (E) at residue 92 is required for this antagonism 
(Seo et al. 2002). Another mechanism postulated for increased virulence is 
presence of postsynaptic density protein (PDZ) 95 ligand domain in NS1 
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(Obenauer et al. 2006). This is present in H5N1 and pandemic 1918 H1N1 viruses 
(Jackson et al. 2008). Notably, pH1N1/09 has truncated protein and hence lacks 
PDZ ligand domain (Hale et al. 2010). NS2 is a serves as a nuclear export protein 
(Neumann et al. 2000; Paterson & Fodor 2012) by translocating viral genetic 
material in association with M1 from the nucleus by its interaction with exportin 
(O’Neill et al. 1998). The important determinants of pathogenicity of IAV are 
summarized in table 1.2. 
Table 1.2: Determinants of influenza virus pathogenicity (Adapted from 
(Schrauwen et al. 2014). 
Protein  Function  Position References 
HA Determines host range and tissue tropism/ 
Receptor binding sites 
 
Determines HA0 will be cleaved by 
which proteases/ Cleavage sites 
 
Potential glycosylation motifs for binding 
226Q to L in H3 






(Matrosovich et al. 
2000) 
 
(Bertram et al. 2010) 
 
 
(de Wit et al. 2010) 






(Subbarao et al. 1993) 
(Li et al. 2005; Gabriel 
et al. 2008)  
(Mehle & Doudna 2009) 
PA/PB-
1/NP/NEP 
Increased polymerase activity Not applicable (Mänz et al. 2013) 
PB1-F2 Proapoptotic, antagonize interferon 
response 
66 (Varga et al. 2012) 
PA-X Host shut-off Not applicable (Jagger et al. 2012) 
NS-1 Evasion of host immune response C-terminal (Obenauer et al. 2006; 
Jackson et al. 2008) 
NA Release of virion 
 




(Xu et al. 2012; 
Matrosovich et al. 2004) 
(Munier et al. 2010; 




1.4 Epidemiology of Influenza 
1.4.1 Seasonal influenza 
        Seasonal influenza viruses cause infections in humans every year when a 
‘new epidemic strain’ emerges by accumulation of mutations in antibody binding 
sites leading to immune evasion and the process is termed as ‘antigenic drift’ 
(Chen & Holmes 2006; Domingo et al. 1998; Lauring & Andino 2010; 
Taubenberger & Kash 2010). Antigenic drift occurs mainly due to lack of 
exonuclease proofreading capability of low fidelity RNA polymerase (Domingo et 
al. 1998). Another mechanism proposed is N-linked glycosylation (Das et al. 
2010). Globally, the annual epidemics of seasonal influenza are estimated to be 
responsible for 3- 5 million cases of severe illness and approximately 250 000- 
500 000 deaths (WHO 2014a). 
1.4.2 Pandemic influenza 
       Pandemic influenza occurs when a ‘novel strain’ of influenza emerges to 
which the human population has no exposure and hence no immunity and then 
efficiently transmits among humans. The process is known an ‘Antigenic shift’ 
and it occurs probably through reassortment (Figure 1-4) or through direct 
adaptation of avian strain in humans after jumping species barrier. The co-
infection of one host cell with two different IAV strains provides a suitable 
environment for reassortment among the various gene segments and when it 
involves HA and/or NA gene segments it is termed antigenic shift (Taubenberger 
& Kash 2010). Reassortment is believed to occur mainly in pigs because pigs are 
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susceptible to infection with both human and avian strains and hence pigs are 
known as ‘mixing vessels’ for influenza strains (Scholtissek 1990). Three 
influenza pandemics occurred in the 20
th
 century. They differed from one another 
in their etiology, epidemiology and severity. The “Spanish” influenza pandemic 
of 1918-19 was extremely virulent and unusually deadly (Taubenberger & 
Morens 2006; Morens et al. 2008). There have been pseudo-pandemics of 
influenza in the past (Kilbourne 2006). In June 2009, the first pandemic of the 21
st
 
century was announced. A novel strain of IAV (H1N1) virus that emerged 
through reassortment was responsible for the pandemic (Garten et al. 2009) 





century is presented in table 1.4. 
 
                                                                     Adapted from Schrauwen et al. 2014 
Figure 1-4: Reassortment and adaptation events of pandemic influenza A viruses. 
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Table 1.3: The Origin of Swine Influenza Virus Segments 
Segments  Origin  
HA/NP/NS  Classical Swine, North American Lineage  
NA/M Eurasian Swine Lineage  
PB2/PA Avian, North American Lineage  
PB1  Human derived H3N2 Swine Lineage  
 
 





(Data obtained from Dawood et al. 2012) 
Pandemic Year  Mortality 
worldwide/  % 
World population 
              Origin Subtype  
Spanish flu 1918-19 40 million  
1-3%  
Uncertain; thought to 
be an adaptation to 
humans of an avian 
virus 
H1N1 
Asian flu 1957 2 million Human/avian 
reassortant  








H3, PB1 avian  
H3N2 
pH1N1/09 2009 284500 
0.001-0.011% 
Human/avian/swine 
reassortant 6 genes 
from triple-reassortant 
North American swine 
and 2 genes (NA and 








1.5 Influenza Diagnostics 
         Isolation and characterization of circulating strains is critical to update 
annual vaccine recommendations, and rapid influenza diagnosis helps to reduce 
unnecessary antibiotic administration and to implement appropriate infection 
control measures (Dwyer et al. 2006; Barenfanger et al. 2000; Jennings et al. 
2009). Various influenza testing methods are compared in table 1.5 (CDC 2014c). 
Table 1.5: Influenza Virus Testing Methods (Adapted from CDC 2014c) 
Method/ Time to 
result 
       Main applications/advantages             Disadvantages 
Conventional 
culture/ 
 3-10 days 
 Vaccine production 
 Antigenic characterization 
 Detection of novel influenza 
strain 
 Influenza surveillance 
 Detection of institutionalized 
outbreaks 
 Monitor antiviral resistance 
 Documents active infection 
 Long turn-around time 
 Requires culture 
facility 
 No information on 
subtype 
 Lower sensitivity than 
PCR 
 
Rapid cell culture 
(shell vials)/  
 1-3 days 
 Influenza surveillance 
 Detection of institutionalized 
outbreaks 
 Co-cultured cells support 
growth of multiple respiratory 
viruses 
 Lower sensitivity than 
PCR 
PCR and other 
molecular assays / 
Varied 
(Generally 1-6 hrs.) 
 Clinical management 
 Influenza surveillance  
 Detection of institutionalized 
outbreaks 
 Monitor antiviral resistance 
 Limited ability to 
detect novel strain 
(unsubtypeables) 





< 30 min. 
 Clinical management 
 Detection of institutionalized 
outbreaks 
 Lower sensitivity than 
culture and PCR 
 No information on 
subtype available 
(except few assays) 
Serology/  
10-14 days 
 Research and surveillance 
 Establish retrospective 
diagnosis 
 Establish diagnosis of novel 
strain and in asymptomatic 
cases 
 Acute infections 
cannot be picked up 
 Limited role in clinical 
management 
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1.6 Prevention and Treatment  
1.6.1 Prevention:  
         The key strategy for primary prevention of seasonal influenza is annual 
vaccination. In Singapore, recommendations are especially in people at higher 
risk of serious influenza complications. The Singapore’s Ministry of Health 
recommends annual influenza vaccination for pregnant women, health care 
workers, children 6 months-5 years, elderly, persons with high risk conditions, 
medical care or hospitalization in previous year, children on long-term aspirin 
therapy and household contacts and caregivers of children (MOH 2010b). 
However, currently in Singapore, there are no recommendations for 
institutionalized individuals, schoolchildren and healthy adults living in closed 
localized communities such as, universities or military camps.  
         On the contrary, CDC recommends vaccination of all individuals 
6months and older unless they have contraindication (CDC 2015). Previous 
studies have shown that vaccinating school children and young adults 
significantly reduces the impact of influenza and is cost-effective (Lisa et al 
2011). On the contrary, a Cochrane review by Jefferson et al. found that 
influenza vaccination has only modest effect on reducing symptoms and 
absenteeism among healthy adults (Jefferson et al. 2010). The vaccine 
purchase is higher in the private sector than in the public sector (Gupta et al. 
2012) which means the vaccine cost will be higher and vaccine reach will 
lower. However, with effect from 2014, the MOH has allowed the use of 
Medisave to pay for the influenza vaccination (MOH 2014).  
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        For vaccine to be effective a good match between the contemporary 
circulating viruses and the strains in the vaccine is required. However, 
influenza viruses are constantly drifting and are being monitored by WHO 
Global Influenza Surveillance and Response System (GISRS) (WHO 2014a). 
WHO biannually updates its recommendation on vaccine composition that 
targets 2 subtypes of IAV (H1N1 and H3N2) and one IBV (Yamagata lineage). 
From the 2013-2014 Northern hemisphere influenza season, the 
recommendation from a conventional trivalent vaccine has changed to a 
quadrivalent vaccine with a second IBV (Victoria lineage) added to the 





           Two classes of anti-influenza drugs (Adamantanes and Neuraminidase 
inhibitors (NAIs)) have been mainly used for the treatment of influenza (Table 
1.6) and these reduce the severity and duration of the illness if administered early 
in the illness (within 48 hours). In Singapore, antivirals are prescribed to 
immunocompromised and those with severe influenza infection whereas in other 
healthy individuals who present with influenza-like illness, the treatment is 















Block M2 proton channel  A (Deyde et al. 2007; 











Inhibit enzymatic activity of  
neuraminidase 
A, B  (García et al. 2009; 
Thorlund et al. 2011) 
 Hemagglutinin 
inhibitors 
DAS 181 Remove sialic acid receptors 
from respiratory epithelium 
cells  
Prevent virus attachment 









Block chain elongation  
Cap binding,  
Block endonuclease 
A,B,C 
*Peramivir and Laninamivir licensed in a few countries (Japan, Korea) 
 
1.7 Drug Resistance  
         Adamantanes had been used successfully used for IAV infections since 
1960s. Unfortunately, high prevalence of amantadine-resistant influenza viruses 
was detected worldwide since 2003 and by 2005-06 almost all the influenza 
strains were resistant to adamantanes globally (Bright et al. 2005; Deyde et al. 
2007). Neuraminidase inhibitors came into usage in 1999 and resistance to these 
drugs had been low till 2007. However, by 2008-09 season almost all strains of 
sH1N1 were resistant to NAIs. In 2009, sH1N1 was completely displaced by NAI 
susceptible pH1N1/09 viruses and 98% of these viruses had been susceptible to 
NAIs in 2013-14 influenza season (CDC 2014d). In view of widespread 
adamantane resistance, the NAIs are the first-line treatment for people requiring 
antiviral therapy (WHO 2014a). 
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1.8 Influenza in Singapore 
         Tropical regions are crucial in understanding the dynamics of influenza 
transmission as seasonality of influenza is substantially different from temperate 
regions and also they are believed to the epicenter of emergence of new strains of 
influenza (Russell et al. 2008). Influenza is present all year round in tropical 
regions whereas single annual influenza epidemic occurs in late autumn or early 
winters in temperate regions. In tropical regions influenza usually causes more 
than one seasonal epidemic per year (Lee et al. 2009a; Yang et al. 2011). 
         Singapore is a tropical city-state with a population of approximately 5 
million. It is also a commercial hub in South-east Asia (SEA) and is very well-
connected globally. Throughout the year, the average temperature is between 23 
and 35 degrees and the relative humidity ranges from 48%-100%. Influenza 
activity peaks  biannually: June through July and November through January 
(Shek & Lee 2003), though sporadic influenza cases may be detected throughout 
the year (Doraisingham et al. 1988; Shek & Lee 2003; Tang et al. 2012). 
         Seasonal influenza is a major public health concern in Singapore and 
previous pandemics have also caused significant morbidity and mortality (Table 
1.7). Influenza infection causes significant morbidity in young adults in Singapore 
with an estimated >3 million doctor visits and approximately 2 million lost work 
days (Ng et al. 2002). The estimated mortality due to seasonal influenza in 
Singapore is at 14.8/100,000 person-years (Lee et al. 2007). The influenza 
mortality in Singapore has been shown to be comparable to temperate and sub-
tropical regions like United States and Hong Kong (Lee et al. 2009a).  
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1918 370,000 2870-6656 18//1000 (Lee et al. 2008) 
 
1957 1.45 million 680 0.47/1000 
1968 2 million 540 .27/1000 
2009 5 million - 0.067/1000 (Cutter et al. 2010) 
         
     Singapore has a nation-wide surveillance program since 1972 (Doraisingham 
et al. 1988) with National Influenza center at Singapore General Hospital. The 
Ministry of Health (MOH), Singapore, conducts the morbidity surveillance and 
weekly publishes the proportion of ILI cases among the polyclinic attendances 
and prevalence of influenza in community (Figure. 1-5). Molecular surveillance is 
conducted by National Public Health Laboratory (NPHL). 
 
Figure 1-5: Influenza surveillance data from Singapore                 
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    After the pH1N1/09, the literature on influenza research increased 
tremendously in Singapore (Liang et al. 2009; Mukherjee et al. 2010; Hsu et al. 
2010; Lee et al. 2011a; Tay et al. 2010; Pada & Tambyah 2011). The studies are 
summarized in table 1.8. Although there have been well defined epidemiological 
and clinical studies in military population and in hospitalized patients, these lack 
the molecular epidemiology of influenza.                   
Table 1.8: Literature review of influenza research in Singapore (2010-13) 
Author/ Year Type of study Target population Influenza 
subtype 
Tan et al. 2014 Clinical and epidemiological Military servicemen P & S 
Chen et al. 2013 Seroepidemiology Adults P 
Siau et al. 2011 Retrospective study  Hospitalized patients P 
Yap et al. 2012 Clinical study Military camps P & S 
Tang et al. 2012 Clinical & epidemiological  Community population P & S 
Lim et al. 2011 Seroconversion Community adults P 
Hsann et al. 2011 Clinical study Hospitalized patients P 
Lee et al. 2011b Clinical diagnostic model Military camps P & S 
Lee et al. 2011a Virological study Hospitalized patients P & S 
Chan et al. 2011b Prospective observational  ED patients P & S 
Chen et al. 2010 Seroconversion  Health care personnel P 
Lee et al. 2010a Diagnostic study  Suspected pH1N1 cases  
(NUH) 
P 
Cutter et al. 2010 Epidemiologic  Confirmed cases of pH1N1 P 
Chan et al. 2010 Review of medical notes Adults with pH1N1 
(TTSH) 
P 
Lee et al. 2010c Sero-epidemiological Military camps P 
Yap et al. 2010 Cross-sectional survery Military personnel 
Health care workers 
P 
Seah et al. 2010 Virological  Military recruits S 
P & S- pandemic and seasonal flu; P stands for pandemic flu; S stands for seasonal flu; pH1N1- pandemic 2009 H1N1 




1.9 Purpose of Research 
          Transmission of ILIs have been historically known to occur more easily in 
relatively closed populations such as, students living on campus, in dormitories or 
military personnels in camps. Similarly, in educational institutions, such as 
schools (Gemmetto et al. 2014) and universities, individuals involved in 
disciplines that are located close together in physical location may be at higher 
risk of influenza transmission from surrounding staff or students. The table 1.9 
tabulates the studies conducted on university population with majority from USA. 
There are not many studies from SEA focusing on the university population. 
 
        University students offer an advantage for surveillance over military 
personnels as local students reflect local community epidemiology while overseas 
students studying in Singapore reflect introductions of new strains from their 
homeland whereas military personnels only interact within their localized 
community. This was evidenced in 1968, when much of the clinical and 
virological information characterizing the influenza pandemic was derived from 
the university students and staff (Kadri 1970). Since then, there has not been 








Table 1.9: Literature review of influenza research in university cohorts 
 
Author/ Year Type of study Country Influenza subtype 
Kadri 1970 Clinical Singapore A/Hong Kong/68 
H3N2 
Pons et al. 1980 Diagnostic, serological 
Outbreak study 
Maryland, USA A/USSR/77 H1N1 
Louie et al. 2005 Diagnostic San Francisco, 
USA 
All 
Aiello et al. 2010 Epidemiological, 
interventional trail 
Ann Arbor, USA pH1N1/09 
Nichol et al. 2010 Modeling, Outbreak study Minnesota, USA Seasonal influenza 
Okoror et al. 2011  Diagnostic, epidemiological, 
serological, Outbreak study 
Nigeria All 
Shafir et al. 2011 Cross sectional, seroprevalence California, USA pH1N1/09 
Guh et al. 2011 Epidemiological, Outbreak Delaware pH1N1/09 
 




Uchida et al. 2011 Survey Japan pH1N1/09 
Uchida et al. 2012; 
Uchida et al. 2014 
Epidemiological, transmission Japan pH1N1/09 





This comprehensive prospective surveillance study was conducted in a university 
cohort with following specific aims: 
 Determine the proportion of ILI caused by influenza A and B viruses and 
other respiratory viruses (Chapter 3) 
The etiology of ILI may be disproportionate in localized communities and 
may vary from that in the general community because of the differing 
social behavior and living conditions and may thus warrant specific 
control measures and prevention strategies targeted towards the causative 
agent. Therefore, there is a need of conducting surveillance for ILI in 
small, crowded and stressed institutional communities like universities in 
parallel with the surveillance in the general community.  
 Define the clinical characteristics of the study population and identity 
clinical predictors of influenza (Chapter 4) 
In current practice in Singapore, especially at the primary care level, 
diagnosis is based primarily on symptoms. Similarly, in the event of an 
influenza epidemic, case definitions are based primarily on symptoms. 
Hence, knowing whether symptoms are significant predictors of influenza 
positivity in mild cases is of clinical significance. 
 Compare the relative performances of reverse transcription PCR (RT-
PCR) and virus isolation for the detection of IAVs (Chapter 5) 
The comparison has been done previously by many researchers but there is 
limited data on comparison in context of mild cases of influenza  
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 Genetic and Antigenic characterization of the various influenza subtypes 
detected on campus and (Chapter 6 & 7)  
WHO recommends biannual vaccination for Northern and Southern 
hemisphere but in Singapore there is no such recommendation. It would be 
of interest to identify vaccine efficiency by looking for vaccine mismatch 
between circulating strains and contemporary vaccine strains to keep 
health authorities well-informed in making recommendations. 
 To investigate molecular markers of resistance to NAIs and adamantanes 
(Chapter 8) 
Limited data on drug resistance are available from Singapore from 2007 to 
early phase of pandemic 2009 (till first epidemic wave). The results may 
help fill the lacunae in the data availability for this time and may serve as 
baseline reference for the healthcare practitioners in Singapore. In current 
practice in Singapore antivirals are not prescribed routinely to ILI cases 
and reserved for patients who are at high risk of influenza complications. 
This study will help identify drug resistance pattern in treatment naïve 
patients in Singapore. 
 Understand the molecular epidemiology and phylogeography of influenza 
in localized university community by integrating molecular data and 
epidemiological data to gain insights into the transmission dynamics of 





Educational institutions have been suspected of being foci for transmission  
of influenza. It would be interesting to test the hypothesis that those living 
within hostels, being a relatively closed community with close contact, 
have a higher risk of influenza transmission by conducting appropriate 
analyses.  
 To my best knowledge, this has never been done on this scale in a localized, 















Chapter 2: Materials and Methods 
2.1 Study population and Data collection 
        The study was conducted at University Health Centre (UHC) at National 
University of Singapore (NUS). Students and staff who sought medical attention 
at UHC were approached for participation. Individuals who met the case 
definition for ILI (Campbell & Rumley 1997) participated in the study. ILI was 
defined as a respiratory illness of at least 2 days' duration with fever at 
presentation (> or = 38 ̊ C oral temperature) or history of fever with/without 
chills or myalgia and at least one of the upper respiratory tract symptoms: running 
nose, sore throat, cough, or hoarseness. Clinical information was recorded as 
discrete dichotomous variable (Yes or No). From each participant, 2 
nasopharyngeal swabs were collected and placed in Copan’s Universal Transport 
media (UTM) (Copan Diagnostics Inc., Murrieta, California). The samples were 
kept at -80˚C till processing. Basic demographic information comprising age, 
gender, nationality status identified by National Registration Identity Card (NRIC) 
status, residence address, faculty, smoking status and any ill/sick contact was also 
collected. The questionnaire used to collect data can be found in appendix III. 
       NUS Institutional Review Board (IRB) approved the study (reference 
number, 06-156; approval number, NUS-282). All the participants provided a 
written informed consent before providing samples. Students were generally aged 
between 17 and 25 and considered under NUS-IRB to be able to give consent 
without parental participation. 
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2.2 Laboratory Methods 
2.2.1 Isolation of influenza viruses in Eggs 
2.2.1.1 Checking the status of the eggs 
     The fertilized chicken eggs (Chew’s Farm, Singapore) were candled by placing 
them under a focused light source to check for the viability of the embryo. In a 
healthy embryonated egg, the veins collapse in mass towards the bottom by 
gravity in an egg held up. On the embryonated eggs to be used, the edge of the air 
sac was marked with a pencil (Szretter et al. 2006; WHO 2002). 
2.2.1.2 Inoculating eggs with clinical specimen 
       The top of each egg (2 eggs per sample) was disinfected with 70% ethanol. A 
small hole was punched in the shell over the sac. Sample was vortexed for 15 sec 
and 200μl of VTM sample was aspirated into the 1 ml syringe with a 27-guage, ½ 
inch needle. The needle was inserted through the hole of the egg and the allantoic 
cavity was inoculated. The hole was sealed with a masking tape. Subsequently, 
the eggs were placed in the incubator at 35˚ C for 3-4 days. Eggs were checked 
daily for embryo death (Szretter et al. 2006; WHO 2002).  
2.2.1.3 Harvesting inoculated eggs  
         Before harvesting, the eggs were chilled at 4˚C for at least 4 hours. The top 
of the eggs was disinfected with 70% ethanol. The shell over the air sac was 
broken with sterile forceps and scissors and the allantoic membrane was pushed 
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aside. A Pasteur pipette was used to aspirate as much of the allantoic and amniotic 
fluid as possible, and the fluid collected was dispensed into the labelled tube. The 
harvested fluids were aliquoted into labelled 5-ml Sterilin bijou bottles and stored 
at -80˚C. Harvested amniotic fluid (200 μl) was used to inoculate Madin-Darby 
Canine Kidney (MDCK) cells (American Type Culture Collection ATCC, CCL-
34, Rockville, MD, USA) that were grown on coverslips for immunofluorescence 
assays. Maintenance media comprising of Dulbecco’s Modified Eagle’s Medium 
(DMEM; Gibco BRL, Grand Island, NY, USA), L-1-tosylamido-2-phenylethyl 
chloromethyl ketone (TPCK)-Trypsin, bovine serum albumin (BSA), 100UI/ml of 
penicillin and 100 µg/ml of streptomycin was added (Cox et al. 2005). The 
infected cells were kept in the incubator at 37˚C in the presence of CO₂. The cells 
were examined daily for cytopathic effects (CPE) and were harvested after 7 days 
of infection (Szretter et al. 2006). For fixing the cells 3% paraformaldehyde was 
used. 
2.2.2 Tissue Culture and Infection 
2.2.2.1 Propagation and Maintenance of MDCK cells 
         MDCK cells were propagated and maintained using Cell Propagation 
Medium consisting of DMEM+GlutaMAX (Gibco) with 10% v/v Fetal Calf 
Serum (Gibco) and Penicillin 100 UI/ml and Streptomycin 100 µg/ml (Gibco) 
supplementation. The cells were kept in medium or large flasks (Corning, USA). 
When the cells reached 90% confluency, the cells were passaged. Briefly, the  
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cells were washed with sterile phosphate buffered saline (PBS) pH 7.2, and 
incubated in Trypsin-EDTA 0.25% (w/v) and later dislodged by tapping the flask. 
Trypsin was inactivated by adding cell propagation medium. The cells were 
directly seeded into new flasks or dishes with desired density. The cells were then 
kept in incubator at 37˚C with 5% CO2 (Szretter et al. 2006; WHO 2002). 
2.2.2.2 Plate centrifugation assay 
      In 24-well tissue culture plates, coverslips (12 mm) were placed after 
sterilizing by dipping in 70% ethanol and flaming. The wells were seeded with 
MDCK cells with a cell density of 8 x 10⁴ cells per well. When the cells were 
90% confluent, the growth medium was removed and cells were washed with 
sterile 1x PBS. Each well was inoculated with 200 μl of clinical sample and the 
plates were centrifuged (Beckman-Coulter Allegra 6R) at 700 g for 45 min at 
25˚C (LaSala et al. 2007; Mills et al. 1989; Shih et al. 1999). Maintenance media, 
as described earlier, was added. The cultures were kept in the incubator at 37˚C in 
the presence of CO₂. After 2 days, the supernatant was saved and the coverslips 
were washed with 1x PBS (Invitrogen, USA) and fixed in 3% paraformaldehyde. 
2.2.2.3 Immunofluorescent staining 
         The coverslips were permeabilized with 0.1% saponin (Sigma, USA) for 15 
min and then washed with prechilled 1x PBS. Coverslips were strained with 10-25 
µl of Mab 8257 (primary influenza A antibody against influenza A virus 
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nucleoprotein antigen; 1:100) (Chemicon USA) for 1 hour followed by staining 
with AP124F (fluorescein isothiocyanate-labeled goat anti-mouse 
immunoglobulin G; 1:100) (Chemicon USA). The coverslips were mounted using 
Dakocytomation Fluorescence Mounting Medium (DAKO) and then examined 
with a Nikon Eclipse 80i Microscope with emission of 532nm. A score ranging 
from 1+ to 3+ was given for the intensity of bright apple green fluorescent nuclei 
observed within the cells which appeared red. The slide was scored 3+ if > 80% 
of the cells showed fluorescence, 2+ if 40-80% showed fluorescence and 1+ if 5-
40% showed fluorescence and was considered negative if fluorescence was <5%. 
2.2.3 Molecular Techniques 
2.2.3.1 RNA/Total nucleic acids extraction 
         RNA extraction was done using QIAGEN RNAEasy Mini Kit (Qiagen, Inc., 
Valencia, CA, USA) or QIAamp Viral RNA mini kit (Qiagen, Inc., Valencia, CA, 
USA) and total nucleic acids were extracted using QIAamp DNA mini kit 
(Qiagen, Inc., Valencia, CA, USA) following instructions by the manufacturer. 
The RNA/total nucleic acids were eluted in 100 µl of Elution buffer. 
2.2.3.2 Multiplex end-point RT-PCR and pyrosequencing for Influenza A and B 
virus detection 
        The primers targeted influenza A and B virus matrix (M) gene for detection 
of influenza infection. This was followed by a specific probe confirmation 
employing Luminex xMAP-based assay (Luminex, Austin, TX, USA) (Inoue et 
al. 2010). Briefly, 5 μl of RNA was added to 45 μl of one-step RT-PCR enzyme 
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mix (Qiagen). Pyrosequencing of the end-products was carried out and the 
subtype of influenza A virus was determined from the DNA sequences. This work 
was kindly performed by Masafumi Inoue’s laboratory at ASTAR. 
2.2.3.3 Five-plex Real-Time TaqMan PCR for influenza A and B virus detection 
         The primers targeted influenza A and B virus M gene and pandemic 2009 
IAV (pH1N1/09), seasonal A/H1N1 (sH1N1) and A/H3N2 virus HA gene. The 
PCR was carried out on Mx 3005P instrument (Stratagene, La Jolla, CA, USA). 
Briefly, 2.5 µl RNA was added to 22.5 µl of master mix comprising of enzyme 
mixture SuperScript (SS) III RT/Platinum Taq, 2X reaction mixture (containing 
0.4 μM of each dNTP and 6 mM of MgSO4) and 7.5 μM of each primer. Reverse 
transcription (RT) (55˚C; 10 min) was followed by denaturation (95˚C; 30 sec). 
Cycling conditions for the PCR were 42 cycles of denaturation (95˚C; 17 sec), 
annealing (55˚C; 31 sec), and extension (68˚C; 32 sec). This method was a 
modification of a previously published method (Leong et al. 2010). 
2.2.3.4 Multiplex RT- PCR protocol for Adenovirus and Bocavirus detection 
Table 2.1: Primer and Probe sequences for Adenovirus and Bocavirus 
Primer/Probe 
name  
Sequence (5'  3’) Reference  
ADV AQ1 GCC ACG GTG GGG TTT CTA AAC TT (Heim et al. 2003) 
 
ADV AQ2 GCC CCA GTG GTC TTA CAT GCA 
CAT C 
BOV01.2 TAT GGC CAA GGC AAT CGT CCA AG (Maggi et al. 2007) 
 
BOV02.2 GCC GCG TGA ACA TGA GAA ACA 
GA 
ADV AP Cy5 - TGC ACC AGA CCC GGG CTC 
AGG TAC TCC GA – BHQ2 
(Heim et al. 2003) 
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BOV probe - (Propriety to DSO National 
Laboratories) 
         Total reaction volume of 20 µl comprised of 5 µl of template and 15 µl of 
PCR Mastermix which was prepared with 10 µl of 2x Supermix UDG (Life 
Technologies Platinum® Quantitative PCR (2X) SuperMix-UDG or compatible 
universal mastermix) with primers and probes listed in table 2.1. Briefly, 1 µl of 
20x ADV-BOV RP forward primer (FP) mix (0.1 µl ADV AQ2 (100 uM) and 0.1 
µl HBOV01.2 (100 uM) rest nuclease free (nf) water; 1 µl 20x AdV-BoV reverse 
primer (RP mix) (0.1 µl AdV AQ1 (100uM) and 0.1 µl HBov02.2 (100 uM); 1 µl 
20x AdV-BoV probe mix (0.04 µl AdV AQ2 (100uM) and 0.04 µl HBov01.2 
(100uM) rest nf water. PCR cycling conditions included incubation (50˚C; 2 min) 
followed by initial denaturation (95˚C; 2 min) followed by 45 cycles of 
denaturation (95˚C; 15 sec) and annealing/elongation (60˚C; 30 sec).  
        For PCR reactions from section 2.2.3.5- 2.2.3.10, one step real-time RT-PCR 
was performed using SuperScriptIII Platinum (SS III) One-step qRT-PCR reagent 
kit (Invitrogen, Carlsbad, CA), on LightCycler AB 7500 machine. Each run of 
PCR had a negative control (sterilized water) and a positive control included 
2.2.3.5 Singleplex Real-time PCR protocol for influenza A virus detection 
Table 2.2: Primer and Probe sequences for influenza A virus 













(Munster et al. 2005) 
 
       The 20 µl of reaction volume consisted of 5µl of total nucleic acids, 10 µl of 
2x SSIII buffer, 1µl of 50 mM MgSO4, primers and probes listed in table 2.2, 0.6 
µl of FluAM-144F, 0.6 µl of FluAM-238R, 0.4 µl of FluAM-184P, 0.5µl of 
SSIII/platinum Taq enzyme mix and 1.9 µl nf water. PCR cycling conditions 
included RT (50˚C; 20 min) followed by initial denaturation at (95˚C; 2 min) 
followed by 45 cycles of denaturation at (94˚C; 20 sec) and annealing/elongation 
(62˚C; 1 min). 
2.2.3.6 Multiplex Real-time PCR protocol for Coronavirus and human 
metapneumovirus detection 




Sequence (5'  3’) Reference  
CoV F1 TGGTGGCTGGGACGATATGT 
 
(Kuypers et al. 2007) 
 
CoV F2 TTTATGGTGGTTGGAATAATATGTTG 
 




(Maertzdorf et al. 2004) 
CoV R1 GGCATAGCACGATCACACTTAGG 
 
(Kuypers et al. 2007) 
 
CoV R2 GGCAAAGCTCTATCACATTTGG 
 
CoV R3 GAGGGCATAGCTCTATCACACTTAGG 
 
HMPV NL-N-R CCTATTTCTGCAGCATATTTGTAATCAG 
 
(Maertzdorf et al. 2004) 
CoV P1-probe FAM-ATAATCCCAACCCATRAG-BHQ1 
 
(Kuypers et al. 2007) 
 
CoV P2-probe FAM-ATAGTCCCATCCCATCAA-BHQ1 
 





             The 20 µl of reaction volume consisted of 5 µl of total nucleic acids, 10 µl 
of 2x SSIII buffer, 1 µl of 50 mM MgSO4, primers and probes listed in table 2.3, 
1µl of 20x FP mix (0.1µl of CoV F, 0.05 µl CoVF2, 0,05 µl of CoVF3 and 0.12 
µl of HMPV NL-N-F rest nf water), 1 µl of RP mix (0.05 µl of CoV R1, 0.05 µl 
of CoVR2, 0.05 µl of CoVR3 and 0.12 µl of HMPV NL-N-R rest nf water), 1 µl 
of probe mix (0.02 µl of CoV probe 1, 0.02 µl of CoV probe 2 and 0.07 µl of 
HMPV NL-N-probe rest nf water), 0.5 µl of SSIII/platinum Taq enzyme mix and 
0.5 µl nf water. PCR cycling conditions included RT (50˚C; 20 min) followed by 
initial denaturation (95˚C; 2 min) followed by 45 cycles of denaturation (94˚C; 15 
sec) and annealing/elongation (60˚C; 1 min). 
2.2.3.7 Multiplex Real-time PCR protocol for Rhinovirus detection 
Table 2.4: Primer and Probe sequences for Rhinovirus 
Primer/Probe 
name  
Sequence (5'  3’) Reference  
RV F1 GGTGTGAAGAGCCSCRTGTGCT 
 
(Brittain-Long et al. 2008) 
 
RV F2 GGTGTGAAGACTCGCATGTGCT 
 
RV F3 GGGTGYGAAGAGYCTANTGTGCT 
 





      The 20 µl of reaction volume consisted of 5 µl of extracted total nucleic acids, 
10 µl of 2x Superscript III buffer, 1µl 50 mM MgSO4, primers and probes listed 
in table 2.4, 1µl of 20x FP mix (0.1 µl of each of RVF1, RVF2 and RVF3 rest nf 
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water), 1 µl of 20x RP mix (0.1 µl RVR3 and rest nf water), 1 µl of RV probe mix 
(0.04 µl of RV probe and rest nf water), 0.5 µl of SSIII/platinum Taq enzyme mix 
and 0.5 µl nf water. PCR cycling conditions included RT (50˚C; 20 min) followed 
by initial denaturation (95˚C; 2 min) followed by 45 cycles of denaturation (94˚C; 
15 sec) and annealing/elongation (58˚C; 1 min).   
2.2.3.8 Multiplex Real-time PCR protocol for Parainfluenza virus detection 
Table 2.5: Primer and Probe sequences for Parainfluenza virus 









PIV2F CCA TTT ACC TAA GTG ATG 
GAA 
(Templeton et al. 2004) 
 
PIV2R CGT GGC ATA ATC TTC TTT TT 
 
PIV3F GGA GCA TTG TGT CAT CTG 
TC 
PIV3R TAG TGT GTA ATG CAG CTC 
GT 
PIV4F CCT GGA GTC CCA TCA AAA 
GT 
PIV4R GCA TCT ATA CGA ACA CCT 
GCT 




PIV2 probe Cy3 - GCT GCC AAT CGC AAA 
AGC TGT TCA GTC ACG GCA 
GC – BHQ2 
(Templeton et al. 2004) 
 
PIV3 probe Tex Red - CGC GCT ACC CAG 
TCA TAA CTT ACT CAA CAG 
CAA CAG CGC G – BHQ2 
PIV4 probe Cy5 - GCT GCC GTC TCA AAA 
TTT GTT GAT CAA GAC AAT 
ACA ATT GGC AGC – BHQ2 
 
      The 20 µl of reaction volume consisted of 5 µl of total nucleic acids, 10 µl of 
2x SSIII buffer, primers and probes listed in table 2.5, 0.3 µl of 40 µM each of 
PIV2F, PIV3F and PIV4F, 0.3 µl of 40µM each of PIV2R, PIV3R and PIV4R,  
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0.34 µl of 20 µM of each PIV2, PIV3 and PIV4 probe, 0.4 µl of 40 µM of each 
PIV1F, PIV1R and UPL 125 probe, 0.5 µl of SSIII/platinum Taq enzyme mix and 
0.5 µl nf water. PCR cycling condition included RT (50˚C; 30 min) followed by 
initial denaturation (95˚C; 5 min) followed by 45 cycles of denaturation (94˚C; 30 
sec), annealing (55˚C; 30 sec) and elongation (72˚C; 30 sec). Data acquisition was 
at annealing step.  
2.2.3.9 Singleplex Real-time PCR protocol for Enterovirus detection 
Table 2.6: Primer and Probe sequences for Enterovirus 
Primer/probe name  Sequence (5'  3’) 
 
Reference  
Kares EV FP CGG CCC CTG AAT GCG GCT AA 
 
(Kares et al. 2004) 
 
Kares EV RP GAA ACA CGG ACA CCC AAA GTA 
 
EV534 P1  
- 
(Propriety to DSO National 
Laboratories)  
EV534 P2  
- 
EV534 P3 - 
 
 
         The 20 µl of reaction volume consisted of 5 µl of total nucleic acids, 10 µl 
of 2x SS III buffer, 0.4 µl 10 mM dNTP, primers and probes listed in table 2.6, 
0.6 µl 20 mM Kares EV FP, 0.6 µl of 20 mM of Kares EV RP, 02 µl of 20 mM of 
each probe EV534P1, EV534P2 and EV534P 3, 0.5 µl of SSIII/platinum Taq 
enzyme mix and 2.3 µl nf water. PCR cycling conditions included RT (50˚C; 30 
min) followed by initial denaturation (95˚C; 2 min) followed by 45 cycles of 
denaturation (95˚C; 30 sec), annealing (55˚C; 30 sec) and elongation (72˚C; 30 
sec).   
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2.2.3.10 Multiplex Real-time PCR protocol for Respiratory Syncytial Virus A and 
B detection 
Table 2.7: Primer and Probe sequences for Respiratory Syncytial virus A and B 
Primer 
name  















RSV-B-P VIC- TTTCCCTTCCTAACCTGGACATA- BHQ1 
 
 
        The 20 µl of reaction volume consisted of 5 µl of extracted total nucleic 
acids, 10 µl of 2x Superscript III buffer, 1 µl 50 mM MgSO4, with primer and 
probe sequences listed in table 2.7 with 0.5 µl of 20 mM of each of RSV-A-F and 
RSV-B-F, 0.5 µl of each of RSV-A-R, 0.5 µl and RSV-B-R, 0.3 µl of each of 
RSV-A-P and RSV-B-P, 0.5 µl of SuperScriptIII/platinum Taq enzyme mix and 
0.5 µl nuclease free water. PCR cycling conditions included RT (50˚C; 20 min) 
followed by initial denaturation (95˚C; 2 min) followed by 45 cycles of 
denaturation at (94˚C; 15 sec) and annealing/elongation (60˚C; 1 min).  
2.2.3.11 Reverse Transcription (RT) for sequencing of Influenza A virus HA and 
NA gene segments 
        SuperScript First-Strand Synthesis System kit (Invitrogen Corporation, CA, 
USA) was used for reverse transcription.
 
8 µl of RNA was mixed with 1 µl of 
dNTP 10mM and 1 µl of Uni 12 primer (5’AGCRAAAGCAGG3’) (Hoffmann et 
al. 2001). The reaction mix was incubated at 65˚C for 5 min and later cooled on 
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ice for at least one minute. RT mix consisting of 2 µl 10x RT buffer, 4µl Mgcl2 25 
mM, 2 µl DTT 0.1 M, 1 µl RNAseOUT (Invitrogen), 1 µl of RT enzyme 
SuperScript III (Invitrogen Corporation, CA, USA) was added and the mixture 
was incubated at 50˚C for 50 min. RT enzyme inactivation at 85˚C for 5 min 
followed this step. The reaction mix was allowed to cool for 1 min on ice. 
Subsequently, 1 µl of RNAse H (Invitrogen Corporation, CA, USA) was added to 
the mix and incubated at 37˚C for 20 min. The final product was cDNA which 
was used for further reactions. 
2.2.3.12 PCR for sequencing of HA and NA gene segments of Influenza A virus 
     PCR was carried out for HA and NA amplification with protocol as described 
by (Hoffmann et al. 2001). The primers used are listed in table 2.8 (Ghedin et al. 
2005; Poddar 2002). 5 µl of cDNA template was used. The PCR mix per reaction 
(50 µl) consisted of 5 µl 10x HiFi buffer, 5 µl dNTP 2 mM, 2 µl MgSO4 50 mM, 
2 µl each forward and reverse primer, 0.5 µl HiFi Platinum Taq (Invitrogen) 
100U/µl and 29.5 µl nf water.  The PCR conditions were as follows: initial 
denaturation (95˚C; 2 min) followed by 30 cycles of denaturation (95˚C; 30 sec), 
annealing (58˚C; 30 sec) and elongation (68˚C; 5 min). The final extension was 
carried out 68˚C for 10 min, followed by cooling. 
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Table 2.8: List of primers for sequencing of surface genes of influenza A virus 
Serotype Fragment Forward Primer (5’- 3’) Reverse Primer (5’- 3’) Size 
(bp) 
Reference 




500 (Hoffmann et al. 2001; 
Ghedin et al. 2005;  






















































































2.2.3.13 Sequencing of Influenza A virus internal genes 
    The primer sequences and amplification conditions were obtained from the 
WHO Collaborating Centre for Reference and Research on Influenza 
in Melbourne (Dr. Tan Boon Huan, personal communication). 
2.2.3.14 DNA separation by Agarose Gel Electrophoresis 
        One percent Agarose gel (BioRad) in 1x TBE buffer (1
st
 Base) was used 
for DNA separation. The gel mixture was prepared in 250 ml Erlenmeyer 
flask. The agarose was heated in microwave until fully dissolved in TBE 
buffer and was subsequently cooled down. To gel mixture, 3 µl of 0.1% 
ethidium bromide (BioRad) was added and gel was poured into 8 cm gel 
casting cassette. Appropriate DNA comb was applied and the gel mixture was 
allowed to set for 1 hour. The Agarose was loaded into DNA Agarose gel tank 
PowerPak. Subsequently, samples were loaded into the wells in the agarose. 
The agarose was run at 120 V/cm for 45 min. The agaorse was viewed under 
UV transilluminator.  
2.2.3.15 Sequencing Reaction Preparation 
     For purification of the PCR products QIAquick Gel Extraction Kit (Qiagen 
Inc. Valencia, CA, USA) was used. Sequencing was performed with primers 
listed in tables 2.7 and 2.8 on ABI Prism Big Dye Terminator (Applied 
Biosystems, Foster City, CA, USA) by Ist Base, Singapore. The assembly and 
editing of raw sequence data were done using SeqMan (DNASTAR, 
Lasergene Version 7, Madison USA). 
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Chapter 3: Viral etiology of ILI on NUS campus (2007-09) 
3.1 Background 
      ILI is an umbrella term used for the illnesses caused by influenza virus and 
other respiratory viruses. Although the most common agent responsible for 
ILIs in adults is influenza virus (Yang et al. 2012; Beilei et al. 2008) other 
respiratory viruses causing ILI may present with clinical features 
indistinguishable from influenza. These viruses include rhinovirus (RV), 
enterovirus (EV), coronavirus (CoV), human metapneumovirus (HMPV), 
adenovirus (AdV), respiratory Syncytial virus (RSV), parainfluenza virus 
(PIV) and bocavirus (BoV).  
                Rhinovirus and enterovirus are both picornaviruses with RNA 
genome. Rhinoviruses are the most common causative agent of ‘common 
cold’ (Jacobs et al. 2013) and respiratory illness by Rhinovirus is more 
common than Enterovirus (Monto 2002; Kelly & Birch 2004) although 
recently there are reports of severe disease caused by EV-D68 (CDC 2014e). 
Human metapneumovirus was first detected in Dutch children with 
bronchiolitis in 2001 (Van den Hoogen et al. 2001; Falsey et al. 2003; Falsey 
2008). It is an RNA virus and belongs to family pneumovirinae. It mainly 
causes infection in children below 5 years but re-infections have been 
documented in 1-9% adults (Falsey 2008). Respiratory Syncytial virus 
infections like HMPV infection are common in children and the clinical 
presentation is also very similar to HMPV (Heikkinen et al. 2008; van den 
Hoogen et al. 2001). Two types of RSV A and B cause infections in human. 
Adenovirus and bocavirus are DNA viruses. Adenovirus infections are more 
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common in military recruits than in the civilian populations (Heo et al. 2014; 
Jeon et al. 2007; Kolavic-Gray et al. 2002; Yun et al. 2014). Bocavirus is a 
parvovirus first described in 2005 (Meriluoto et al. 2012; Kupfer et al. 2006) 
and causes respiratory disease especially in children. One of the characteristics 
of bocavirus is co-infection with other respiratory pathogens (Schildgen et al. 
2008). Parainfluenza virus is a less common cause of ILI in adults (Kelly & 
Birch 2004; Hasman et al. 2009). Coronaviruses are RNA viruses and four 
types of coronaviruses OC43, 229E, NL 63 and HKU1 are endemic in humans 
(Zaki et al. 2012). In 2002-03 Severe Acute respiratory Syndrome virus 
(SARS) and in 2012 Middle East Respiratory Syndrome virus (MERS CoV) 
were two novel coronaviruses recognized and were associated with severe 
respiratory disease (Assiri et al. 2013). 
        In this chapter, the basic demographic characteristics of study population 
and viral etiology of ILI, with focus mainly on the influenza viruses detected 
on NUS campus during the study period from 2007-2009, are presented. The 
proportion of influenza-like illnesses due to influenza infection has been well-
defined in Singapore in military settings (Seah et al. 2010; Tan et al. 2014). 
However, there has not been a similar study done in university students 
recently. Although university population and military population represents 
localized community, there are differences in the epidemiology of the two 
populations based on the different social behaviors and movement patterns and 





3.2 Materials and Methods 
3.2.1 Laboratory methods 
 The details are given in chapter2, under sections 2.3.3.2 to 2.3.3.9. 
3.2.2 Statistical analysis 





percentile calculated. Categorical variables were summarized as percentages. 
 
3.3 Results 
       Between 7 May 2007 and 15 September 2009, a total of 510 
nasopharyngeal swabs were collected. There was no sample collection in June 
2007 and July 2007 and from November 2007 to January 2007 due to 
university vacations or leave of the research assistant and from June 2008 to 
April 2009 due to administrative reasons. A total of 500 subjects' clinical data 
and demographic data were analyzed as data were missing for 10 subjects. 
 
       Basic demographic characteristics of the study population are summarized 
in table 3.1. Gender was approximately equal, 48% female (240/500) and 52% 
male (260/500). The ages of the subjects ranged from 17 years to 70 years 





Table 3.1: Demographic characteristics of study population (N=500) 
N-Number of subjects analyzed; Data in absolute numbers with percentage in bracket 
*Not included within analysis 
aLife Sciences: Medicine, Science, Nursing  
bNon-life Sciences: Engineering, Business, Computing, Design and Environment, Arts and Social Sciences 
 
            Influenza virus was the predominant agent detected during the entire 
study period on average (32.8%) that comes form 18% in 2007, 24% in 2008 
and 59% in 2009, followed closely by adenovirus. The viral etiology data for 
ILI are summarized in figure 3-1 and table 3.2. 
Age (years) 
           25% Percentile 






           Male 








           Singaporean 








           Never smoked 








           Student 
           Non-student 









           Life Sciences
a
  
           Non-life sciences
b
  









           Hostel 
           Non hostel 












Figure 3-1: Viral etiology of ILIs detected on NUS campus from 2007-2009              
Table 3.2: Viral etiology of ILI on NUS campus (2007-09)                
                                      Respiratory Viruses detected on NUS campus (N=500) 
Influenza A and B  
Influenza A virus  (IAV) 




Adenovirus (AdV) 152 (30.4%) 
Rhinovirus (RV) 53 (10.6%) 
Enterovirus (EV) 35 (7%) 
Coronavirus (CoV) 17 (3.4%) 
Respiratory Syncytial virus (RSV) 7 (1.4%) 
Parainfluenza virus (PIV) 7 (1.4%) 
Human metapneumovirus (HMPV) 5 (1%) 
Bocavirus (BoV) 0 
*Data in absolute numbers with Percentage in brackets; N-Number of samples tested 
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         Co-infections were detected in 106/500 (21%) cases and no virus was 
detected in 175/500 (35%) cases. Co-infection with three viruses was detected 
in 16 samples and of two viruses in 90 samples (Table 3.3). In dual infections, 
adenovirus was the most common agent with 56% of adenovirus infections 
having one or more viral agent detected. Adenovirus and influenza co-
infections were the most common (55), followed by adenovirus and rhinovirus 
(6) and adenovirus and enterovirus co-infections (4). In triple infections also, 
adenovirus was the most common co-infection.  
 
Table 3.3: Absolute numbers of viral co-infections               
                                      Respiratory Virus Co-infections (N=106) 
IAV+ AdV 55 
IAV+ CoV/EV/RV 3 
RV+ EV 14 
AdV+ CoV/ PIV 4 
AdV+ RV 6 
AdV+ RSV 3 
AdV+ EV 4 
AdV+ HMPV 1 
AdV+ RV+ EV 7 
IAV+ RV+ EV 3 
IAV+ AdV+ RV/CoV 4 
AdV+ RSV+ EV 1 










Figure 3-2: Bar chart representing total number of samples collected and 
number of samples positive for influenza A virus 
 
 
   Two hundred and sixty-four samples were analyzed in 2007 of which 45 
tested positive for influenza A; 85 samples were analyzed in 2008 of which 19 
tested positive for influenza A and 151 samples were analyzed in 2009 of 
which 89 tested positive for influenza A infection. The data are shown in 
figure 3-2. Two more IAVs were detected in 2007 but were excluded from 








               
 
Figure 3-3: Pie chart showing percentages of influenza A subtypes detected 
on campus from 2007-09 (at the top) and influenza subtypes detected in 2007, 




       During the entire study period the predominant subtype detected was 
pH1N1/09 comprising 47% (72/153), followed by H3N2 subtype 36% 
(55/153) and sH1N1 comprising 13% (20/153). However, for six samples the 
subtype could not be determined. The details are summarized in figure 3-3 and 
table 3.4. In 2007 and 2008, H3N2 subtype was the predominant subtype 
detected, whereas in 2009 with the emergence and efficient human-to-human 
transmission of pH1N1/09, the predominant subtype on campus was 
pH1N1/09 followed by H3N2. There was very low influenza B detection and 
subtype sH1N1 was not detected at all in 2009.   
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    Distribution of influenza was clustered across different time periods 
although there were gaps in the collection of data during the university 
vacations and due to the leave of the research assistant. The epidemiological 
curve representing the temporal distribution of total influenza, influenza types 
and subtypes is shown in figure 3-4. Influenza B was isolated more often 
within early 2007, H3N2 was noted across the entire study period, pH1N1/09 
was isolated only in the latter half of 2009 and seasonal H1N1 was detected 




Figure 3-4: Epidemiological curve showing temporal distribution of total 
influenza, influenza types and subtypes during the overall study period from 
May 2007-September 2009. IAV stands for influenza A virus and IBV for 
influenza B virus. ND are not-determined influenza subtypes. 
  
3.4 Discussion 
      Influenza surveillance is critical for influenza preparedness plans 
worldwide. ILIs due to laboratory confirmed influenza virus infections have 
been well studied within the temperate regions, but there are only a few 
studies on university students in tropical and subtropical settings (Kadri 1970). 
In Florida, USA, a cohort study was done on participants presenting to the 
university health clinic for ILIs (Mullins et al. 2011). The study was limited by 
small number of 60 participants with influenza infection confirmed in 63% of 
participants. Another study with the same number of participants was 
conducted in 2002 in temperate San Francisco (Louie et al. 2005) and  
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influenza was detected in 20% of students, which is similar to the findings in 
this study (32.8%). For IAV a 30.6% positive rate was detected. This is similar 
to the positive rate for influenza A virus of 24% found in a military study in 
Singapore (Seah et al. 2010). 
      A significant number of cases of ILI in this study were caused by viruses, 
and such information may facilitate decision of clinicians in case management 
and can prevent over-prescription of antibiotics for febrile respiratory tract 
infections. A viral agent was detected in 325/500 (65%) cases of ILI in this 
study. Another ILI study by Tan et al., on military population identified viral 
etiology in 52% cases, a rate lower than that found in this study (Tan et al. 
2014). Lekana Douki et al., identified viral etiology in 61% cases of ILI 
(Lekana-Douki et al. 2014). The other cases of ILI in which the etiology could 
not be ascertained may have been due to other viral agents not tested in this 
study, or bacterial agents or could have been due to a non-infectious cause. 
Influenza virus was detected as the most common agent responsible for ILI. 
Previous studies have identified influenza virus as the cause of ILI in 5-41% of 
cases (Kasper et al. 2011; Tan et al. 2014; Arango et al. 2014; Comach et al. 
2012; Beilei et al. 2008; Razanajatovo et al. 2011; Ahmed et al. 2012; 
Hombrouck et al. 2012; Schlaudecker et al. 2012). The wide difference in the 
rates of influenza in these studies can be attributed to the differences in the 
study populations, for example, the rate of detection of influenza has been 
lower in paediatric population than in adults, or may be due to the difference 
in the prevalence of various viral infections in different geographic regions of 
the world. In this study, the rate of detection of influenza was 33% which 
concurs with studies in other adult populations (Seah et al. 2010; Tan et al. 
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2014). A study by Seah et al., in 2009 on Singapore military recruits found 
prevalence rate of influenza to be 36% in cases of febrile respiratory illnesses 
which concurs with the rate found in this study (Seah et al. 2010). Tan et al., 
2014 found influenza virus in 40% cases of ILI in military recruits in 
Singapore which again is close to the results in this study (Tan et al. 2014). 
Surprisingly, the second most common agent of ILI identified in young adults 
in this study was AdV in 30.4% cases of ILI. This is in contrast to a very low 
detection rate of AdV of 0.4% in military recruits found in another study in 
Singapore (Seah et al. 2010) although there have been reports of emerging 
adenovirus infections (Li et al. 2014; Arango et al. 2014; Ampuero et al. 2012; 
Ahmed et al. 2012). Interestingly, a study published in 2014 and conducted in 
San Antonio on military recruits found high incidence of adenovirus (59.7%) 
(Yun et al. 2014). Historically, adenoviruses have been the most common 
cause of febrile respiratory tract infections in young adults, except during the 
adenovirus vaccine era from 1980-96 (Yun et al. 2014). Human adenovirus re-
emerged after the cessation of vaccine with numerous outbreaks in both 
military and civilian communities (Chang et al. 2008, Saat et al. 2010; Yusof 
et al. 2012; CDC 1998). New oral vaccines for AdV have been approved by 
FDA since March 2011 but only for at-risk military populations (Hoke & 
Snyder 2013). The third most common agent was rhinovirus found in 10.6% 
cases, followed by enterovirus in 7% cases. Rhinovirus and enterovirus cross 
reactivity during PCR assays- due to genetic similarity- has been previously 
reported (Lu et al. 2008; Scheltinga et al. 2005; Do et al. 2010). In this study, 
cross reactivity cannot be ruled out completely as the assays were not very 
specific and each of the assays may pick-up both enterovirus and rhinovirus 
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although at a lower sensitivity than for the virus that they were intended to be 
specific. The detection rates of CoV (3.4%), RSV (1.4%), PIV (1.4%) and 
HMPV (1%) were low. The rates of these infections were lower probably 
because these agents cause illness mainly in children; in adults the infections 
are usually mild and asymptomatic (Razanajatovo et al. 2011). PIV-1 was 
found in 1 case, PIV-2 in 5 cases and PIV-3 in 1 case, with no detection at all 
of PIV-4. Co-infection rate of 21% was detected in this study. Previous studies 
have detected co-infection in 11-47% cases (Huo et al. 2012; Drews et al. 
1997; Tanner et al. 2012; Razanajatovo et al. 2011). The differences in co-
infection rates in these studies may be due to differences in the populations 
studied. Higher co-infection rates have been reported in immunocompromised 
patients and pediatric populations (Razanajatovo et al. 2011). The clinical 
significance of co-infections has been studied in these populations with some 
studies identifying association between co-infections and increased severity of 
disease (Calvo et al. 2008; Richard et al. 2008; Yoshida et al. 2013; Goka et al. 
2013) and others finding no such association (Brouard et al 2000; Nascimento 
et al. 2010; Asner et al. 2014). Co-infections are not uncommon in 
immunocompetent adults (4-20%) but are under-reported in literature because 
these are either not investigated or single infectious agent is looked for. There 
are few studies that have investigated immunocompetent adults for presence of 
co-infections (Nissi et al. 2010; Silva et al. 2014). Co-infections in 
immunocompetent adults may not be life-threatening, nevertheless, should be 
investigated because they still increase morbidity and health care cost and lead 
to loss of productive time which is spent on the visit to health clinic. Hence 
there is an urgent need to identify all the agents responsible for ILIs in 
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immunocompetent adults, especially those living in close contact as in hostels, 
as well. In order to decrease the burden of such co-infections, vaccination 
effective against multiple agents may be proposed. Adenovirus was more 
common agent in co-infections as compared to influenza A virus. This may 
suggest that probably there was dominance of influenza A infection that was 
interfering with infection with other viral agents. It was noted that the cycle 
threshold (ct) value of adenovirus was higher (low viral load) in majority of 
co-infections with influenza A virus infection or with other viral agents which 
also suggests influenza dominance. However, the adenovirus infection needs 
to be characterized further to draw any meaningful conclusions about 
significance of these co-infections and the role of adenovirus as a pathogen. 
             Influenza pH1N1/09 was first detected in Singapore on 26 May 2009, 
and local community transmission was detected on 18 June 2009. The 
pandemic of 2009 occurred in three successive waves: the first wave of 
pH1N1/09 occurred from mid-June to August (Cutter et al. 2010), followed by 
the second wave from November 2009 to February 2010, and third wave from 
April to June 2010 (Lee et al. 2011b). In this study, samples were collected 
during the first wave. The pH1N1/09 infection remained mild in Singapore as 
was the case in other countries too.  Cutter et al., 2010 studied the outbreak of 
pH1N1/09 from May to September in community using the polyclinic 
attendance data and found that maximum number of cases occurred in week 
30 (26 July-1 August) (Cutter et al. 2010). In this study, the peak in pH1N1/09 





        This study highlights the varied viral etiology of ILI with co-circulation 
of more than one respiratory virus in one-fifth of young adults in the setting of 
university campus in tropical Singapore climate. Influenza virus and 
adenovirus were identified as the main causative agents of ILI, and in one 
third of the cases they were co-circulating in young adults in the university 
population. Co-infections are not un-common in immunocompetent adults 
presenting with influenza-like illness and hence should be screened for 
employing multiplex assays. Adenoviruses are increasingly recognized as the 
causative agent of ILI in young adults in the recent times (Lewis et al. 2009; 
CDC 2011). The study also underscores the importance of conducting 
surveillance for ILI in small, crowded and stressed institutional communities 
like universities in parallel with the surveillance in the general community. 
The etiology of ILI may be disproportionate in these semi-closed communities 
and may vary from that in the general community because of the differing 
social behavior and living conditions and may warrant specific control 
measures and prevention strategies targeted towards the causative agent. 
Furthermore, this study provides a baseline prevalence of influenza infection 







Chapter 4: Demographic and Clinical Characteristics of Study population 
4.1 Background 
        Seasonal influenza infection does not have distinctive signs/symptoms 
and therefore requires laboratory support to confirm the infection. However, 
there are situations where laboratory support is either not cost-effective as in 
mild cases, or where the patient’s illness is serious and requires immediate 
administration of medication without waiting for the laboratory report. In such 
situations, a good clinical predictor based on the clinical symptoms can help 
the clinician to decide on patient management. Moreover, the various 
influenza subtypes present with differing clinical symptoms. Determining 
clinical differences between pandemic and seasonal influenza, and amongst 
various influenza subtypes may provide critical information to guide clinicians 
in patient management, and to aid policy makers in making decisions about the 
health care interventions in times of epidemics and pandemics of influenza.  
            Influenza causes significant morbidity in young adults in Singapore. 
There are studies from Singapore (Tang et al. 2010b; Yap et al. 2012; Lee et 
al. 2011b.; Chan et al. 2010; Ong et al. 2009) and elsewhere (Cao et al. 2009; 
Lee et al. 2007; Chan et al. 2011a) that have compared the clinical differences 
between seasonal and pandemic influenza and amongst various influenza 
subtypes. However, these studies have focused on either hospitalized patients 
or military populations. Hospitalized patients usually have moderate to severe 
infections, while military populations and university populations have mild to 
moderate infections. However, the clinical characteristics of influenza may 
vary in the two populations because of the inherent differences. 
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         To this end, this surveillance study was undertaken on NUS campus. 
This chapter describes and compares the clinical and demographic 
characteristics among various influenza types and subtypes and across 
influenza negative cases in a university setting in tropical Singapore. The 
study also attempts to determine the clinical predictors of influenza infection 
and association of various demographic factors with transmission of 
influenza.  
  
4.2 Materials and Methods 
  4.2.1 Laboratory methods 
       The details are given under sections 2.2.3.1 to 2.2.3.3.  
4.2.2 Statistical Analyses 
      Data were analysed with STATA 12th Edition, to obtain confidence 
intervals and Odds ratios. Sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) were calculated using standard 
formulas. Bonferroni correction conducted to determine predictors of 
influenza with all the potential clinical and demographic risk factors for 
influenza included with either Chi-square or Fischer exact tests for comparing 
proportions and t-test/Wilcoxon rank sum test for continuous variables where 
applicable. A p value of <0.05 was considered statistically significant. For 
identification of independent risk factors predictive of influenza multivariable 
logistic regression analysis was performed with those risk factors with a 
p<0.05 (5% level of significance) in bivariate analysis. Individuals with 
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incomplete or invalid data of the variable being analysed were excluded from 
analysis.  
 
4.3 Results  
       Data for 500 subjects were analysed. Of the seven symptoms of ILI 
elicited, 5 were noted to have a significant association with laboratory 
confirmed influenza: muscle aches (OR 1.61), cough (OR 1.43), stuffy or 
runny nose (OR 1.33), chills (OR 1.51) and fever (OR 2.36). The positive and 
negative predictive values of each symptom are summarised in table 4.1.  
Table 4.1: Symptom distribution in subjects  
Symptom Number (%) OR of 
Influenza 
(95% CI) PPV NPV 
Fever 280  (56.0) 2.36 (1.74 - 3.20) 0.43 0.81 
Chills 214  (42.8) 1.51 (1.18 - 1.94) 0.4 0.73 
Aches 246  (49.2) 1.61 (1.24 - 2.09) 0.4 0.74 
Stuffy/runny 
 nose 
280  (56.0) 1.33 (1.02 - 1.73) 0.36 0.72 
Sore throat 325  (65.0) 1.26 (0.96 - 1.67) 0.35 0.72 
Cough 252  (50.4) 1.43 (1.10 - 1.84) 0.38 0.72 
Hoarseness 216  (43.2) 1.22 (0.95 - 1.57) 0.36 0.7 
OR: Odds Ratio, PPV: Positive Predictive Value, NPV Negative Predictive Value,  
In red are the statistically significant OR where the 95% CI does not include 1. 
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     Of the total of 500 subjects, 216 (44.17%) lived on-campus in hostels at 
time of presentation while 273 lived off-campus. Eleven did not provide a 
valid address or hostel location. Comparison between those living on-campus 
and off-campus was not significant (p = 0.070) for overall influenza positivity 
disregarding type or subtype. However, on-campus hostel residence was a 
significant risk factor for IAV infection (OR 1.31 [1.00 - 1.71], p = 0.043) and 
in particular for pH1N1/09 infection (OR 1.96 [1.25 - 3.08], p = 0.002). The 
results are summarised in table 4.2. 
           Of the total of 500 subjects, 400 (80.4%) were students. For 3 of the 
participants, it was not stated whether they were students or staff. Students and 
staff with ILI had similar rates of laboratory confirmed influenza positivity (p 
= 0.662). However, students had a significantly larger proportion testing 
positive for subtype pH1N1/09 (OR 4.12 [1.54 - 11.0], p = 0.001). The results 
are summarised in table 4.2 
            Subjects were also stratified according to faculties they were associated 
with based on the geographical distribution of the different schools and 
faculties on campus. The life science part of campus included Medicine, 
Science and Nursing while the Non-life science part of campus included 
Engineering, Business, Arts and Social Sciences, Design and Environment, 
and Computing. A total of 481 subjects were identified according to this 
stratification. No association was found between faculty and the influenza 
types and subtypes detected. The results are summarised in table 4.2. 
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Non-life Science campus includes Engineering, Business, Computing, Arts and Social Sciences, Design and Environment; Life Science campus includes: Nursing, Science and Medicine 
OR- Odds ratio, In red are the statistically significant OR where the 95% CI does not include 1. 
Table 4.2: Laboratory confirmed influenza positivity according to population characteristics 
Laboratory confirmed 
Positivity of: 
Influenza Influenza A Influenza A / 
Seasonal H1N1 
Influenza A / 
Pandemic H1N1 
Influenza A / H3N2 Influenza A / Not 
determined 
Influenza B 
Odds Ratio (95% CI) Odds Ratio (95% CI) Odds Ratio (95% CI) Odds Ratio (95% CI) Odds Ratio (95% CI) Odds Ratio (95% CI) Odds Ratio (95% CI) 
 Age        
        >25 years 0.900 (0.658 - 1.225) 0.841 (0.602 - 1.176) 1.103 (0.410 - 2.971) 0.247 (0.102 - 0.600) 1.892 (1.137 - 3.146) 0.662 (0.078 - 5.610) 1.892 (0.564 - 6.349) 
Gender        
        Female 0.729 (0.563 - 0.944) 0.738 (0.563 - 0.968) 0.464 (0.181 - 1.189) 0.689 (0.444 - 1.070) 0.902 (0.547 - 1.490) 1.083 (0.221 -5.316) 0.619 (0.184 - 2.088) 
Occupation        
        Student 1.075 (0.774 -1.493) 1.175 (0.821 - 1.683) 0.565 (0.223 - 1.435) 4.123 (1.542 - 11.02) 0.591 (0.345 - 1.012) - 0.424 (0.127 - 1.421) 
Nationality        
        Singaporean 0.857 (0.666 - 1.102) 0.815 (0.624 - 1.063) 1.488 (0.619 - 3.578) 0.793 (0.516 - 1.221) 0.661 (0.397 - 1.102) 0.992 (0.202 - 4.868) 1.737 (0.515 - 5.856) 
Domicile location        
        Hostel 1.264 (0.981 - 1.629) 1.316 (1.007 - 1.718) 0.583 (0.226 - 1.509) 1.966 (1.254 - 3.081) 1.053 (0.639 - 1.736) 1.263 (0.258 - 6.200) 0.722 (0.214 - 2.435) 
Symptoms        
        Fever 2.357 (1.735 - 3.202) 2.463 (1.779 - 3.410) 0.786 (0.333 - 1.854) 3.255 (1.866 - 5.677) 3.143 (1.663 - 5.941) 1.571 (0.290 - 8.501) 1.375 (0.408 - 4.637) 
        Chills 1.510 (1.176 - 1.940) 1.504 (1.155 - 1.957) 1.336 (0.566 - 3.153) 1.264 (0.825 - 1.937) 2.339 (1.390 - 3.934) 0.267 (0.315 - 2.271) 1.604 (0.496 - 5.185) 
        Muscle Aches 1.613 (1.244 - 2.093) 1.625 (1.250 - 2.164) 0.845 (0.356 - 2.003) 1.531 (0.989 - 2.370) 2.753 (1.562 - 4.854) 0.516 (0.095 - 2.793) 1.239 (0.383 - 4.007) 
        Stuffy / Runny nose 1.327 (1.020 - 1.726) 1.400 (1.059 - 1.851) 3.143 (1.066 - 9.267) 1.100 (0.713 - 1.698) 1.615 (0.946 - 2.757) 0.786 (0.160 - 3.855) 0.655 (0.202 - 2.117) 
        Sore throat 1.264 (0.956 - 1.671) 1.253 (0.935 - 1.678) 1.615 (0.597 - 4.370) 0.897 (0.578 - 1.394) 1.929 (1.045 - 3.562) 1.077 (0.199 - 5.821) 1.436 (0.386 - 5.344) 
        Cough 1.425 (1.102 - 1.843) 1.406 (1.073 - 1.842) 1.476 (0.614 - 3.549) 1.230 (0.800 - 1.892) 1.722 (1.023 - 2.899) 0.984 (0.201 - 4.829) 1.722 (0.511 - 5.810) 
        Hoarse voice 1.222 (0.952 - 1.569) 1.264 (0.972 - 1.645) 1.972 (0.821 - 4.740) 0.887 (0.573 - 1.372) 1.972 (1.185 - 3.283) 0.263 (0.031 - 2.234) 0.751 (0.223 - 2.534) 
Campus         
        Non-Life-science 0.861 (0.653 - 1.134) 0.858 (0.642 - 1.147) 1.004 (0.365 - 2.762) 0.807 (0.506 - 1.288) 0.818 (0.476 - 1.405) 1.931 (0.228 - 16.37) 0.901 (0.236 - 3.433) 
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      Study subjects were stratified according to their nationality into 
Singaporean (50.2%) and Foreigner (49.8%) groups. Nationality was used as a 
surrogate for travel history, given that the vast majority of overseas students at 
the university returned to their home countries during university vacations. No 
significant difference in influenza positivity was found between the two 
groups. The results are summarised in table 4.2 
            Of the seven symptoms elicited, influenza-positive cases were 
significantly more likely (p<0.01) to present with fever (p<0.001), chills 
(p<0.001), aches (p<0.002), running nose (p<0.009), and cough (p<0.0062), 
and less likely with sore throat (p<0.0932) and hoarseness (p<0.1168). 
Influenza negative subjects had fewer signs and symptoms. The results are 
summarized in table 4.3. 
Table 4.3: Clinical characteristics: Influenza negative vs positive cases  
Symptom Flu Negative 
(336/500) 





 95%CI  
(p value) 
Fever 157 (67.2) 123 (75) <.0001 1.87;  
1.5-2.3 
(<.0001) 
Chills  127 (37.8) 87 (53) <.0001  
Aches 146 (43.5) 100 (61) <.0002  
Stuffy/Runny 
Nose 
177 (52.7) 103 (62.9) <.0009 1.78 ;  
1.2-2.7 
 (0.005) 
Sore throat 210 (62.5) 115 (70.1) <.0932  
Cough 155 (46.1) 97 (57.2) <.0062  
Hoarseness 137 (40.8) 79 (48.2) <.1168  
In red are the statistically significant p values (<0.05).              
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        Clinical characteristics were also correlated with demographic 
characteristics to predict the characteristics with significant association with 
influenza infection. Fever, running nose and male gender (Shown in Tables 
4.3 and 4.4 in boldface) were found to have significant association with 
influenza. The results are summarized in table 4.3 and 4.4. 
 
Table 4.4: Demographic characteristics: Influenza negative vs positive cases 
Characteristic Flu Negative 
(336/500) 




Adjusted OR;  
95%CI  
(p value) 
Male 162 (48.2) 98 (59.8) 0.0153 1.49;  
1.006-2.2 (0.046) 
Singaporean 175 76 0.2285  
Student 267 133 0.6713  
Smoking 41 23 0.5656  
Ill contact 65 35 0.0471  
Non-life sciences 240 107 0.1583  
Life-sciences 86 48 0.3833  
Hostel 136 80 0.0782  
In red are the statistically significant p values (<0.05).              
 
           As seen in figure 4.1, the frequency of occurrence of all the symptoms 
except hoarseness was more in seasonal flu when compared to pH1N1/09 and 
this was statistically significant (p value <0.05). Although fever was found to 
be more common with pH1N1/09 than with seasonal flu the difference was not 
statistically significant. The results are summarized in table 4.5. 
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Table 4.5: Comparison of clinical characteristics across influenza types and subtypes  













      vs 
 other ILI 
 P value 
pH1N1/09  
    vs  
seasonal 
P value 
Fever 58 (80.6) 44 (80) 222 61 (71) 0.8875 <0.001 0.1625 
Chills  35 (48.7) 35 (63.7) 179 51 (59.3) 0.0913 0.2814 0.1785 
Aches 43 (59.8) 40 (72.8) 203 55 (64) 0.1269 0.0534 0.5838 
S/R Nose 42 (58.4) 37 (67.3) 238 58 (67.4) 0.8624 0.6629 0.2367 
Sore throat 45 (62.5) 43 (78.2) 280 66 (76.8) 0.0577 0.6315 0.0512 
Cough 40 (55.6) 35 (63.7) 212 54 (62.8) 0.3593 0.3454 0.3565 
Hoarseness 29 (40.3) 33 (60) 187 49 (57) 0.0276 0.5270 0.0365 
 
 
*Data in absolute numbers with percentage in bracket   S/R- Stuffy/Runny 




Data presented in percentage 
Figure 4-1: Distribution of various clinical symptoms across influenza types, 
subtypes and influenza negatives 
 
4.4 Discussion 
     Transmission of influenza is humans is multifactorial with both viral and 
human factors playing a critical role. The important human factors include 
host immune response and human social behaviour. Kucharski et al., using a 
modelling approach, found strong evidence that age and social behaviour have 
a strong influence on acquisition of infection, and the effect was more 
pronounced when social mixing occurred among the peers of same age group 
63 
 
rather than with personal reported contacts (Kucharski et al. 2014). 
Universities provide a good opportunity to study the effects of human 
behaviour and spatial mixing on the transmission of influenza. The effect of 
mixing events on the dynamics of pH1N1/09 outbreaks at small residential 
colleges was studied by Palin et al., 2012 who found that the disruptions to 
campus rhythms due to vaccine clinics may be a potential cause of pH1N1/09 
spread (Palin & Greer 2012). Holmes et al., conducted a molecular 
epidemiology study in San Diego University population to determine the 
spatial spread of pH1N1/09 virus and found that the influenza virus was able 
to spread easily on campus (Holmes et al. 2011). However, in their study there 
was lack of clustering by university residence. 
            Overall, influenza was found to be significantly more common in 
students living on-campus within hostels especially for the pH1N1/09 subtype. 
This does bear out the hypothesis that influenza will be higher in close contact 
areas like hostels especially for novel strains of influenza. In many temperate 
countries, meningococcal vaccination is recommended for students living in 
dormitories on-campus as a preventive measure against infections that spread 
easily in close contact within closed communities such as hostels. Influenza is 
one such pathogen. In Singapore, only high risk groups, have definite 
recommendations for influenza vaccination. Perhaps even in tropical 
countries, influenza vaccination should be recommended for students living 
on-campus in hostels in close contact as influenza can spread even amongst 
healthy young adults in such close proximity. The vaccination history was not 
recorded in this study and it was assumed that the students and staff were not 
vaccinated against influenza.  
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          There was no significant difference in laboratory confirmed influenza 
between the life-sciences and the other faculties, suggesting that physical 
location of classes may not be an important factor for on-campus transmission. 
This may be due to the high movement and mixing of students and staff across 
faculties at closed ventilation areas such as libraries, canteens, sports facilities 
and lecture halls. 
           Being a student as compared to being a staff or faculty member 
appeared to be a risk factor only for the pH1N1/09 subtype, however, the 
sample size for these two categories was significantly different and the 
comparison may not be that justifiable. The proportions of infected students 
and non-students were not significantly different for other types and subtypes 
of influenza virus infections. This could be due to older staff members having 
some degree of immunity to the pH1N1/09 strain or perhaps to a higher degree 
of close contact among students compared to staff when the pH1N1/09 
emerged. There were smaller numbers of seasonal H1N1 and influenza B 
viruses detected in the university cohort which may have led to missing an 
association for these types and subtypes. 
               Certain clinical symptoms were identified as being more commonly 
associated with laboratory confirmed influenza: fever, chills, aches and cough. 
These are commonly used in case definitions of ILI (Govaert et al. 1998; 
Falcão et al. 1998; Aguilera et al. 2003). A previous clinical diagnostic model 
study found fever, running nose, cough and chills to be predictive of influenza 
which is similar to the results of this study (Lee et al. 2011b). In this study, no 
significant difference in having sore throat and hoarseness of voice was 
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detected whether one had confirmed influenza or other ILIs as found 
previously (Lee et al. 2011b).  In current practice in Singapore, especially at 
the primary care level, diagnosis is based primarily on symptoms. Similarly, in 
the event of an influenza epidemic, case definitions are based primarily on 
symptoms. Hence, knowing whether symptoms are significant predictors of 
influenza positivity is of clinical significance.        
      However, for pH1N1/09, only fever was identified as being significant in 
distinguishing influenza from other ILI. This highlights the importance of a 
high index of suspicion for influenza diagnosis clinically even for those with 
relatively atypical presentations. The various studies on pH1N1/09 influenza 
are summarized in table 4.6. 










Tang et al. 2010b 
Singapore 
 
79.3 88.1 53.7 49.9 ND ND ND 
Otera et al. 2011 
Japan  
 
100 100 81.3 81.3 43.8 ND ND 
Dawood et al. 2009 
USA  
 
94 92 66 ND ND ND ND 
Cao et al. 2009  
China  
 
67.4 69.5 ND 76 ND ND ND 
Heininger et al. 2013 
Switzerland 
 
87 78 67 ND ND ND ND 
Ong et al. 2009  
Singapore 
 
88 80 51 60 40 ND ND 
Chowell et al. 2012 
 Mexico  
 
80.4 92.8 57.3 69.9 73.3 66.1 ND 
Chan et al. 2011a 
USA  
 




80.6 55.6 62.5 58.4 59.8 48.7 40.3 
Data in percentage; ND= No Data     
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  No significant difference was observed in symptomatology of seasonal and 
pandemic flu which is agreeable with previous studies (Chan et al. 2010; Chan 
et al. 2011b) except for hoarseness which was associated more with H3N2 
subtype. This suggests that hoarseness was predictive of H3N2 subtype 
infection. Summary of various studies comparing clinical features across 
pH1N1/09 and seasonal influenza is presented in table 4.7. 
Table 4.7: Summary of studies comparing clinical characteristics: Pandemic 
vs Seasonal influenza 
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         Fever, running nose and male gender were independent risk factors for 
acquiring influenza and are hence predictive of influenza. This suggests that a 
male presenting with fever and running nose is likely to be suffering from 
influenza. More influenza was detected in males than females and in 
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engineering faculty than science faculty. This could probably be due to more 
males than females in engineering faculty (2:1). Male gender has been 
identified as independent risk factor by other studies (Cao et al. 2009) and 
fever was highly predictive of influenza in another study (Ong et al. 
2009).Previous studies have classified influenza into mild, moderate and 
severe (Siau et al. 2011), however, in this study such a classification was not 
relevant as majority of the cases were mild.  
               This study has some important limitations. Data collected were from 
a single university, so making generalization to the other similar institutions 
would be difficult although the NUS does have a very high proportion of 
students from the region compared with most institutions worldwide. 
Additionally, the study also did not include students or staff who were 
clinically asymptomatic but may have been positive for influenza. 
Additionally, the study also did not take into account individuals who did not 
seek medical treatment or sought treatment outside of the UHC although 
anecdotally, the majority of ill staff and students do seek medical attention at 
the UHC. 
 Sample collection was also affected by the university academic 
calendar. The majority of the samples were obtained during term periods, 
while few or no samples were obtained during university vacation periods. 
This was possibly due to a much smaller population on-campus and thus 
smaller numbers seeking medical attention at the university health centre. 
 Sample sizes for type IBV and subtypes H3N2, sH1N1 and those with 
subtypes not-determined were also small, making any subgroup analyses for 
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these subtypes and strains difficult. Nevertheless, this study provides baseline 
influenza surveillance data in young adults in a university in a tropical region. 
 
 4.5 Conclusions 
         This study highlights the importance of a high index of suspicion for 
influenza diagnosis clinically even for those with relatively atypical 
presentations and the inadequacy of clinical diagnosis of influenza based on 
symptoms alone. Furthermore, those with seasonal influenza A infection, and 
more specifically H3N2 infection, were more likely to present with 
hoarseness. Being a male and presenting with fever and running nose was 
likely to be predictive of influenza infection. The data suggests that influenza 
was the most common and also the most symptomatic of all the viral illnesses 
amongst the university cohort. Influenza is present all-year round in Singapore 
and the fact that influenza is one of the vaccine preventable illnesses provides 
a strong argument for recommending influenza vaccination for students living 
in close contact in hostels in whom high concentration of laboratory-
confirmed influenza was identified. Influenza vaccination has been 
recommended in healthy adults from the pharmacoeconomic point of view for 
both seasonal (Postma et al. 2002) and pandemic H1N109 influenza (Sander et 
al. 2009). Additionally, it has been found that high influenza vaccination 
coverage contributed to significant reduction in influenza cases (Silva et al. 
2014). Dr. Wong advocated for the annual influenza vaccination of those 
above 6 months by extrapolating the US CDC data on the reduction in 
outpatient attendances and hospitalizations after annual influenza vaccination 
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of those above 6 months (Wong 2014). The vaccination may help in reducing 
the number of cases of influenza and hence transmission of influenza among 
the students who live in close contact in the hostels. In a high income country 
like Singapore, vaccine availability should not be an issue. Therefore, it would 
be worth to vaccinate the healthy adults and evaluate the cost-effectiveness 
and the percentage of coverage and lastly the vaccine effectiveness. Given the 
diverse student body, the universities can also act as a sentinel site for 
surveillance and control of influenza in large tropical institutions. This may be 















Chapter 5: Comparison of Molecular methods and culture methods  
5.1 Background 
        The clinical features may not be able to establish accurate diagnosis of 
influenza in cases of atypical presentations as shown in the previous chapter. 
Additionally, the clinical features of influenza are not very specific and many 
other respiratory pathogens  can present with signs and symptoms that are 
indistinguishable from influenza (Gavin & Thomson 2003; Petric et al. 2006). 
Therefore, laboratory support is required to establish a diagnosis of influenza. 
Accurate laboratory diagnosis is invaluable in clinical management and in 
implementation of prevention and control strategies (Dwyer et al. 2006; 
Nicholson et al. 2003). 
        Traditional methods for influenza diagnosis include cultivating influenza 
viruses in embryonated chicken’s eggs or cell cultures but these require cell 
culture facility (Landry 2011) and a longer time to establish diagnosis 
(Leonardi et al. 2010; Cheng et al. 2010), making clinical management 
impractical (Wang & Taubenberger 2010). Nevertheless, it amplifies the virus 
which can be used in vaccine production, in monitoring antigenic change and 
for research purposes such as in studying viral replication kinetics. However, 
cell culture techniques have replaced egg isolation in virtually all clinical 
laboratories (Nicholson et al. 2003). Rapid cultures such as MDCK (R-mix 
Too) provide shorter turn-around times (Landry 2011). 
          Rapid influenza antigen detection tests (RIDTs) also known as ‘point-
of-care tests’ are based on the principle of detection of viral proteins by 
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specific antibodies. These have shorter turn-around time but are less sensitive 
than other diagnostic methods and false-positive rates are higher.  
         Molecular assays are valuable tools for the rapid detection, typing, and 
subtyping of influenza viruses (Eggers et al. 2012). RT-PCR is the most 
commonly used molecular amplification method for RNA viruses. The 
superiority of molecular assays over conventional methods for diagnosis of 
respiratory viral infections in various populations is well-established (Mahony 
2008; Nolte 2008;
.
 Petric et al. 2006; Schweiger et al. 2000).  
             In this chapter, comparison of the relative performance of reverse 
transcription-PCR (RT-PCR) and viral isolation for the detection of seasonal 
and pandemic IAVs in mild cases of influenza in the localized university 
community is presented. There are not many studies of their comparison in 
mild cases as in this study.  
 
5.2 Materials and Methods 
    5.2.1 Laboratory methods 
      For detection of influenza viruses, two molecular assays and two different 
culture methods were used. The molecular assays were a) End-point RT-PCR 
with pyrosequencing and b) Multiplex RT-PCR. The details of the methods 
are given in materials and methods chapter under sections 2.3.3.2 and 2.3.3.3. 
The culture methods were a) Conventional egg isolation and b) plate 
centrifugation assay described in chapter two under section 2.3.1 and 2.3.2.  
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5.2.2 Determination of influenza A virus infection  
        Samples which tested positive by either of the two methods- RT-PCR or 
viral isolation- were regarded as true positive for IAV infection and this was 
considered the gold standard. Only RT-PCR was used for testing of IBV. 
5.2.3 Statistical analyses 
         Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were calculated using standard formulas (Clinical 
Calculator 1 (accessed at http://faculty.vassar.edu/lowry/clin1.html). The 
validity values are reported with 95% confidence level (CI). Proportions were 
compared using Chi Square or Fisher’s exact test as appropriate. A p-value of 
< 0.05 was considered statistically significant. 
 
5.3 Results 
        Between 7 May 2007 and 15 September 2009, a total of 510 
nasopharyngeal swabs were collected. However, only 502 swabs were tested 
for influenza. Eight of the samples were not transported under appropriate 
temperature conditions so were not tested. Figure 5.1 shows the 
epidemiological curve describing IAV infection detected employing RT-PCR 
and viral isolation techniques during the study period. The peak in influenza A 
infection was observed in May in 2007, in April in 2008 and in early August 
in 2009. May is the examination season in NUS and students are considered 
more prone to infections probably because the examination stress lowers the 
immunity. In 2009, the peak shifted to July-August due to emergence of the 
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pH1N1/09 virus and the data concur with MOH data (Cutter et al. 2010). 
There was a steep increase in influenza A positivity in 2009 (p < 0.05) when 
compared to 2007 and 2008 also because of the H1N1 2009 pandemic.  
 
Figure 5-1: Epidemiological curve showing influenza cases positive by RT-
PCR and viral isolation methods 
 
    Table 5.1: Number (percentage) of samples positive for influenza A virus 
infection detected employing RT-PCR and viral isolation methods during the 
surveillance period (May 2007- September 2009).  
 
Diagnostic 
method                                                                                                     
   
  2007 [
1
N= 266]                 2008 [
1










                 












Viral isolation  
 
1N is the total number of samples collected; Data as absolute numbers with percentage in bracket 
 
        The percentages of samples positive for IAV were 18% in 2007, 24% in 
2008 and 59% in 2009 (Table 5.1). The predominant IAV subtype was H3N2 
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in 2007 (55%) and 2008 (100%), but was pH1N1/09 (81%) in 2009 (Figure 
5.2); this concurs with the national surveillance data published by the Ministry 
of Health, Singapore (MOH 2010a). However, there were 6 samples with no 
influenza A subtyping probably due to low viral load in these samples and 
these are reflected as not-determined in Figure 5.2. 
 
Figure 5-2: Frequency of influenza A subtypes during the study period 
detected using reverse-transcription polymerase chain reaction (RT-PCR). 
 
        In 2007, 18% (47/266) of samples tested positive for the presence of IAV 
and 3% (9/266) for IBV. Eighteen percent of the samples were positive for 
IAV by RT-PCR, and 8% by conventional viral isolation in eggs (Table 5.1).  
In this study, 25 out of 47 samples detected by RT-PCR were not detected by 
conventional viral isolation but all samples positive by viral isolation were 
also positive by RT-PCR. However, when these 25 samples were tested with 
plate centrifugation assay, additional 6 positives were detected. This may 
probably be because the low-speed centrifugation step in plate assay causes a 
low level of damage to the surface of the cells, thus increasing infectivity by 
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facilitating virus entry into the cells and decreasing the time necessary for 
infection (Jayakaerthi et al. 2006). 
         In 2008 similar techniques for RT-PCR and viral isolation were 
employed as in 2007 and the influenza was exclusively seasonal influenza.  In 
2008, overall, 24% (19/85) of samples tested positive for the presence of IAV, 
and only one sample out of 85 tested positive for IBV. Twenty-four percent of 
the samples were positive for IAV by RT-PCR and 2% by viral isolation 
method (Table 5.1).  In this study, 17 out of 19 samples detected by RT-PCR 
were not detected by viral isolation in eggs, but all samples positive by viral 
isolation were also positive by RT-PCR. Although PCR was found to be more 
sensitive than egg isolation, it is worth mentioning that egg isolation detects 
live virus, whereas PCR detects dead or non-viable virus as well. Furthermore, 
diagnosis by egg isolation is dependent on the skills/expertise of the performer 
and also on the quality of the specimen, whereas it is not that critical in case of 
PCR. 
          In 2009, using diagnostics different from previous seasons, overall 59% 
(89/151) of samples tested positive for the presence of IAV, and only one out 
of 151 tested positive for IBV. Fifty-nine percent of the samples were positive 
for IAV by RT-PCR and 32% by plate centrifugation method (Table 5.1).  In 
this study, 41 out of 89 samples detected by RT-PCR were not detected by 
plate centrifugation assay, but all samples positive by plate centrifugation 
assay were also positive by RT-PCR. In 2009, 72/89 influenza positive cases 
were of pH1N1/09 subtype, 12/89 were H3N2 subtype, 5 were indeterminate, 
and one was influenza B.  Seasonal influenza A/H1N1 was not detected at all 
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in 2009. Out of 72 RT-PCR positive pH1N1/09 cases, 48 were positive by 
plate centrifugation assay. This gave a sensitivity of 67% (95% CI between 54 
and 77) for plate centrifugation assay against sensitivity of 100% for RT-PCR 
and a sensitivity difference of 33% for pandemic influenza 2009. On the other 
hand, out of 12 RT-PCR positive A/H3N2 cases, none was positive by plate 
centrifugation assay. Hence, the sensitivity difference between seasonal and 
pandemic 2009 influenza came was statistically significant (p value <0.05). 
       Of the total 155 influenza positive samples, 78 were positive by combined 
viral isolation methods. The overall sensitivity for combined RT-PCR assays 
was 100% (95% Confidence Interval; CI, 96-100%) and for combined viral 
isolation techniques was 50% (95% CI, 42-58%). The sensitivity difference 
between combined RT-PCR methods and combined viral isolation methods 
was 50%. The specificity and positive predictive value for each of the methods 
was 100%. The negative predictive value for PCR and viral isolation method 
was 100% and 38% respectively. However, it is worth mentioning that the 
PCR was 100% sensitive based on the criteria used in the study that a sample 
will be considered positive if detected by either or both PCR and culture. None 
of the PCR negative sample was culture positive which brought the sensitivity 
to 100% based on the criteria used in this study. However, it is possible that 
some of the influenza strains might have been PCR negative due to either very 
low viral load or due to mutations in the primer region and so were missed and 
the sensitivity may have been missed. The sensitivity of PCR and viral 
isolation for 2007 were 100% and 60% respectively (exclusively seasonal 
influenza) and for 2008 were 100% and 10% (exclusively seasonal influenza) 
while for 2009 were 100% and 54% (both seasonal and pandemic 2009 
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combined) (Table 5.2). The sensitivity difference between combined RT-PCR 
methods and combined viral isolation methods for detection of seasonal IAV 
was 61%. 
Table 5.2: Sensitivity of molecular and viral isolation methods for detection 
of influenza A virus infection during the period of surveillance and the 
methods employed. 
 
Year Sensitivity for  molecular 
 methods 
(95% confidence interval) 
Sensitivity for  viral 
isolation 
(95% confidence interval) 
2007 100% (91-100)
 1










 54 % (43-43)
 4
 
1RT-PCR with pyrosequencing                  2Multiplex Real-Time TaqMan PCR 
3Conventional viral isolation                      4Plate centrifugation assay      
   
       The two types of viral isolation methods: conventional viral isolation 
(used for isolation of seasonal influenza) and plate centrifugation assay (used 
for isolation of both seasonal influenza detected in 2009 and pandemic 2009) 
were also compared against each other. The sensitivity of conventional viral 
isolation was 35% and of plate centrifugation assay was 47% (Table 5.3).  
Table 5.3: Comparison of sensitivity of conventional viral isolation and plate 
centrifugation assay 




          The association between cycle threshold (ct) values and successful or 
unsuccessful isolation in the cell culture was also investigated for seasonal and 
pH1N1/09. Samples with ct >34 did not yield a successful isolation whereas 
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those with ct value <26 gave 100% successful isolation and those with ct value 
ranging from 26-34 gave 76% successful viral isolation. The results are 
presented in table 5.4. However, no such association was found for seasonal 
influenza isolates probably due to lower isolation rate. 
 





      In general, molecular-based methods performed superior to viral isolation 
methods. The lower sensitivity of viral isolation may have been due to 
suboptimal sampling, inactivation of virus during transportation to laboratory
 
(Smith et al. 2003) or samples with low titre. RT-PCR has previously been 
shown to be a more sensitive method than viral isolation for the detection of 
seasonal influenza
 
(Reina et al. 2010; Cheng et al. 2010; Liao et al. 2009) as 
well as pandemic influenza infection (Roa et al. 2011).  
           The overall sensitivity difference for IAV detection using RT-PCR 
versus viral isolation was 50%. For total seasonal influenza A, the sensitivity 
differential was 61%, whereas for pandemic influenza A 2009 was 33%. This 
shows that RT-PCR was superior to viral isolation techniques in detecting both 
seasonal and pandemic 2009 influenza A infection in mild cases of influenza. 
ct value                 PCR positive pH1N12009 (72) 
Culture positive (48)                        Culture negative (24) 
<26 9 0 
26-<31 27 1 
31-34 12 5 
>34 0 18 
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For seasonal influenza, predominantly egg isolation was used, and for 
pandemic 2009 influenza, plate centrifugation assay was used and this may 
limit the sensitivity comparison.  
         Previous studies have reported that viral isolation techniques may not be 
able to diagnose seasonal influenza in 3-46% cases (Weinberg et al. 2004; 
Magnard et al. 1999; van Elden et al. 2001; Li et al. 2011; Gharabaghi et al. 
2008; Boivin et al. 2001; Roa et al. 2011). A difference of 17-44% for 
seasonal influenza A and B viruses (Liao et al. 2009; Pérez-Ruiz et al. 2007), 
and a sensitivity difference of 14-43% for detection of seasonal IAV has been 
reported (Zitterkopf et al. 2006; Hindiyeh et al. 2005; Louie et al. 2005). 
Previous studies on patients with longer illness duration of >4 days with 
seasonal influenza A and B showed wider sensitivity gap of 63% between RT-
PCR and virus culture (Lee et al. 2009b). In this study, a slightly wider 
sensitivity gap of 61% for seasonal IAV was found probably because of the 
difficulty encountered in culturing the seasonal strains. This may be 
attributable to variable replication capacity of each strain of IAV during viral 
isolation. RT-PCR on the other hand is not much affected by such variations in 
growth characteristics. Additionally, the viral loads of seasonal IAVs were 
generally found to be lower than the pandemic IAV which may have 
accounted for the sensitivity difference. Moreover, seasonal IAV was more 
readily detected by RT-PCR than viral isolation methods in this study.  
        A sensitivity difference of 4% has been reported for detection of 
pandemic IAV where the samples were collected early during the illness and a 
difference of 33% for samples collected >4 days after illness onset (Lee et al. 
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2009b). Roa et al., reported a sensitivity difference of 31% in hospitalized 
patients for the detection of pandemic influenza A virus (Roa et al. 2011). The 
reasons stated for wider sensitivity difference in their study were that the 
patients were under treatment, processing of samples was delayed or the 
samples were collected late in the illness. In this study a sensitivity gap of 33% 
for pH1N1/09 IAV was found which concurs with their study.
 
However, the 
majority of cases in this study were tested early in their illness and the 
participants were not under treatment. Also, the study was done in a health 
centre where only mild cases were reported.  
        In 2007 and 2008, viral isolation was done employing conventional 
methods but later method was revised to a plate centrifugation assay for 2009 
samples. Plate centrifugation assay indeed performed better (sensitivity 47%) 
than conventional viral isolation in detecting influenza A infection with 
shorter turn-around time of 2 days compared to 7 days by conventional culture 
(sensitivity 35%). The low-speed centrifugation in plate assay increases 
infectivity and decreases time to results by facilitating virus attachment and 
entry into the susceptible cells (Jayakaerthi et al. 2006). For 2007 and 2008 
samples, pyrosequencing was employed for subtyping but later with technical 
developments, a five-plex Taq Man probe-based assay was employed for the 
simultaneous detection and subtyping of IAV. The multiplex probe-based 
assay did indeed turn out to be more sensitive than pyrosequencing. Samples 
from healthy university population were not obtained, and that may limit the 
assessment of specificity which can thus be confined only to the population 
with ILI. Although employing different methodologies for seasonal influenza 
and pandemic influenza does not allow a fair comparison, nevertheless it was 
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observed that pandemic 2009 H1N1 was easier to culture than the seasonal 
influenza virus. 
          Additionally, an inverse relationship between ct value and successful 
viral isolation in case of pH1N1/09 viruses has been found in other studies 
(Corzo et al. 2013). Although the results confirm that molecular-based 
methods have more diagnostic value than viral isolation for surveillance 
purposes in university population, they should not completely replace viral 
isolation. Viral isolation provides an isolate of viable/live virus instead of a 
mixture of live and dead virus by PCR that can be further characterized for 
purposes, such as, vaccine development, for epidemiological studies of 
seroprevalence e.g. neutralization test, to study replication kinetics of viruses 
and can be stored for future studies.  
 
 5.5 Conclusions 
           RT-PCR was superior to viral isolation techniques in detecting both 
seasonal and pandemic influenza A infection. Additionally, seasonal influenza 
A was more readily detected by molecular-based than viral isolation methods 
as compared with pandemic influenza A infection. This further suggests that 
sentinel surveillance should make use of molecular-based methods for 
detection of emerging and re-emerging influenza viral threats. Nevertheless, 
PCR should not completely replace viral isolation, instead viral isolation 




Chapter 6: Genetic and Antigenic Characterization of full genome of 
seasonal and pandemic 2009 influenza viruses circulating on campus 
6.1 Background:  
      Influenza viruses possess formidable capacity to modify their genetic 
make-up and keep evolving by circumventing human immune defences. It has 
been shown that an infected individual may harbour many diverse variants of 
influenza virus known as quasispecies (Lauring & Andino 2010). SEA has 
been proposed (Russell et al. 2008) as the source of new epidemic strains that 
are seeded later into temperate regions of the world, responsible for the role of 
source in the so called ‘source sink model’ (Rambaut et al. 2008; Nelson et al. 
2007). There are two hypothesis regarding the origin of epidemic influenza 
strains. According to one,  tropical regions are the source of these epidemic 
strains and there is viral persistence after the epidemic (Rambaut et al. 2008; 
Russell et al. 2008). According to the other hypothesis, a variety of geographic 
regions may serve as potential sources of epidemic strains and there is not 
much viral persistence after the epidemic in the temperate regions. The 
migration of virus between the hemispheres is required for the continuous 
circulation of influenza viruses which drives the global transmission of 
influenza viruses (Bedford et al. 2010; Cheng et al. 2013; Bahl et al. 2011).  
         While there is availability of data from the temperate regions, the data 
from tropical regions is limited and the role played by tropics in the 
epidemiology of influenza still remains uncertain. However, the dynamics of 
tropical and temperate regions are interlinked. Therefore, influenza viral 
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genome data from the tropics are critical in understanding viral origin and 
migration.        
         Genetically diverse influenza viruses have incessantly infected humans 
since the pandemic of 1918 by subtype H1N1. The world has witnessed three 
more pandemics since then in the years 1957 (H2N2 subtype), 1968 (H3N2 
subtype) and recently in 2009 (H1N1 subtype). In the periods between the 
pandemics, the pandemic strains have circulated in humans in the form of 
seasonal strains. Two subtypes of IAVs H3N2 and H1N1 are currently co-
circulating in humans since 1977.  
          Whole genome approach to study molecular evolution of IAVs provides 
a comprehensive understanding of the emergence of new antigenic variants 
which again is critical for the composition of influenza vaccines. In this 
chapter, the data on genetic characterization of full genomes of seasonal 
A/H1N1 and A/H3N2 viruses detected during 2007-08 and pH1N1/09 viruses 
detected during the early pandemic period in 2009 are presented. This whole 
genome analysis of seasonal and pandemic 2009 influenza viruses, to my 
knowledge, represents the first attempt to investigate the spatio-temporal 
dynamics of IAV in a semi-closed setting of a university in tropical Singapore. 
The aim of the phylogenetic and antigenic analysis was to determine the 
lineage of the virus, relationship with the vaccine and reference strains and for 
emergence of any potential virulence markers. The lineage grouping sheds 
light on reassortment and spreading pattern of the virus whereas the antigenic 
analysis helps to identify antigenic variants. 
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6.2 Material and Methods 
6.2.1 Sample selection 
       For sequencing whole genome, viruses with Cycle threshold (ct) value of 
more than 34 were excluded as the quantity of RNA was insufficient.  
6.2.2 Laboratory methods 
       Detailed methods for sequencing are described in section 2.3.311-2.3.315. 
6.2.3 Phylogenetic analysis 
         Nucleotide sequences of all the genes were compared with WHO vaccine 
strains, reference strains  and with other published 2007 sequences retrieved 
from GenBank (http://www-ncbi-nlm-nih-
gov.libproxy1.nus.edu.sg/genomes/FLU/FLU.html) using Megalign 
(DNASTAR, Lasergene Version 7) by the Clustal W algorithm. For H3N2 
subtype A/Wisconsin/67/2005 and A/Brisbane/10/2007 and for seasonal H1N1 
subtype (sH1N1), A/New Caledonia/20/1999, A/Solomon Islands/3/2006 and 
A/Brisbane/59/2007 were used, and for pandemic 2009 (pH1N1/09) virus 
A/California7/2009 was used. Analyses were also conducted with 
representative global strains with one strain randomly selected from each week 
from May to September 2007 from the GenBank isolates. Percent (%) 
nucleotide (nt) and amino acid (aa) identities were calculated for each gene. 
Phylogenetic trees were constructed using the Neighbor-Joining method. Boot 
strap analysis with 500 replicates was conducted. The trees were drawn to 
scale, with branch lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. The evolutionary distances were 
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computed using the Maximum Composite Likelihood method and were in the 
units of the number of base substitutions per site. Evolutionary analyses were 
conducted in MEGA 6 (Tamura et al. 2013). Phylogenetic trees were viewed 
with TreeExplorer (v2.12, http://evolgen.biol.metro-u.ac.jp/TE/TE_man.html). 
6.2.4 Determination of the closest vaccine reference  
         Flusurver research tool available at website URL (http://flusurver.bii.a-
star.edu.sg) was used to determine the closest reference vaccine strain. It also 
provided the list and frequency of mutations in the study sequences with 
reference to the vaccine virus. 
6.2.5 Determination of lineage  
          Protein sequences were examined for clade-specific/cluster-specific aa 
changes with reference to World Health Organization (WHO) clade 
classification as shown in tables 6.1-6.5. 
Table 6.1: Clade-specific amino acid changes in HA of H3N2 viruses (WHO 
2008) 
Clade Representative strain     aa changes in HA1 of representative strains 
A
1
















1Relative to A/Wisconsin/67/05   aa=amino acid     HA-Hemagglutinin 
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Table 6.2: Clade-specific amino acid changes in NA of H3N2 viruses (WHO 
2008) 



















1Relative to A/Wisconsin/67/2005       aa=amino acid        NA-Neuraminidase 
 
Table 6.3: Clade-specific amino acid changes in HA of sH1N1 viruses (WHO 
2008) 
Clade Representative strain aa change in HA of representative strain 
1



































Table 6.4: Clade-specific amino acid changes in NA of sH1N1 viruses (WHO 
2008) 
Clade Representative strain aa change in NA of representative strain 
1










































1Relative to A/New Caledonia/20/99, including common differences:  NA, V48I; 05   aa=amino acid 
NA- Neuraminidase 
 
Table 6.5: Cluster-specific changes in six gene segments of pH1N1/09 virus 
(Fereidouni et al. 2009) 
Cluster HA 


























1.3 T (S) T (L) G (D) G (Q) G (A) A (I) A (A) A (I) G (K) 
2 A (T) T (L) G (D) A (Q) A (A) A (I) A (A) G (V) A (K) 
Nucleotide position and amino acid position (in bracket) are counted from the start codon; HA-Hemagglutinin, NA-
Neuraminidase, MP-Matrix, NS-Non-structural, NP-Nucleoprotein, PB-2-Polymerase Basic Protein-2 
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6.2.6 Detection of amino acid variations in epitopes of HA1 
           In H3N2 subtype HA0 is cleaved into HA1 (1-328) and HA2 (330-550) 
(Skehel & Wiley 2000) excluding the 16 aa signal peptide. The ectodomain of 
HA is composed of the globular head (58-272 of HA1) and fibrous stem (1-57 
and 273-328 of HA1 and 330-514 of HA2) (Skehel et al. 1982; Sriwilaijaroen 
& Suzuki 2012). The ectodomain of HA in H3N2 subtype bears the 5 epitopes 
A, B, C, D and E (Table 6.6) (Lee & Chen 2004).  
Table 6.6: List of amino acid residues (n=131) distributed in epitopes A, B, C, 
D, and E of Hemagglutinin 1 of H3N2 viruses (Adapted from Lee and & Chen 
2004) 
        A (19)         B (22)              C (27)                   D (41)     E (22) 
122 128   44 96 218 57 
124 129   45 102 219 59 
126 155   46 103 226 62 
130 156   47 117 227 63 
131 157   48 121 228 67 
132 158   50 167 229 75 
133 159   51 170 230 78 
135 160   53 171 238 80 
137          163    54 172 240 81 
138          164    273 173 242 82 
140          165    275 174 244 83 
142         186    276 175 246 86 
143 187   278 176 247 87 
144 188   279 177 248 8 
145 189   280 179  91 
146 190   294 182  92 
150 192   297 201  94 
152 193   299 203  109 
168 194   300 207  260 
 196   304 208  261 
 197   305 209  262 
         198 307 212  265 
  308 213   
  309 214   
  310 215   
  311 216   
  312 217   
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               The HA of H1N1 viruses consists of signal peptide (1-17), HA1 (18-
343) and HA2 (345-566). The HA1 subunit of H1N1 viruses contains 4 
antigenic sites: Sa, Sb, Ca1 and Ca2 (Caton et al. 1982; Igarashi et al. 2010) 
(Table 6.7). The aa sequences were aligned using Multalin tool (Corpet 1988) 
and were inspected for mismatches against the contemporary vaccine and 
vaccine strains of upcoming season. 
Table 6.7: List of amino acid residues distributed in antigenic sites Sa, Sb, 
Ca1, Ca2 and Cb of Hemagglutinin 1 of H1N1 viruses (Adapted from Igarashi 
et al. 2010) 
Sa (n=13) Sb (n=12) Ca1 (n=11) Ca2 (n=8) Cb (n=6) 
141 201 154 220 87 
142 202 155 221 88 
170 203 156 222 89 
171 204 157 238 90 
172 205 158 239 91 
173 206 159 252 92 
174 207 183 253  
176 208 184 254  
177 209 185   
178 210 186   
179 211 187   
180 212    
181     
 
6.2.7 Structural modelling 
       Best-scoring models were generated using the MODELLER program 
using a structural template and a target reference (Eswar et al. 2007; Xu et al. 
2008; Cho et al. 2013). The structural templates and target references used are 
listed in table 6.8  Mutations relative to this reference strain were highlighted 
in YASARA, either in red, magenta or green for different HA monomers. 
Residue numbering follows HA protein numbering. This work was kindly 
performed by Dr. Vithiagaran Gunalan (ASTAR). 
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Table 6.8: Structural templates and target references for structural modelling 
 Structural Template Reference Target reference 
 
H3N2 HA A/Hong Kong/4443/2005  
(PDB ID: 2YP7) 
 
(Lin et al. 2012) A/Wisconsin/67/2005 
 
H3N2 NA A/Tanzania/205/2010  
(PDB ID: 4GZO) 
 
(Zhu et al. 2012) 
sH1N1 HA A/Thailand/CU44/2006           
(PDB ID: 4EDB) 
(Cho et al. 2013) A/New Caledonia/20/1999  
 
sH1N1 NA A/Brevig Mission/1/1918 
(PDB ID: 3BEQ) 
 




 (PDB ID: 3LZG) 
 
(Xu et al. 2010) A/California/7/2009 
HA- Hemagglutinin, NA- Neuraminidase PDB- Protein Data Bank 
6.3 Results 
      Complete genomes of 10 sH1N1, 10 H3N2 viruses and 34 pH1N1/09 
viruses were successfully sequenced in this study. However, 40 HA, 35 NA, 
38 MP, 34 NS, 34 NP and 34 polymerase genes of pH1N1/09 viruses were 
sequenced. The sequences were deposited in GenBank (accession numbers in 
appendix I) 
6.3.1 Seasonal H3N2 viruses 
6.3.1.1 HA and NA diversity  
     The phylogenetic analyses HA & NA (Figure 6-1) of H3N2 viruses with 
vaccine strains A/Brisbane/10/2007 (vaccine strain Northern Hemisphere 
2008-09 and Southern Hemisphere 2008) and A/Wisconsin/67/2005 (vaccine 
strain Northern hemisphere 2006-08 and Southern hemisphere 2007) and 6 




Figure 6-1. Neighbor-Joining trees of Hemagglutinin (HA) and Neuraminidase (NA) gene segments of 10 H3N2 strains detected in 2007 in a 
Singapore university campus(green), WHO vaccine(red) and reference strains(black) from 2003-2009. Boot strap values 60 and over are shown 
at the branches. Analyses were done in MEGA 6. Clade-specific amino acid (aa) changes are shown at the nodes. The bar at the bottom of the 
tree represents number of as substitutions per site. 
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    Nine out of 10 strains were closely related to A/Brisbane/10/2007 than to 
A/Winsconsin/67/2005. The percentage nt and aa sequence identity with 
A/Brisbane/10/2007 in HA were between 98.42-99.77% and 98.48-99.83% 
respectively (Table 6.9) and in NA were between 98.51-99.79% and 99.36-
99.79% (Table 6.10) respectively. Of note, the genotype of most of the 
Singapore strains was different from the then recommenced vaccine strain, 
A/Wisconsin/67/2005. Furthermore, the phylograms showed that the study 
isolates fell into 2 distinct clades (supported by long-branch length and high 
boot strap value of 99): A/Brisbane/10/2007 (Brisbane-like) and 
A/Nepal/921/2006 (Nepal-like). Nine out of the 10 H3N2 isolates fell within 
Brisbane-like clade, but A/Singapore/139N/2007 (hereafter 139N) fell within 
A/Nepal/921/2006-like clade (WHO 2008). Strain 139N was closer to 
A/Wisconsin/67/2005 (>99%) than to A/Brisbane/10/2007 (<99%) as reflected 
in both HA and NA trees. This suggests that at least 2 genetically distinct 
lineages of H3N2 viruses were co-circulating in 2007 on the university 
campus: Brisbane-like and Wisconsin-like. 
           The nt sequences in HA gene segment of H3N2 study strains were also 
compared with representative sequences from the viruses isolated from the 
USA (Figure 6-2A) and with global sequences (Figure 6-2B) from the same 
time period to investigate the phylogenetic relatedness. The analysis showed 
that the majority of the Singapore strains clustered into the 
A/Brisbane/10/2007-like clade that was a well-defined major cluster at that 
time. The results were in agreement with the global distribution of clade 
assignments (WHO 2008) wherein A/Nepal/921/2006 was in clade B and 




Figure 6-2. Neighbor-Joining trees of Hemagglutinin (HA) of 10 H3N2 strains detected in 2007 in a Singapore university campus(green), WHO 
vaccine(red) strains from 2003-09 with representative (A) USA strains(black); (B) global strains(black) from the same time period in 2007. Boot 
strap values 60 and over are shown. Analyses were conducted in MEGA 6. The bar at the bottom of the tree represents number of amino acid 
substitutions per site. 
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       The phylogenetic analysis so far showed that strain 139N formed a 
separate cluster from the other Singapore strains. On correlation of 
phylogenetic information with the epidemiological information of subject with 
strain 139N, it was found that the subject was a Vietnamese student staying on 
campus. This strain did not appear in subsequent samples from local students 
in this study or in Singapore GenBank strains.  
         To further understand the genetic diversity of this isolate, the sequence 
was blasted in NCBI flu database and most of the hits were sequences from 
the Vietnam. A phylogenetic tree for HA gene with Singapore strains, vaccine 
strains, top 10 blast hits for the sequence 139N and 20 Vietnam strains from a 
published study (Le et al.  2013) (Figure 6-3) was constructed. The 
phylogenetic tree showed two major clades. Clade B contained the strain 139N 
with top 10 blast hits which also included A/Nepal/921/2006 and Clade A 
included the rest of the Singapore strains, Vietnam strains from the study (Le 
et al. 2013) and A/Brisbane/10/2007.      
      The number of aa differences observed in HA and NA between the 
deduced protein sequences of 9/10 study strains and the A/Brisbane/10/2007 
ranged from 1 to 4 except for strain 139N. Ten aa differences were observed in 
HA and 7 in NA relative to A/Wisconsin/67/2005. The data are summarized in 



























Figure 6-3. Neighbor-Joining tree of Hemagglutinin (HA) of 10 H3N2 strains 
detected in 2007 in a Singapore university campus (green), WHO vaccine 
(red) strains from 2003-09, 20 strains from Vietnam (black) from the same 
time period in 2007 and top 10 blast hits of A/Singapore/139N/2007 (black). 
The strain 139N is shown in grey box. Boot strap values 60 and over are 
shown. Analysis was conducted in MEGA 6. The bar at the bottom represents 
amino acid substitutions per site. The strain name is followed by month and 


































































Table 6.9: Percentage amino acid identity and mutations observed in HA of 
H3N2 viruses compared to closest WHO vaccine reference 
Study sequences (H3N2) 
HA 
Best Reference hit aa 
identity 
(%) 
List of mutations  
A/Singapore/25Z/2007 A/Brisbane/10/2007 99.470 T16A, P20T, I377T 
A/Singapore/53C/2007 A/Brisbane/10/2007 99.647 T16A, V545I 
A/Singapore/64K/2007 A/Brisbane/10/2007 99.293 T16A, K342R, 
I377T, A546V 
A/Singapore/68Q/2007 A/Brisbane/10/2007 99.823 T16A 
A/Singapore/78L/2007 A/Brisbane/10/2007 99.647 T16A, I377T 
A/Singapore/87Z/2007 A/Brisbane/10/2007 99.468 T16A, K189N, 
I390V 
A/Singapore/103C/2007 A/Brisbane/10/2007 99.823 T16A 
A/Singapore/105L/2007 A/Brisbane/10/2007 99.470 T16A, I258M, 
I377T 





A/Singapore/238T/2007 A/Brisbane/10/2007 99.647 T16A, N187K 
HA-Hemagglutinin, aa-amino acid 
 
Table 6.10: Percentage amino acid identity and mutations observed in NA of 
H3N2 viruses compared to closest WHO vaccine reference 
Study sequences (H3N2) NA Best Reference hit aa identity 
(%) 
List of mutations 
A/Singapore/25Z/2007 A/Brisbane/10/2007 100.00 - 
A/Singapore/53C/2007 A/Brisbane/10/2007 99.787 T312I 
A/Singapore/64K/2007 A/Brisbane/10/2007 99.787 T312I 
A/Singapore/68Q/2007 A/Brisbane/10/2007 99.787 T312I 
A/Singapore/78L/2007 A/Brisbane/10/2007 99.360 T312I, R430K, 
N441T 
A/Singapore/87Z/2007 A/Brisbane/10/2007 99.344 F42L, R292I, T312I 
A/Singapore/103C/2007 A/Brisbane/10/2007 99.787 T312I 
A/Singapore/105L/2007 A/Brisbane/10/2007 99.574 T312I , S367N 




A/Singapore/238T/2007 A/Brisbane/10/2007 99.787 T312I 




Amino acid variants in epitopes of HA1 of H3N2 viruses  
 
       Comparison of epitopes A, B, C, D and E in the H3N2 strains sequenced 
in this study with the contemporary and upcoming season vaccine strains is 
shown in table 6.11. It was found that the H3N2 strains sequenced in this 
study shared same aa at the 5 epitopes with A/Brisbane/10/2007 vaccine strain 
which is the vaccine strain of the upcoming influenza season 2008-09 (Table 
6.11). Brisbane-like clade is characterized by signature G50E and K140I 
mutations in HA and same aa were present in 9/10 study strains whereas 
Nepal-like clade is characterized by N6I, R142G and K173E mutations in the 
HA as described earlier on in Table 6.1 and same aa were found in 139N. 
Table 6.11: List of amino acid residues changes distributed in epitopes A, B, 
C, D, and E of Hemagglutinin 1 (HA1) surface protein of H3N2 viruses 
isolated in this study compared to WHO vaccine strains 
 







Mismatch Hits to 
contemporary vaccine 
(n=10) 
A D122N N N D 10 
A S138A A A S 10 
A K140I I I K 9 
A G142R R R R 1 
B A128T T T T 1 
B V186G G G V 10 
C G50E E E G 9 
D K171N N N N 1 
D N/E173K K K K 2 
D M242I I I I 1 






 Structural modelling of H3N2 viruses 
      Structural models representing aa changes in HA and NA relative to 
vaccine strain A/Wisconsin/67/2005 are shown in figures 6-4 and 6-5. In the 
HA of 9/10 strains, mutations in HA relative to Wisconsin were G50E and 
K140I (WHO 2008). Eight out of 9 strains had 173K and one has 173N. 
Similar to Wisconsin strain, study strains had 128T, 142R, 131T, 157L, 158K 
and 261Q. Strain 139N had 50G, 128A, 140K, 142G, 131T, 157L, 158K, 
173E and 261R. Notably, site 128 is a potential glycosylation site and 
mutation at this site leads to loss of a glycosylation site. The role of this 
mutation in strain 139N needs to be studied further using functional assays. In 
NA, the mutations relative to Wisconsin were present in 9/10 study strains: 
150R, 194I, 310H, 370S, 372L and 387K. Strain 139N had 150H, 194V, 









Figure 6-4. Best-scoring models representative of the H3N2 Hemagglutinin 
(HA) trimer (above) and monomer (below) were generated using the 
MODELLER program using the A/Hong Kong/4443/2005 HA (PDB ID: 
2YP7) as a structural template and A/Wisconsin/67/2005 as a target reference. 
Mutations relative to this reference strain were highlighted in YASARA, either 
in orange, red or green for different HA monomers. Residue numbering 






Figure 6-5. Best-scoring models representative of the H3N2 Neuraminidase 
(NA) dimer (above) and monomer (below) were generated using the 
MODELLER program using the A/Tanzania/205/2010 NA (PDB ID: 4GZO) 
as a structural template and A/Wisconsin/67/2005 as a target reference. 
Mutations relative to this reference strain were highlighted in YASARA in 
orange or green for different NA monomers. Residue numbering follows N2 
protein numbering. Strain 139N had only one mutation relative to Wisconsin 






6.3.1.2 Diversity of internal genes 
     The analysis of MP gene segment (Figure 6-6) showed 99.59-99.90% nt 
identity with vaccine strains A/Brisbane/10/2007 and A/Wisconsin/67/2005 
for all the study strains except strain 139N for which it was 98.07%. However, 
at aa level, the percentage identity within the study strains and with vaccines 
strains was 100% except 139N (Table 6.12). 
Table 6.12: Percentage amino acid identity and mutations observed in MP of 
H3N2 viruses compared to closest WHO vaccine reference 
Study sequences (H3N2) 
MP 
Best Reference hit aa 
identity 
(%) 



































        The analysis of NP gene (Figure 6-6) showed 98.49-99.74% nt identity 
with A /Brisbane/10/2007 except strain 139N. However, at aa level, the 
percentage identity within the study strains and with vaccine strain 
A/Brisbane/10/2007 was 100% except 139N. S131A, M447I, T472A and 




Figure 6-6. Neighbor-Joining trees of Matrix (M), Non-structural (NS), Nucleoprotein (NP), Polymerase Basic-2 PB-2, Polymerase acidic (PA), 
and Polymerase Basic-1 (PB-1) gene segments of 10 H3N2 strains detected in 2007 in a Singapore university campus(green), WHO vaccine(red) 
and reference strains(black) from 2003-2009. Boot strap values 60 and over are shown at the nodes. Analyses were conducted in MEGA 6. The 
bar at the bottom of each tree represents number of amino acid substitutions per site. 
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       The NS gene (Figure 6-6) of study strains showed 98.58-99.88% nt 
identity with A/Brisbane/10/2007 and 98.93-99.53% with 
A/Wisconsin/67/2005. However, at aa level, the NS, NS1 and NS2 were 100% 
identical to A/Brisbane/10/2007 except for A/Singapore/53C, 
A/Singapore/87Z/2007 and 139N. Compared with A/Wisconsin/67/2005, the 
aa identity in NS2 was 100% but for NS1 ranged from 98.27-99.13%. 
     The analysis of PA gene (Figure 6-6) showed the nt identity of 99.41-
99.82% with A /Brisbane/10/2007 and 99.22-99.45%. for 
A/Wisconsin/67/2005. However, at the aa level, the percentage identity with 
A/Brisbane/10/2007 was 100% in all the strains except 139N which had a 
mutation D347E.  For A/Wisconsin/67/2005 % aa identity was 99.72-99.86%. 
       The PB-2 gene of H3N2 viruses (Figure 6-6) shared 100% identity with 
A/Brisbane/10/2007 at nt level and aa level, however, there was 99.6% 
identity at aa level with A/Wisconsin/67/2005.  
      The PB-1 gene (Figure 6-6) of H3N2 viruses shared 98.87-99.61% identity 
at nt level, 99.47-99.87% at aa level with A/Brisbane/10/2007 and 99.2-99.6% 
identity at all level with A/Wisconsin/67/2005. I10L and L576I mutations 
were found in all the strains relative to Brisbane strain but 139N strains has 






6.3.2 Seasonal H1N1 viruses 
6.3.2.1 HA and NA diversity  
      The phylogenetic analysis of full-length HA & NA gene segments of 
sH1N1 viruses (Figure 6-7) with vaccine strains A/Brisbane/59/2007 (vaccine 
strain of Northern Hemisphere 2008-10 and Southern Hemisphere 2009), 
A/Solomon Islands/3/2006 (vaccine strain of Northern hemisphere 2007-08 
and Southern hemisphere 2008), A/New Caledonia/20/1999 (vaccine strain of 
Northern hemisphere 2000-07 and Southern hemisphere 2000-07), and 5 
reference strains was conducted to assess the phylogenetic relatedness. The 
percentage nt and aa identities with A/Brisbane/59/2007 in HA were 97.36-
97.53% and 97.35-97.88% respectively and in NA were 98.04-98.34% and 
96.81-97.23%, respectively. The nt and aa identities with the vaccine strain 
A/Solomon Islands/3/2006 in HA were 97.47-97.65% and 98.05-98.41% 
respectively, and in NA were 96.81-97.38% and 95.20-95.63% respectively. 
The data are presented in tables 6.13 and 6.14. The nt and aa identities in HA 
with strain A/Hong Kong/2652/2006 were 99.31-99.57 and 98.97-99.48% 
respectively, and in NA were 99.29-99.71% and 99.14-99.79% respectively. 
The analysis was also conducted with representative global strains collected 
during the same time period (Figure 6-8). Similar clustering was observed. 
The HA and NA sequences of the 10 sH1N1 viruses isolated from the 
university campus fell within clade 2C represented by A/Hong 
Kong/2652/2006. The WHO clade classification is presented earlier on in 




Figure 6-7. Neighbor- Joining trees of Hemagglutinin (HA) and Neuraminidase (NA) gene segments of 10 seasonal H1N1(sH1N1) strains 
detected in 2007 in a Singapore university campus(green), WHO vaccine strains(red) and reference strains(black) for 2000-09. Boot strap values 
60 and over are shown. Analyses were conducted in MEGA 6. Clade-specific amino acid changes are shown at the nodes. The bar at the bottom 
represents number of amino acid substitutions per year 
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Table 6.13: Percentage amino acid identity and mutations observed in HA of 
sH1N1 viruses compared to closest WHO vaccine reference 
 
  












List of mutations 
A/Singapore/20J/2007 A/Solomon 
Islands/3/2006 
98.23 S53N, R90K, K99R, 
T145V, R205M, A206T, 




98.41 S53N, R90K, K99R, 
T145V, R205M, A206T, 




98.41 S53N, R90K, K99R, 
T145V, R205M, A206T, 
I434V, S467N, N512 
A/Singapore/30L/2007 A/Solomon 
Islands/3/2006 
98.23 S53N, R90K, K99R, 
T145V, R205M, A206T, 
I434V, S467N, N512 
A/Singapore/44T/2007 A/Solomon 
Islands/3/2006 
98.41 S53N, R90K, K99R, 
T145V, R205M, A206T, 
I434V, S467N, N512 
A/Singapore/49O/2007 A/Solomon 
Islands/3/2006 
97.88 K2E, S53N, R90K, K99R, 
T145V, R205M, A206T, 




98.23 S53N, R90K, K99R, 
T145V, R205M, A206T, 




98.41 S53N, R90K, K99R, 
T145V, R205M, A206T, 
I434V, S467N, N512 
A/Singapore/106L/2007 A/Solomon 
Islands/3/2006 
97.05 S53N, R90K, K99R, 
P135H, T145V, T146N, 
E157K, R205M, A206T, 




98.23 S53N, R90K, K99R, 
T145V, R205M, A206T, 




Table 6.14: Percentage amino acid identity and mutations observed in NA of 








List of mutations 
A/Singapore/20J/2007 A/Brisbane/59/2007 97.021 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D341N, D354G, L367I, 
V393I, T453I 
A/Singapore/23J/2007 A/Brisbane/59/2007 97.021 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D341N, D354G, L367I, 
V393I, T453I 
A/Singapore/24D/2007 A/Brisbane/59/2007 97.234 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D354G, L367I, V393I, 
T453I 
A/Singapore/30L/2007 A/Brisbane/59/2007 96.809 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, F256Y, I267M, 
1287T, E329K, D354G, 
L367I, V393I, T453I 
A/Singapore/44T/2007 A/Brisbane/59/2007 97.234 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D354G, L367I, V393I, 
T453I 
A/Singapore/49O/2007 A/Brisbane/59/2007 96.809 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D341N, D354G, L367I, 
M373I,  V393I, T453I 
A/Singapore/86D/2007 A/Brisbane/59/2007 97.021 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 
D341N, D354G, L367I,  
V393I, T453I 
A/Singapore/89Z/2007 A/Brisbane/59/2007 97.234 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T,, 
D354G, L367I,  V393I, 
T453I 
A/Singapore/106L/2007 A/Brisbane/59/2007 97.021 N45H, E78K, S82P,  
R130K, M188I, K249G, 
I267M, 1287T, E329K, 
D354G, L367I,  V393I, 
T453I, T453I 
A/Singapore/115C/2007 A/Brisbane/59/2007 97.021 N45H, E78K, S82P, 
Y100H, R130K, M188I, 
K249G, I267M, 1287T, 









Figure 6-8. Neighbor-Joining tree of Hemagglutinin (HA) of 10 seasonal 
H1N1 strains detected in 2007 in a Singapore university campus (green), 
WHO vaccine and reference strains (red) from 2000-2009 and representative 
global strains from the same time period in 2007 (black). Boot strap values 60 
and over are shown. Analysis was conducted in MEGA6. The bar at the 






Figure 6-9. Best-scoring models representative of the Hemagglutinin (HA) of 
seasonal H1N1 trimer (above) and monomer (below) were generated using the 
MODELLER program using the A/Thailand/CU44/2006 HA (PDB ID: 4EDB) 
as a structural template and A/New Caledonia/20/1999 as a target reference. 
Mutations relative to this reference strain were highlighted in YASARA, either 
in red, magenta or green for different HA monomers. Residue numbering 









Figure 6-10. Best-scoring models representative of the seasonal H1N1 
Neuraminidase (NA) dimer (above) and monomer (below) were generated 
using the MODELLER program using the A/Brevig Mission/1/1918 NA (PDB 
ID: 3BEQ) as a structural template and A/New Caledonia/20/1999 as a target 
reference. Mutations relative to this reference strain were highlighted in 
YASARA in yellow. Residue numbering follows N1 numbering. 
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Amino acid variants in epitopes of HA1 of H1N1 viruses 
 
     In HA of study strains, relative to A/New Caledonia/20/1999 vaccine 
strain, 4 aa changes were present in epitope Sb (205M, 206T, 210K) and one 
in Ca (157E). Relative to A/Solomon Islands/3/2006, 2 aa changes were found 
in epitope Sb (205M, 206TC) and one in epitope Cb (90K) and relative to 
A/Brisbane/59/2007 vaccine strain, 3 aa changes were found in epitope Sb 
(205M, 206T, 210K). 
Structural modelling 
The aa changes in HA and NA of sH1N1 sequences in the study strains 
relative to A/New Caledonia/20/1999 are shown in figures 6.9 and 6.10. In HA 
36N, 145K, 188M, 189T and 193K were found. In NA 82P, 130K, 188I, 
214G, 222Q, 267M, 344N, 367I, 393I AND 453I were found. 
6.3.2.2 Diversity of internal genes  
      The analysis of MP gene segment (Figure 6-11) showed 99.28-99.38% nt 
identity to A/Hong Kong/2652/2006, 98.30-98.40% to A/Brisbane/59/2007 
and 98.98-99.09% with A/Solomon Islands/3/2006 (Table 6.15). The M1 
protein was highly conserved with no aa differences when compared with 
A/Hong Kong/2652/2006 and vaccine strain A/Solomon Islands/3/2006 but 
there was one aa change when compared to A/Brisbane/59/2007. The M2 
protein showed 98.95-100% aa identity with A/Hong Kong 2652/2006, 96.91-
97.94% with both A/Solomon Islands/3/2006 and A/Brisbane/59/2007. There 
were 3 common mutations, S31N (relative to both vaccine strains), G61R 
(relative to A/Solomon Islands/3/2006) and D89G (relative to 




Figure 6-11. Neighbor-Joining trees of Matrix (M), Non-structural (NS), Nucleoprotein (NP), Polymerase Basic-2 PB-2, Polymerase acidic 
(PA), and Polymerase Basic-1 (PB-1) gene segments of 10 seasonal H1N1(sH1N1) strains detected in 2007 in a Singapore university 
campus(green), WHO vaccine(red) and reference strains(black) from 2000-2009. Boot strap values 60 and over are shown at the nodes. Analyses 
were conducted in MEGA 6. The bar at the bottom of each tree represents number of amino acid substitutions per site. 
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Table 6.15: Percentage amino acid identity and mutations observed in MP of 
sH1N1 viruses compared to closest WHO vaccine reference 
Study sequences 
(H1N1) MP 
Best Reference hit aa identity 
(%) 
List of mutations 
A/Singapore/20J/2007 A/Solomon Islands/3/2006 98.30 S31N, S48F, G61R 
 
A/Singapore/23J/2007 A/Solomon Islands/3/2006 98.30 S31N, S48F, G61R 
 
A/Singapore/24D/2007 A/Solomon Islands/3/2006 98.30 S31N, S48F, G61R 
 
A/Singapore/30L/2007 A/Solomon Islands/3/2006 98.40 S31N, G61R 
 
A/Singapore/44T/2007 A/Solomon Islands/3/2006 98.40 S31N, G61R 
 
A/Singapore/49O/2007 A/Solomon Islands/3/2006 98.40 S31N, G61R 
 
A/Singapore/86D/2007 A/Solomon Islands/3/2006 98.30 S31N, H57Y, G61R 
 
A/Singapore/89Z/2007 A/Solomon Islands/3/2006 98.40 S31N, G61R 
 
 
A/Singapore/106L/2007 A/Solomon Islands/3/2006 98.40 S31N, I39T, G61R 
 
A/Singapore/115C/2007 A/Solomon Islands/3/2006 98.40 S31N, G61R 
 
aa=amino acid 
         
        For the NS gene segment (Figure 6-11) the % identity between the study 
strains and A/Brisbane/59/2007 was 97.80-98.02% at the nt level. The 
sequences of A/Solomon Islands/3/2006 and A/Hong Kong/2652/2006 were 
not available in public databases for comparison.     
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        At the nt level, for the NP gene segment (Figure 6-11), the identity 
between the study strains and A/Brisbane/59/2007 was 97.66-97.86% whereas 
with A/Solomon Islands/3/2006 was 98.74-98.94%. The NP protein of study 
strains shared 100% identity with A/Solomon Islands/3/2006 but shared a 
homology of 99.4-99.6% with A/Brisbane/59/2007. 
           At the nt level for the PA gene segment (Figure 6-11) the identity 
between the study strains and A/Brisbane/59/2007 was 98.08-98.45% whereas 
with A/Solomon Islands/3/2006 was 97.53-98.08%. The PA protein of study 
strains shared 99.02-99.30% identity with A/Brisbane/59/2007. 
         For the PB2 gene segment (Figure 6-11) the identity between the study 
strains and A/Brisbane/59/2007 was 98.10-98.27% at the nt level. The 
sequences of A/Solomon Islands/3/2006 and A/Hong Kong/2652/2006 were 
not available in genetic databases for comparison.  
          For the PB1 gene segment (Figure 6-11) the identity between the study 
strains and A/Brisbane/59/2007 was 96.83-96.96% at the nt level. The 
sequences of A/Solomon Islands/3/2006 and A/Hong Kong/2652/2006 were 










6.3.3 Pandemic H1N1/09 viruses 
6.3.3.1 HA and NA diversity  
      The phylogenetic trees of 40 HA and 35 NA gene segments of pH1N1/09 
viruses circulating on campus during the early pandemic period of 2009 are 
presented in the figure 6-12. The percentage nt identity in HA ranged from 
99.17-99.57% and aa identity ranged from 99.18-99.47 relative to 
A/California/7/2009. The percentage nt and aa identity in NA ranged from 
99.65-99.79% and 99.36-99.54% relative to A/California/7/2009. There were 
in total 3-5 mutations in HA (Table 6.16) and 2-3 mutations in NA with 
reference to the A/California/7/2009. 
                Two HA mutations P100S and I338V were found in all the 40 
viruses and these are represented in structural model in Figure 6-13. These 
mutations have been reported 98.21% times and 94.64% times respectively, in 
all samples collected with this particular gene globally and deposited in the 
flusurver database. These are the common variants marker in the outbreak. 
Fereidouni et al., 2009 identified 2 clusters among the early pandemic viruses 
and Nelson et al., 2009 defined 7 clades of pandemic viruses with S200T 
mutation (numbering starting from the first nucleotide) being the cluster 2 and 
clade VII marker (Figure 6-13) (Fereidouni et al. 2009; Nelson et al. 2009a). 
36/40 viruses fell into cluster 2 based on HA with characteristic changes in six 
gene segments and 4/40 viruses fell in cluster 1.3. S220T which is the major 
non synonymous mutation defining cluster 2 occurred 86.37% times in all 
samples collected with this particular gene globally (flusurver). 4/40 isolates 
harboured mutations K2E and Q310H in HA. P321S mutation was seen in 3  
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isolates; R563K and V6I in 2 isolates. I183V, Q561P, S551I and D111N 
occurred in singleton isolates. E391K, V267A, E516K, N142D mutations were 
not detected. However, the closest reference strain was A/New York with 
which the study stains shared 99.76-100% nt and 99.47-100% aa identity and 
maximum of 3 mutations. 
        The HA of pH1N1/09 viruse was also compared to the other Singaporean 
sequences deposited in the GenBank (Figure 6-13). Since these represent 
different cohorts but contact with the university students/staff is likely, the 
potential interaction of the wider community with the study cohort was also 
tested. We found that the close clustering of highly similar NUS sequences 
was still maintained with no community sequences in between. 
Table 6.16: Mutations in HA relative to vaccine strain A/California/7/2009 
Means not present at antigenic site; Numbering starting from first methionine; N- Number of strains 
         V106I and N248D mutations were found in the NA of all the pH1N1/09 
strains relative to A/California/7/2007. Additionally, mutations V241L, 
S456F, N50S, N386D, N222S and S79A mutations were found in the 
singleton strains. The closest reference strain was A/New York/20/2009 with 
which the study strains shared 99.70-100% nt and 99.79-100% aa identity. 
Sporadic mutations such as V241L, S456F, N50S, N386D, S79A and N222S 
relative to A/New York/20/2009 were detected. 
Mutations in HA (Total 12) Influenza Strains (N=40) Antigenic site 
P100S, I338V In all the strains - 
 S220T (Clade VII marker) 36/40 Ca1 
K2E (Clade VI) 4/40 - 
Q310H (Clade VI) 4/40 - 
P321S 3/40 - 
V6I ,R563K 2/40 - 
I183V, Q561P, S551I ,D111N 1/40 - 




Figure 6-12. Neighbor-Joining trees of 40 Hemagglutinin (HA) and 35 Neuraminidase (NA) gene segments of pH1N1/09 strains detected in 
2009 in a Singapore university campus (black) and WHO vaccine and closest reference strains for 2009 (red). Boot strap values 60 and over are 
shown. Analyses were conducted in MEGA 6. Common mutations are shown at the branches and sporadic mutations are shown at the end of the 





Figure 6-13. Neighbor-Joining tree of Hemagglutinin (HA) of pH1N1/09 
strains (in red are on-campus and in green are off-campus strains) detected in 
2009 (July & August) on a Singapore university campus and community 
strains (in black). Boot strap values 60 and over are shown. Analysis was 
conducted in MEGA6. The bar at the bottom represents number of amino acid 




Figure 6-14. Best-scoring model representative of the pandemic 2009 H1N1 
Hemagglutinin (HA) trimer was generated using the MODELLER program 
using the A/California/04/2009 HA (PDB ID: 3LZG) as a structural template 
and A/California/07/2009 as a target reference. Mutations relative to this 
reference strain were highlighted in YASARA, either in orange, red or green 
for different HA monomers. Residue numbering follows HA protein 
numbering. 
 
Antigenic site and Receptor binding site analysis: 
     The antigenic sites: Sa, Sb, Ca1, Ca2 and Cb were investigated for any 
mutations at these sites relative to A/California/7/2009 which may lead to 
potential antigenic change. However, only one mutation S220T was found at 
antigenic site Ca1 with none found in any other antigenic sites. The S220T is 
present in HA1 region and is the signature non-synonymous mutation for the 
clade VII viruses (Figure 6-14). The Receptor binding site analysis relative to 
A/California/7/2009 [loop 130 (position 151), helix 190 (position 200, 203, 









Figure 6-15. Neighbor-Joining trees of 38 Matrix (MP), 34 Non Structural (NS) and 34 Nucleoprotein (NP) gene segments of pH1N1/09 strains 
detected in 2009 in a Singapore university campus(black) with WHO vaccine and closest reference strains for 2009(red). Boot strap values 60 
and over are shown. Analyses were conducted in MEGA 6. Common mutations are shown at the branches and sporadic mutations are shown at 




Figure 6-16. Neighbor-Joining trees of Polymerase Basic-2 (PB-2), Polymerase acidic (PA) and Polymerase Basic-1 (PB-1) gene segments of 34 
pH1N1/09 influenza viruses circulating in 2009 in a university in Singapore (black) with WHO vaccine and closest reference strain for 
2009(red). Boot strap values 60 and over are shown. Analyses were conducted in MEGA 6. Common mutations are shown at the branches and 
sporadic mutations are shown at the end of the strain name. The bar at the bottom represents number of amino acid substitutions per site. 
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6.3.3.2 Diversity of internal genes  
    The phylogenetic trees of 38 MP, 34 NS and 34 NP gene segments of 
pH1N1/09 viruses circulating on campus during the early pandemic period of 
2009 are presented in the figure 6-14. The percentage nt identity in MP ranged 
from 99.65-99.79% and percentage aa identity ranged from 99.36-99.54 when 
compared to vaccine strain A/California/7/2009. Each strain had about 2-3 
mutations with reference to the A/California/7/2009 vaccine strain. The 
percentage nt identity in NS ranged from 99.65-99.79% and percentage aa 
identity ranged from 99.36-99.54 when compared to vaccine strain 
A/California/7/2009. There were in total 2-3 mutations with reference to the 
A/California/7/2009 vaccine strain. The percentage nt identity ranged in NP 
ranged from 99.65-99.79% and percentage aa identity ranged from 99.36-
99.54 when compared to vaccine strain A/California/7/2009. There were in 
total 2-3 mutations with reference to the A/California/7/2009 vaccine strain. 
              The phylogenetic trees of PB-2, PA and PB-1 gene segments of 34 
pH1N1/09 viruses circulating on campus during the early pandemic period of 
2009 were constructed (Figure 6-15). The percentage nt identity in PA gene 
ranged from 99.72-99.86% and percentage aa identity ranged from 99.58-
99.865% when compared to vaccine strain A/California/7/2009. There were in 
total 1-3 mutations with reference to the A/California/7/2009 vaccine strain. 
P224S mutation was found in all the strains. Sporadic mutations E18K, 
A714T, V628M, L345I, S291T, L275F, R57Q and K213N were found in 
singleton strains. The nt similarity with closest reference strain, A/New 
York/20/2009, was 99.77-100% and aa identity ranged from 99.72-100%. 
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          The PB-2 gene segment shared 99.65-99.87% nt identity and 99.74-
99.87% aa identity with A/California/7/2009. 29/34 strains shared 100% aa 
identity with both A/California/7/2009 and A/New York/20/2009. The K660R 
mutation was found in 5/34 samples. V292I, V584I and T105I mutations were 
found in some strains. The closest reference strain, however, was 
A/Victoria/5/2010 with which the study strains shared 99.86-100% aa 
homology. The PB-1 gene segment shared 99.78-100% nt identity and 99.74-
100% aa homology with A/California/7/2009. 5/40 strains shared 100% aa 
identity with both A/California/7/2009 and A/New York/20/2009 strains. 
Mutations such as R393K, V660I, I530V, G216D, K486R, K391T, K52R, 
D398E and I667V were found in some strains. The PB1-F2 protein was 
truncated because of the stop codon at position 220 in all strains. 
 
6.4 Discussion 
      In 2007, A/Brisbane/10/2007-like H3N2 viruses and A/Hong 
Kong/2652/06-like sH1N1 viruses were co-circulating on the NUS campus 
and in 2009 A/New York/20/2009-like pH1N1/09 viruses were circulating. 
          H3N2: Majority of the H3N2 sequences, based on the whole genome 
characterization, fell into clade A represented by vaccine strain 
A/Brisbane/10/20072007 (vaccine strain of Northern Hemisphere 2008-09 and 
Southern Hemisphere 2008). The sequences were similar to sequences of other 
influenza A/H3N2 viruses circulating globally at that time (WHO 2008; 
Nelson et al. 2008). CDC reported that 71% of H3N2 viruses were 
A/Brisbane/10/2007-like viruses in the latter half of 2007 (CDC 2008a). 
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Indeed, A/Brisbane/59/2007 like viruses were dominant lineage during 
influenza season 2007-08 (Nelson et al. 2008). However, the vaccine strain in 
2007 was A/Wisconsin/67/2005 which implies that the circulating strains had 
drifted from the then recommended vaccine strain and were closer to the 
vaccine strain of the upcoming season. The influenza H3N2 Brisbane-like 
viruses first emerged in Australia (CDC 2008b). The molecular evolution of 
influenza A/H3N2 viruses from 1968-2003 has been well characterized by 
Smith et al., and from 2002-2007 by Russell and co-workers (Smith et al. 
2004; Russell et al. 2008).  Russell et al., found that the viruses in SEA are 
more advanced than the rest of the world and new variants of IAV emerge in 
Asia (Russell et al. 2008).  
         Intriguingly, there was an influenza strain, 139N, isolated from one of 
the subjects whose surface and internal genes on phylogenetic analysis formed 
separate clusters in the respective trees from the rest of the Singapore H3N2 
strains sequenced in this study. The strain clustered with A/Nepal/921/2006 
which according to WHO clade assignments (WHO 2008) was in clade B and 
A/Brisbane/10/2007 in clade A. Subsequently, the phylogenetic information 
was correlated with the epidemiological information and it was found the 
subject was a Vietnamese student staying on campus. This strain did not 
appear in subsequent samples from local students in this study or in Singapore 
GenBank strains. This suggests that the imported 139N strain likely represents 
part of the introduction of a second major clade into Singapore from Vietnam 
as the collection dates of majority of the BLAST hits precede 139N. To further 
strengthen our findings the deduced protein sequences of HA and NA of  
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139N, A/Brisbane/10/2007, A/Wisconsin/67/2005 and A/Nepal/921/2006 
were compared. The HA of strain 139N was found to harbor amino acid 
changes similar to A/Nepal/921/2006 [(N6I, 142G, K173E and (T128)(-
CHO)] and similarly the NA of 139N had amino acid changes characteristic of 
A/Nepal/921/2006 (Le et al. 2013). Amino acid changes characteristic of 
A/Brisbane/10/2007 were not found in the strain 139N. Also, the branch 
length of the Singapore 139N strain was worth noting which was longer than 
other strains in the clade. This may suggest that the Singapore strain 139N, 
while clustering with Vietnamese strains, is not very closely related. 
Clustering with Vietnamese strains would only suggest a possibility of an 
origin in that country. In this type of scenario, the availability and use of 
epidemiological data argued strongly for a Vietnamese origin.  
        The markers of severity of disease in HA1 of H3N2 viruses, as identified 
in previous studies, such as N145S (epitope A), A198S (epitope B) and V223I 
(Moussi et al. 2014) were not detected in this study which underscores their 
association with severe disease as most cases in this study were mild. Previous 
studies have shown aa changes at epitopes A and B are associated with major 
antigenic change (Koel et al. 2013). In this study, the contemporary vaccine 
strain differed from the circulating strains at 3 sites in epitope A and 1 site 
each in epitope B and C. Additionally, another substitution I223V relative to 
A/Wisconsin/67/2005 was not present at an antigenic site. The recent H3N2 
virus drift phenomenon causing outbreaks in Hong Kong 
(http://www.straitstimes.com/news/singapore/health/story/flu-outbreak-hong-
kong-6-things-you-need-know-about-flu-vaccination-2015) and USA 
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leading to reduced vaccine effectiveness underscores the importance of 
monitoring antigenic/genetic changes which may lead to vaccine mismatch 
(http://www.cdc.gov/media/releases/2015/p0115-flu-vaccination.html). CDC 
first noted drifted H3N2 viruses in March of 2014, and by that time the 
manufacturing of vaccine for the flu season 2014-2015 was already in-process. 
Unfortunately, the influenza season 2014-2015 was predominated by seasonal 
H3N2 and the drifted virus greatly compromised the vaccine effectiveness for 
the 2014-2015 influenza season. (http://www.cidrap.umn.edu/news-
perspective/2014/12/cdcs-flu-warning-raises-questions-about-vaccine-match). 
Furthermore, three mutations T128A, R142G and K173E were found in strain 
139N. It has been reported that T128A mutation leads to removal of one 
glycosylation site. These mutations have been proposed to be associated with 
moderate to severe disease in previous studies. Investigating the role of these 
mutations with aid of functional studies would be interesting as they were 
found in mild cases in this study. 
          Seasonal H1N1: Majority of the sH1N1 sequences, based on the whole 
genome sequencing, fell into clade 2C represented by A/Hong 
Kong/2652/2006 reference strain. In latter part of 2007, 91% of viruses 
characterized at CDC were A/Solomon Islands/3/2006 vaccine strain for 2007- 
2008 for Northern Hemisphere and 2008 for Southern Hemisphere (CDC 
2008a). In this study, the sH1N1 viruses were closer to A/Solomon 
islands/3/2006 vaccine strain which was the upcoming season’s vaccine strain. 
Of note is the fact the A/Solomon islands/3/2006 vaccine was used for a single 
season and was changed to A/Brisbane/59/2006 in influenza season 2008-09. 
The evolution of seasonal H1N1 viruses had been slower than H3N2 viruses 
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from 2000- 2007 as the vaccine strain for sH1N1 had remained the same 
whereas H3N2 vaccines needed updates. However, the NA gene was closer to 
A/Brisbane/59/2007 which may suggest that the evolution of NA gene was 
faster as compared to other gene segments. Antigenic characterization showed 
3 aa changes in majority of the study strains relative to vaccine strain 
A/Brisbane/59/2007 (antigenic site Sb) and A/Solomon Islands/6/2003 (Sb 
and Cb) and 4 aa changes relative to A/New Caledonia/20/1999 (Sb and Ca) at 
the HA1 epitopes. The previous data indicate that > or = 4 aa substitutions at > 
or = 2 antigenic sites on the HA molecule may lead to emergence of new drift 
variants (Wilson and Cox 1990; Smith 2002). Russell et al., found that 3 aa 
changes equal 1 antigenic unit change and 2 antigenic units represent 4-fold 
difference in HA titer, representing significant antigenic change warranting 
vaccine update. 
         pH1N1/09: The pH1N1/09 virus emerged in the spring of 2009 in 
Mexico and then spread globally mainly through air travel (Khan et al. 2009). 
In many countries, the introduction of pH1N1/09 virus was through an 
imported case and Singapore was no exception. In Singapore, the first 
imported case was identified on 26 May 2009. In Singapore the importation 
was mainly by travellers from North America during the first wave and 
Australasia during the second wave (Mukherjee et al. 2010). The community 
transmission started in June and the first wave of pH1N1/09 lasted till 
September 2009.   
       The pH1N1/09 viruses were very closely related genetically to each other 
and to vaccine strain A/California/7/2009 and reference strain A/New 
York/20/2009 for the all the gene segments except PB-2. The PB-2 gene 
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segment was more closely related to A/Victoria/5/2010. The diversity of study 
strains in comparison to vaccine strain A/California/7/2009 was maximum in 
surface genes and in PB-2 gene.  
        Fereidouni et al., clustered early pH1N1/09 viruses into two clusters 
based on six gene segments (HA,NA,MP,NS,NP,PB-2) (Fereidouni et al. 
2009). In this study, similar clustering was identified with cluster 2 being 
dominant. The other cluster that circulated on campus was cluster 1.3. 
           A total of 12 mutations were detected in the HA of all the strains with 
reference to A/California/7/2009. P100S, a major non-synonymous mutation, 
detected in all the strains has occurred 98.2% of all the samples with this gene 
sequence in the flusurver database. S220T occurred in 86.38%, I338V 94.64% 
,K2E 2.78%, Q310H 3.32%, P321S 0.52% and D111N 0.47% of all the 
samples with this gene sequence in the flusurver database suggesting these 
mutations have become fixed in the viral sequences (flusurver). Q310H has 
been associated with founder effect rather than with severity in a previous 
study (Lee et al. 2010b). Its detection in mild cases collected in this study 
provides evidence that it is not associated with severe influenza. D111N 
mutation (Su et al. 2008) was detected in one sample and a mutation at this 
position has been associated with host specificity shift (avian to human) which 
hypothetically suggests some survival advantage to humans. However, V267A 
mutation which is exclusively found with D111N was not detected (Maurer-
Stroh et al. 2010). E391K mutation associated with mostly mild to few severe 
symptoms that emerged in late 2009 and early 2010 in Singapore, Australia 
and New Zealand and dual mutants E391K and N142D that emerged in April 
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2010 were not detected (Maurer-Stroh et al. 2010). D222G (Kilander et al. 
2010) change associated with severe outcome was not detected. The variants 
that emerged latter with characteristic aa changes stratifying the illness as mild 
(N125D, A134T, A141S/T, S183P, I295V) or severe (R205K, I216V, D222G, 
V249L) were also not detected (Piralla et al. 2011). A total of 8 mutations 
were found in the NA. V106I has been detected in 85.07% of all samples with 
this gene sequence in flusurver database. Only a single mutation was detected 
in MP gene segment of a single strain. A total of 9 mutations were detected in 
the NS gene. A total of 5 mutations were detected in the NP gene. A total of 9 
mutations were detected in the PA gene. A total of 4 mutations were detected 
in PB-2 gene. A total of 7 mutations were detected in PB-1 gene segment. A 
total of 55 mutations were detected in the whole genome of the study strains 
relative to A/California/7/2009. The MP was highly conserved gene amongst 
all gene segments and HA showed the most diversity. Genetic variation in PB-
2 of study strains from both A/California/7/2009 and A/New York/20/2009 
was detected. The genetic variants (29/34) possessed K660R mutation in the 
PB-2 gene segment. As of 19 Sep 2009, this mutation has occurred in 8.13% 
of all samples with this gene sequence in flusurver database. The mutation was 
first detected in A/Singapore/276/2009.  
             Furthermore, to define the broader relationship with other 
geographically distinct strains, the HA gene of the pH1N1/09 of NUS 
sequences was compared with other global strains for the same time period. 
Clustering of the NUS sequences was still maintained which provides stronger 
evidence that the NUS strains were closely related and there was in fact some 
degree of on-campus transmission. 
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6.5 Conclusions  
      Circulating over time the influenza viruses accumulate genetic changes 
and are harbingers of new variant viruses which may be antigenically distinct 
from the dominant circulating strain or may be markers of disease severity. 
Good surveillance activities can timely identify these genetic changes and can 
aid in vaccine composition recommendation and in clinical management of 
patients. In this study, the seasonal influenza viruses matched the vaccine 
strain of the upcoming influenza season. However, the comparison of 
sequences from this study with global sequences did not provide any evidence 
that the viruses first emerged in Singapore or elsewhere in Asia. Additionally, 
the results highlight that phylogenetic analysis alone may not be the best 
approach for elucidation of evolutionary dynamics of IAVs and to better 
understand these dynamically changing viruses, sequence data should be 










Chapter 7: Prediction of N-linked glycosylation sites on the glycoproteins 
HA and NA of influenza A viruses 
7.1 Background 
         IAVs can encode up to 16 proteins (Schrauwen et al. 2014). However, 
only 2 glycoproteins, HA and NA, undergo post-translational modification 
known as N-linked glycosylation whereby the Asparagine (Asn) residue in the 
Asn-X-S/T sequon (X could be any amino acid except proline) attaches to 
oligosaccharides/glycans through N-glycosidic linkages (Kornfeld & Kornfeld 
1985). There are no reports on O-linked glycosylation in IAVs (Zhirnov et al. 
2009; Blake et al. 2009). The number, position, composition and structure of 
the glycans depend on the host cell where glycosylation occurs and also on the 
subtype of IAV that undergoes glycosylation (Nakamura & Compans 1979).  
           HA and NA have been well-established as markers of virulence 
(Kobasa et al. 2004; Pappas et al. 2008). Structurally, both HA and NA 
possess a head and a stalk region (Klenk et al. 1975; Taubenberger 1998). 
Glycans can be attached to either the head or the stalk region. It has been 
shown that the glycans attached to the stalk region are crucial for the protein 
stability and are thus known to be conserved in influenza viruses (Gallagher et 
al. 1992; Roberts et al. 1993). Furthermore, the glycans can mask the antigenic 
sites on the head of both the HA and NA, causing antigenic drift, and thus 
facilitating immune evasion by the viruses. This is an important but largely 
overlooked mechanism behind antigenic drift (Abe et al. 2004; Das et al. 
2010). However, the glycans in the head of the HA and NA may attenuate 
infectivity of these viruses by affecting various biological activities, for 
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example, the presence of glycans at HA0 hinders the cleavage into HA1 and 
HA2, the presence of glycans at or near RBS attenuates infectivity (Abe et al. 
2004; Gallagher et al. 1988; Jayaraman et al. 2012; Ohuchi et al. 2002; 
Gambaryan et al. 1998). 
           Surfactant Protein (SP-D) belongs to the family of collectins which 
includes mannose binding lectin (MBL) and Conglutinin (CL43).  SP-D binds 
glycans on the surface of HA/NA and increase susceptibility to innate immune 
response by bringing about the neutralization of viruses thus playing a major 
role in innate immune defences against IAVs (Tate et al. 2014; Hartshorn et al. 
2008; Hawgood et al. 2004). Hartshorn et al., 2008 have shown that pandemic 
viruses lack susceptibility to SP-D and this may contribute to their higher 
virulence (Hartshorn et al. 2008). 
          An increase in the number of glycosylation sites in HA of influenza 
viruses with frequent gain and loss of glycosylation sites at various positions 
has been observed in IAVs (Sun et al. 2011; Zhang et al. 2004; Abe et al. 
2004). However, the number of glycosylation sites has remained constant in 
NA of influenza viruses (Zhang et al. 2004). The 1918 H1N1 virus had only 
one glycosylation site in the HA in the head region. Subsequently, the H1N1 
viruses started gaining glycosylation sites and the sH1N1 viruses before the 
emergence of pH1N1/09 had 4-5 glycosylation sites. However, pH1N1/09 
viruses have the same sites as H1N1 1918 virus because the HA is from the 
swine origin. H3N2 viruses also have gained glycosylation and the currently 
circulating H3N2 viruses have 6-7 glycosylation sites (Abe et al. 2004; 
Igarashi et al. 2008). 
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         Glycosylation sites can be either predicted employing various prediction 
tools available online or can be definitively determined using functional 
assays. The first method employs screening the deduced amino acid sequence 
for the presence of glycosylation motif N-X-S/T. This method has a 
disadvantage in that all the predicted sites may not be actually glycosylated in 
vivo. Biochemical assays or structural modelling are needed to ascertain the 
presence of glycosylation sites and to determine the composition of glycans. 
Reverse genetics approaches and site-directed mutagenesis have been 
extensively used to study the effect of gain or loss of a glycosylation site on 
the glycoproteins (Vigerust et al. 2007; Tate et al. 2011). However, these 
approaches are tedious and require cell culture facility or animal model 
experiments for observing the effects on viral growth or virulence 
 
7.2 Material and Methods 
7.2.1 Deduced protein sequences 
       Full-length sequencing of HA and NA gene for 10 sH1N1, 10 H3N2 and 
40 pH1N1/09 HA and 35pH1N1 NA was performed. The detailed methods for 
sequencing are presented in chapter two sections 2.3.3.10-2.3.3.14. Amino 
acid sequences were deduced using ExPASy tool by SIB Swiss Institute of 





7.2.2 Prediction of N-linked glycosylation sites   
        NetNGlyc server 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc) was 
used to predict glycosylation sites on HA and NA (Gupta 2002). The 
NetNGlyc server uses artificial neural networks that examine the sequence 
context of Asn-Xaa-Ser-/Thr sequons (Gupta 2002) for prediction. The 
number of glycosylation sites was obtained from single monomer of HA/NA 
and the numbering of the glycosylation sites begins from the first methionine 
in the respective protein. 
 
7.3 Results 
7.3.1 Glycosylation patterns in sH1N1 viruses 
        Five potential glycosylation sites were predicted in HA (Figure 7-1) of 
sH1N1 viruses at the following positions with predicted glycosylation sequon 
in brackets: 28 (NST), 40 (NVT), 304 (NSS), 498 (NGT) and 557 (NGS) 
(numbering starts at first methionine) in the stalk region. The first 2 sites were 
in the HA1 stalk and the latter 3 in the HA2 stalk. However, another known 
glycosylation site at position 27 in the stalk region was not predicted. On the 
side of head of HA1, 2 glycosylation sites were predicted at positions 71 
(NCS) and 104 (NGT). Additionally, two glycosylation sites were predicted at 
top of the head at positions 142 (NHT) and 177 (NLS). Structurally, these 2 
sites are present in the receptor binding domain and glycosylation at these sites 




Figure 7-1: Graph showing predicted N-glycosylation sites in HA of 
representative sH1N1 virus at threshold of 0.5. 
 
     For NA of sH1N1 viruses, 8 glycosylation sites were predicted at the 
following positions with predicted glycosylation sequon in bracket: 44 (NHT), 
58 (NST), 63 (NHT), 70 (NNT), 88 (NSS), 146 (NGT), 235 (NGS) and 434 
(NTT). Four sites were predicted on the stalk and four on the head. 
7.3.2 Glycosylation Patterns in H3N2 viruses 
       For 9/10 H3N2 strains, starting from the beginning of the first methionine 
of the HA protein, 9 potential glycosylation sites were predicted at the 
following positions with glycosylation sequon in bracket: 24 (NST), 38 
(NGT), 79 (NCT), 142 (NCT), 149 (NGT), 181 (NVT), 262 (NST), 301 
(NGS) and 499 (NGT) (Figure 7-2, Table 7.1). However, strain 139N had 
eight glycosylation sites with loss of a glycosylation site at position 142 
(Figure 7-3). The glycosylation pattern of Singapore isolates was identical to 
A/Brisbane/10/2007 which also has the same 9 glycosylation sites. 
A/Wisconsin/67/2005 also contains 9 glycosylation sites with positional 





Figure 7-2: Graph showing predicted N-glycosylation sites in HA of H3N2 




Figure 7-3: Graph showing predicted N-glycosylation sites in HA of 
A/Singapore/139N/2007 at threshold of 0.5. 
 
Table 7.1: Potential glycosylation sites predicted in HA protein of H3N2 
viruses isolated from Singapore in 2007 
*Numbering starts from the first methionine 
aRepresentative strain- 9/10 H3N2 strains had the same sites so data from one representative strain is shown 























+ + + + + - + + + + 
A/Singapore/139N/2007 + + + - + - + + + + 
A/Brisbane/10/2007 + + + + + - + + + + 
A/Wisconsin/67/2005 + + + - + + + + + + 
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      For NA of seasonal H3N2 viruses, 5 glycosylation sites were predicted 
starting from the first methionine at the following positions with glycosylation 
sequon in brackets 61 (NIT), 70 (NIT), 86 (NWS), 146 (NDT) and 234 (NGT).  
7.3.3 Glycosylation Patterns in pH1N1/09 viruses 
In the HA monomer of all the pH1N1/09 viruses sequenced in this study, 6 
glycosylation sites were predicted at a threshold of 0.5 starting from the first 
methionine (Figure 7-4). The potential glycosylation sties were predicted at 
following positions with glycosylation sequon in bracket: 28 (NST), 40 
(NVT), 104 (NGT), 304 (NTS), 498(NGT) and 557 (NGS) (Figure 7-5).  
 
 
Figure 7-4: Graph showing predicted N-glycosylation sites in HA of 
pH1N1/09 viruses at threshold of 0.5. 
 
 
Figure 7-5: Sequence of a representative strain of pH1N1/09 virus isolated in 




    Seven glycosylation sites were predicted in NA of pH1N1/09 starting from 
the first methionine at the following positions with glycosylation sequon in 




        Glycosylation in IAVs refers to addition of oligosaccharides to the 
globular head region and is an evolutionary adaptation to escape antibody 
mediated recognition and clearance. Two mechanisms of protein glycosylation 
alteration have been proposed to be involved in the antigenic evolution of 
IAVs (Sun et al. 2011). The first being an increase in the glycosylation sites 
and this mechanism has been well described by many previous studies (Das et 
al. 2010; Zhang et al. 2004; Igarashi et al. 2010; Vigerust et al. 2007; Wei et 
al. 2010) and was involved during the early stages of evolution of influenza A 
viruses before 1950s. The second mechanism also known as ‘positional 
conversion’ involves loss or gain of a glycosylation site which also has been 
well studied previously and was involved in the later stages of evolution of 
IAVs after 1950s (Sun et al. 2011). However, hyperglycosylated proteins are 
targeted by the host innate immune defences such as SP-D subsequently 
neutralized and cleared from the body (Skehel et al. 1984; Hartshorn et al. 
2008). 
             In this study, potential glycosylation sites were predicted on HA and 
NA protein molecules of the seasonal and pandemic 2009 viruses. An 
assumption was made that all the potential glycosylation sites were occupied.  
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        The pandemic 1918 virus had only one glycosylation site in the head 
region at position 104 (Stevens et al. 2004). Structurally, this position is 
located on the side of the head below Ca2 antigenic site. However, 
glycosylation variant Asn (136) with enhanced virulence in mice was not 
predicted (Job et al. 2013). 
             Seasonal H1N1 viruses have been co-circulating with H3N2 viruses 
since 1977. Subsequently, over the years, the seasonal H1N1 viruses 
accumulated more glycosylation sites at position 71,142, 144, 172, 177, 179 
(all at the top of the head) and at antigenic site Sa near the RBS and 286 (side 
of HA). The seasonal H1N1 viruses circulating worldwide before the 
emergence of pH1N1/09 had four glycosylation sites at positions 71, 104, 142 
and 177 with the first two on the side of the head and last two at the top of the 
head represented by A/Solomon Islands/3/2006 (Sun et al. 2013). Glycans at 
position 142 and 177 are present at the receptor binding domain-A and provide 
resistance to antibodies (Sun et al. 2011).  Glycan 144 has been suggested to 
bind to SP-D and increases the susceptibility to neutralization (Sun et al. 2013) 
and eventually clearance of the virus. Glycosylation sites at position 28, 40, 
104, 304, 498 and 557 on HA stalk have been conserved in all H1N1 subtype 
viruses (Gallagher et al. 1992; Klenk et al. 2002; Ohuchi et al. 1997). In the 
sH1N1 viruses and pH1N1/09 viruses isolated in this study, the glycosylation 
sites have been conserved as well. However, glycosylation sites at positions 
142 and 177 on the head of HA were not observed in the HA of pH1N1/09 
viruses isolated in this study, but were predicted in the sH1N1 isolates 




      The influenza A H3N2 viruses are in circulation since 1968 after the 
pandemic of 1968 (Simonsen et al. 2000). The 1968 pandemic virus had 2 
glycosylation sites in the head region, but the seasonal H3N2 viruses 
circulating since then have acquired additional 6-7 glycosylation sites (Abe et 
al. 2004; Vigerust et al. 2007; Zhang et al. 2004) in the head region. In 
influenza H3N2 strains sequenced in this study, 9 potential glycosylation sites 
were predicted, i.e. 4 in the head and 5 in the stalk region and same sites were 
also present in A/Brisbane/10/2007 vaccine strain. The contemporary vaccine 
strain in 2007 was A/Wisconsin/67/2005, and 9 glycosylation sites were also 
predicted. This may imply that in the event of drift from Wisconsin strain to 
Brisbane strain, the number of glycosylation sites remained the same but 
positional conversion occurred from 144 to 160.  However, in one of the 
strains sequenced in this study, there were 8 sites which suggests loss of a 
glycosylation site. In this study, experiments to confirm the predicted 
glycosylation sites were not performed.  
           The limitation of using sequencing data to predict glycosylation is that 
not all the predicted sites are glycosylated in vivo. This could be due to 
presence of 2 potential glycosylation sites in close proximity to each other 
causing steric hindrance or could be due to certain combinations that inhibit 
glycosylation (N-X-S/T-Trp or N-X-S/T-Glu) (Mellquist et al. 1998; Kasturi 
et al. 1995; Tate et al. 2014). Further analysis employing 






       The results corroborate the finding that pandemic viruses have fewer 
number of glycosylation sites than seasonal influenza viruses. Some of the 
glycosylation sites have been conserved in HA of various influenza subtypes 
especially in the stalk region which underscores the importance of 
glycosylation in the survival of IAVs. At the same time, there are variable 
glycosylation sites usually on the head region which imply evolutionary 
adaptation. Knowledge of N-linked glycosylation is critical in understanding 


















Chapter 8: Characterization of Drug Resistance 
8.1 Study Background 
      In the majority of the cases, influenza is a self-limiting infection and does 
not require administration of anti-influenza drugs. However, in patients who 
are immunocompromised or are critically ill with severe influenza, antiviral 
administration is believed to help in improving infection prognosis. Two main 
groups of antivirals are used for the prevention and treatment of influenza: M2 
channel blocker/adamantanes and Neuraminidase inhibitors (NAIs). 
        Genotypic assays, also defined as molecular assays, for drug resistance 
testing detect the amino acid mutations associated with drug resistance (WHO 
2012a) and include Sanger sequencing, pyrosequencing and real-time RT-PCR 
allelic discrimination. The advantages are shorter turn-around time and the 
option of direct performance with clinical samples obviating the need to 
culture which has been shown to induce mutations and may confound the 
interpretation of data (Lee et al. 2013). The phenotypic assays are 
neuraminidase inhibition assays (NAI assays) which are functional assays that 
allow detection of viruses with drug-resistant mutations. These are either 
fluorescence-based or chemiluminescence-based (WHO 2012b) and utilize 
small synthetic substrates and also require cultured viruses (Hurt et al. 2012). 
            Various mechanisms have been proposed to explain the emergence of 
drug resistance in influenza viruses including reassortment whereby the virus 
exchanges drug sensitive genes for drug resistant genes and single nucleotide 
polymorphism (SNP) whereby the virus acquires a mutation in a gene at the 
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sites where the drug binds to the virus. Additionally, drug resistance may arise 
de novo or from selection pressure of the drug. There are 5 well-characterized 
mutations in M2 gene that confer resistance to adamantanes: L26F, V27A/T, 
A30T/V, S31R and G34E. Molecular markers of resistance to adamantanes are 
not subtype specific. Serine to Asparagine substitution at position 31 (S31N 
mutation) has been the dominant mutation in M2 protein to date and this leads 
to resistance phenotype of the virus. Due to high level of resistance to 
adamantanes, WHO recommends against the use of adamantanes in treatment 
and prophylaxis of influenza (WHO 2012b)  
          The molecular markers of resistance to NAIs are type and subtype- 
specific (Abed 2006). The catalytic site of NA is constituted by 8 functional 
residues (R-118, D-151, R-152, R-224, E-276, R-292, R-371, and Y-406), 
surrounded by 11 framework residues (E-119, R-156, W-178, S-179, D-198, I-
222, E-227, H-274, E-277, N-294, and E-425) (N2 numbering) and these sites 
are conserved in IAVs and IBVs (Samson et al. 2013; Arvia et al. 2013; 
Colman et al. 1983). Oseltamivir molecule has a large hydrophobic side chain 
and to accommodate this molecule, the NA must undergo structural 
rearrangements. For this rearrangement, interaction of aa E276 with R224 is 
required (Collins et al. 2008; Malaisree et al. 2008). Any mutations that affects 
this rearrangement may reduce the binding affinity of oseltamivir leading to 
reduced efficiency. Till date, mutation histidine to tyrosine (H274Y), has been 
the principal mutation associated with oseltamivir resistance. Additionally, 
mutations R292K and N294S have been commonly associated with 
oseltamivir reduced sensitivity, have been shown to affect the interaction of aa 
E276 and R224 (Wang et al. 2002).  
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           An analysis of HA, NA and M1/2 proteins of viruses isolated on 
campus from 2007 to 2009 was conducted to better understand the 
epidemiology of drug resistance in a semi-closed university setting. The data 
from the university campus from year 2007-09 may help fill in some of the 
gaps in data availability from the tropical regions of SEA as there is a dearth 
of data from this region as highlighted by WHO survey in 2010 (WHO 
2012c).  
 
8.2 Materials and methods 
         The nucleotide sequences were aligned and edited using the Lasergene 
software. The nucleotide data were translated to protein using the ExPASy 
translate tool available at http://web.expasy.org/translate/. The deduced amino 
acid sequences were aligned employing the multiple alignment tool, multalin, 
available at http://multalin.toulouse.inra.fr/multalin/. M1 alignment had 252 
aa, M2 97 aa; NA 469 aa and HA1 326 aa. The alignments were visually 
inspected for the presence of well-established and published molecular 
markers of drug resistance in the individual proteins. The M2 protein was 
investigated for molecular marker which are common in all subtypes: L26F, 
V27A/T, A30T/V, S31R and G34E (Hay et al. 1986). The molecular markers 





Table 8.1: Differential susceptibility of various influenza subtypes to 





  Phenotype in NA inhibition 
assays
b 
Oseltamivir   Zanamivir   
Peramivir 
Reference 
sH1N1 H274Y HRI S HRI (Mishin et al. 2005) 
Q136K S HRI - ( Hurt et al. 2009a) 
pH1N1/09 N294S HRI S RI (Pizzorno et al. 2011) 
H274Y HRI S HRI (Baz et al. 2009) 
S246N/H274Y HRI S HRI (Hurt et al. 2011) 
I222V/H274Y HRI S HRI (Pizzorno et al. 2011) 
I222R/H274Y HRI RI HRI (Pizzorno et al. 2012; 
Nguyen et al. 2010) 
I222R RI RI RI (Pizzorno et al. 2012;  
Eshaghi et al. 2011) 
E119G S HRI RI (Pizzorno et al. 2011) 
E119V RI HRI RI (Pizzorno et al. 2011) 
H3N2 N294S HRI S - (Kiso et al. 2004.) 
R292K HRI S/RI - (Carr et al. 2002;  
Sheu et al. 2008;  
Yen et al. 2006) 
DELETION 
245-248 
HRI S S (Abed et al. 2009) 
D151A/D S HRI - (Sheu et al. 2008)  
Q136K S RI - (Dapat et al. 2010) 
E119V/I222V HRI S S (Baz et al. 2006) 
E119V HRI S  (Mishin et al. 2005) 
R224K HRI HRI - (Yen et al. 2006) 
R371K RI RI - (Yen et al. 2006) 





     Ten full-length sequences of each of NA, M2 and HA1 for each of H3N2 
and sH1N1 viruses and 35 full-length sequences of NA, 38 full-length M2 and 
40 full-length HA1 of pH1N1/09 viruses were successfully sequenced from 
native clinical samples. The rest of the influenza positive samples could not be 
sequenced probably because of a high ct value (>34) suggesting low titres of 
virus. 
8.3.1 Characterization of drug resistance in H3N2 viruses  
   MP gene: Of the 5 well-established molecular markers: L26F, V27A/T, 
A30T/V, S31R and G34E for drug resistance in M2 protein, only S31N was 
detected in 9/10 sequenced H3N2 strains. However, there was one strain 
A/Singapore/139N/2007 which was adamantine sensitive as it harboured S 
(Serine) in place of N (Asparagine) at position 31. The M1 protein was highly 
conserved in the H3N2 sequences and was 100% identical at amino acid level 
to both A/Brisbane/10/2007 and A/Wisconsin/67/2005 for 90% of study 
strains. One strain, A/Singapore/139N/2007, had M1 and M2 proteins 100% 
identical to A/Nepal/921/2006.   
   HA gene: All the sequenced H3N2 strains harboured S193F and D225N 
mutations in the HA. 
   NA gene: A total of 10 H3N2 viruses were sequenced and visually inspected 
for oseltamivir resistance. H274Y (N2 numbering) mutation which is the 
primary mutation responsible for oseltamivir resistance or any other marker of 
oseltamivir resistance was not detected in any of the isolates.  
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Figure 8.1: Amino acid alignment (97 aa) of M2 protein of H3N2 (A), sH1N1 
(B), p09H1N1 (C) and combined H3N2 and sH1N1 (D) viruses 
A: M2 H3N2 
 
B: M2 sH1N1 
 





D: H3N2 and sH1N1 M2 protein 
 
 
8.3.2 Characterization of drug resistance in sH1N1 viruses 
    MP gene: Only S31N substitution was detected and no other substitution 
(L26F, V27A/T, A30T/V, S31R and G34E) was found in all the 10 sequences 
sequenced in this study.  
    NA gene: Neither H274Y nor Q136K (N2 numbering) marker of resistance 
to oseltamivir and zanamivir respectively was detected in NA of any of the 10 
sH1N1 viruses. However, permissive mutations R222Q and V234M which 
may compensate the defect caused by H275Y (N1 numbering) mutation, were 
detected. 
    HA gene: 9/10 had T82R and one had T82K; K141E mutation was found in 





8.3.3 Characterization of drug resistance in pH1N1/09 viruses 
    MP gene: Only S31N substitution was detected and no other substitution 
(L26F, V27A/T, A30T/V, S31R and G34E) was found in all the 38 p09H1N1 
viruses sequenced. 
     NA gene: None of the substitutions such as E119V, E119V/I222V, Q136K, 
D151A/D, R224K, H274Y, R292K,N294S, R292K,R371K reported in the 
literature to be associated with neuraminidase inhibitor resistance were not 
found in any of the 35 pH1N1/09 sequences.  
 
8.4 Discussion 
       The genetic make-up of viruses affects the replication capacity and 
transmissibility of viruses. Permissive mutations such as D344N, V234M and 
R222Q in NA of A/Brisbane/59/2007 like viruses allowed the introduction of 
H275Y mutation (N1 numbering) without compromising viral fitness (Bloom 
et al. 2010; Abed et al. 2011). Bloom et al., assessed the role of permissive 
mutations in NA on the replication capacity of pH1N1/09 viruses using 
computational analysis and identified permissive mutation N369K (Bloom et 
al. 2011). Two more mutations V241I and N386S were predicted to be 
associated with facilitating H275Y substitution (Hurt et al. 2012b; Samson et 
al. 2013). Pizzorno et al., have shown that E119V and E119G substitutions 
confer multidrug resistance phenotype but showed poor replication kinetics in 
cell culture suggesting lower transmissibility (Pizzorno et al. 2011). 
Furthermore, double mutants H275Y and I223V (N1 numbering) and H275Y 
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and S247N have been shown to compensate for any loss in NA activity by 
H275Y mutation and increase replication capacity of pH1N1/09 virus 
(Pizzorno et al. 2011; Nguyen et al. 2010). In sH1N1 subtype N294S 
mutations have been shown to markedly decrease the sensitivity to oseltamivir 
(Abed et al. 2006). In H3N2 subtype, R292K and E119V mutations 
predominate in clinical samples (Kiso et al. 2004; Whitley et al. 2001). 
Notably, Abed et al., 2009 also found a role of NA deletion mutations in NAI 
resistance (Abed et al. 2009).   
         The association between permissive mutations in HA and development 
of resistance to NAIs has been proposed by Barr et al., but  Deyde et al., with 
larger sample size and wider geographic coverage found this association does 
not uphold in all cases (Barr et al. 2007; Deyde et al. 2007). Ginting et al., in 
identified mutations in HA that may have helped in emergence of oseltamivir 
resistant strains (Ginting et al. 2012).  
           In this study, the resistance pattern in influenza viruses of various 
genetic backgrounds that were isolated from the NUS campus from 2007-2009 
was studied in order to better understand the epidemiology of drug resistance 
prevailing on campus. 
8.4.1 H3N2 viruses   
       In 2007-08 influenza season, globally almost 100% of H3N2 viruses in 
Asia were resistant to adamantane (Deyde et al. 2007). N lineage viruses were 
the predominant circulating strains globally then back in 2005 with some S 
lineage strains also co-circulating. N lineage viruses had the characteristic 
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changes in HA protein: S193F and D225N. These changes are also found in 
vaccine strains A/Wisconsin/67/2005 and A/Brisbane/10/2007 (Nelson et al. 
2009). N lineage was further subdivided into N lineage resistant strains 
(S193F and D225N in HA and S31N in M2) and N lineage sensitive strains 
(S193F and D225N in HA and without S31N in M2). Furuse et al., in have 
shown that N lineage sensitive strains acquired MP gene that was adamantane 
sensitive by reassortment with A/California/7/04 and that the combination 
S193F and D225N in HA was not necessarily associated with fitness (Furuse 
et al. 2009). S lineage did not harbour S193F or D225N and was sensitive to 
adamantanes. The mutation S31N was introduced 11 times during 1997 to 
2007 as shown by Nelson et al., but only the introduction number 7 became 
dominant globally and these strains acquired new HA which later became 
A/Wisconsin/67/2005 (N lineage) lineage (Nelson et al. 2009). Ninety percent 
of H3N2 strains (9/10) sequenced from university cohort in 2007-08 were 
adamantine resistant, however, only A/Singapore/139N/2007 was adamantine 
sensitive. The mutation responsible for the resistance to adamantanes was the 
well-established substitution mutation S31N (Hay et al. 1986; Boivin et al. 
2002). Adamantane resistant viruses are genetically stable and easily 
transmissible (Hayden et al. 1989; Abed et al. 2005), however, the virulence or 
pathogenicity is not very different from the wild-type virus (Hayden et al. 
1991). Ninety percent (9/10) of the H3N2 strains sequenced in this study were 
N lineage resistant Brisbane-like strains and 10% were N lineage sensitive 
Wisconsin-like strains. S lineage was not detected in this study. The markers 
for highly reduced susceptibility to oseltamivir in clinical practice such as 
N294S, R292K, H274Y, deletion 245-248, E119V/I222V, E119V (N2 
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numbering) were not detected (Carr et al. 2002; Sheu et al. 2008; Abed et al. 
2009; Kiso et al. 2004).  
8.4.2 sH1N1 viruses 
       Almost all sH1N1, A/Brisbane/59/2007 like viruses world-wide were 
resistant to oseltamivir in influenza season 2008-09 (Thorlund et al. 2011; 
Deyde et al. 2010) but were sensitive to zanamivir. In Singapore, resistance  to 
adamantanes like elsewhere was highly prevalent during the study period from 
2007-09 reference (Tang et al. 2012). In this study, a high prevalence of 
adamantane resistance in sH1N1 viruses that circulated in 2007 on the 
university campus was detected. The molecular marker indicating resistance to 
oseltamivir, H275Y (N1 numbering) (Mishin et al. 2005) and of resistance to 
zanamivir, Q136K (Hurt et al. 2009b) were, however, not detected in any of 
the sequenced sH1N1 viruses. In Singapore, NAIs are only prescribed for 
patients who are immunocompromised or clinically very ill that might partly 
explain low prevalence of NAI resistance in study isolates (Tang et al. 2012). 
Ginting et al., identified permissive mutations T82K, K141E and R189K 
(Ginting et al. 2012). In HA1, T82R mutation was observed in 9/10 sequences 
and T82K was found in only one isolate, K141E was observed in 9/10 isolates 
and R189M mutation was found instead of R189K. The latter two mutations 
were at antigenic sites Ca2 and Sb. Bloom et al., suggested the role of 
permissive mutations R222Q and V234M in NA in compensating the defect 
caused by H275Y mutation, and this mutation was present in all the sequenced 
sH1N1 isolates in this study (Bloom et al. 2010). Unfortunately, there were no 
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sequences of sH1N1 viruses from 2008-09 to analyse for the emergence of 
neuraminidase resistance.  
8.4.3 pH1N1/09 viruses  
      Pandemic 2009 viruses are reassortant viruses carrying NA and MP gene 
from Eurasian adamantane resistant swine influenza virus. After their 
emergence in spring of 2009 they were initially sensitive to NAIs with only 
sporadic cases of resistance reported in patients on drug therapy (Deyde et al. 
2010). But later on, pH1N1/09 viruses with H275Y (N1 numbering) as major 
mutation conferring resistance phenotype were detected (Harvala et al. 2010; 
Ledesma et al. 2011). Nevertheless, 98% strains of pH1N1/09 are still 
susceptible to NAIs (CDC 2014d). In this study, the sequenced influenza 
strains were from the early phase of pandemic and did not harbour any of the 
markers of clinical neuraminidase resistance such as H275Y, combined 
mutants H275Y/I223V/R or H275Y/S247N and reduced susceptibility mutants 
with I223V (N1 numbering) (Eshaghi et al. 2011; Nguyen et al. 2010). 
However, the S31N mutation in M2 protein which causes clinical resistance to 









       Characterization of drug resistance in a university cohort from 2007-2009 
showed absence of oseltamivir resistance and very high prevalence of 
adamantane resistance in both seasonal and pH1N1/09 virus. Limited data on 
drug resistance are available from Singapore from 2007 to early phase of 
pandemic of 2009 (till first epidemic wave). The results may help fill the gaps 
in the data availability for this time and may serve as baseline reference for the 
healthcare practitioners in Singapore. Furthermore, emergence of drug 
resistant mutants de novo without drug selection pressure underscores the 
importance of continued drug resistance monitoring worldwide, especially in 

















Chapter 9: Molecular epidemiology and Transmission of influenza  
9.1 Background 
      Molecular data have been instrumental in studying the  origin (Smith et al. 
2009) as well as persistence and migration (Le et al. 2013) of influenza 
viruses. In addition, molecular studies provide detailed virus characteristics 
such as type, subtype, lineage, virulence and drug resistance markers. It also 
provide insights into the pathways of viral transmission (Cheng et al. 2013). 
Such studies perhaps confer one of the most obvious advantages over 
epidemiological data alone (Viboud et al. 2013). However, they are not 
without limitations such as sampling bias, for example, samples are collected 
predominantly during the epidemics in temperate regions and for the purposes 
of vaccine strain selection. Therefore, the study of phylogeography of 
influenza virus requires integrating the molecular data with epidemiological 
data. The term ‘molecular epidemiology was first coined in a 1973 article 
entitled, “The molecular epidemiology of influenza” (Kilbourne 1973). In 
recent years, the sequencing data on influenza virus have expanded 
enormously, but not many studies have linked molecular data with 
epidemiological data. A better integration of molecular and epidemiological 
data may (i) help unfold the dynamics of spatial transmission, (ii) provide 
insights into the global migration patterns of influenza viruses and the 
existence of source populations, and (iii) help public authorities to plan more 
targeted intervention strategies.  In an event of impending pandemic, a better 
understanding of migration patterns of novel or emerging viruses may help 
public authorities to develop effective pandemic preparedness plans and 
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decide on the need of border screening or travel restrictions. Similarly, a better 
understanding of transmission dynamics in localized communities could help 
identify foci of influenza transmission for more targeted interventions, such as 
school closure or household prophylaxis (Viboud et al. 2013). In recent years, 
the approach of molecular epidemiology has been applied to  emerging 
influenza viruses, pH1N1/09 and H7N9 virus in particular (Kidd 2014). 
Although there is availability of data on the spatial and temporal dynamics of 
influenza at global and national levels from temperate regions, the 
transmission dynamics have not been thoroughly explored in tropical regions 
and especially in localized, semi-closed settings such as universities or 
military camps.  Holmes et al., examined the spatial diffusion of pH1N1/09 
virus in a localized community of the University of California, and found that 
although there was intra-campus transmission, there was no significant 
association of residence with clustering of similar viral strains (Holmes et al. 
2011). 
          The work presented in this chapter was undertaken to identify 
distinctive epidemiological factors associated with transmission of influenza 
on campus and to explore the molecular epidemiology of influenza in the 
university setting. The study determined what proportion of influenza is 
indeed transmitted on campus and what proportion was introduced from 
sources outside the university. This has tremendous implications for the 
response to future pandemics. If the majority of influenza is transmitted on 
campus, i.e. there is substantial virus clustering on campus and the influenza 
strains isolated are proven by molecular epidemiology to be closely linked,  
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then possible closure of large institutions or on-campus intervention methods 
to halt influenza transmission, such as quarantine of hostels, cancellation of 
lectures, shut-down of canteen areas or closure of facility areas may be an 
important and useful strategy in the next pandemic. If on the other hand, the 
majority of influenza strains are distinct and there is no evidence of clustering, 
suggesting importation from contacts off campus, then the major intervention 
strategies would be very different. 
 
9.2 Materials and methods  
9.2.1 Part A 
           Eleven hemagglutinin (HA) genes of seasonal (sH1N1 and H3N2) and 
40 HA genes of pH1N1/09 influenza viruses were included in this analysis. 
The fifty-one sequences of HA gene were then divided into two groups- 
“shared” strains versus “non-shared” strains  which represented clustered 
transmission groups versus isolated introductions. The criteria for shared 
strains were 100% aa identity in two or more strains with date of collection 
within 5 days of each other, or from the preceding one in the cluster 
respectively. This would probably suggest that some kind of active 
transmission was going on. The two groups were then compared across 
various demographic characteristics such as age, gender, on-campus residence, 





9.2.2 Part B  
       Analysis was conducted on full-genomes of 34 pH1N1/09 viruses 
successfully sequenced in this study. 
9.2.2.1 Phylogenetic analysis  
         For the whole genome concatenation Geneious R7  
http://www.geneious.com / (Kearse et al. 2012) was used. The coding regions 
of gene segments PB-2, PB-1, PA, HA, NP, NA, M1, M2, NS1 and NS2 were 
concatenated using the software. The whole genomes were then used for the 
construction of phylogenetic trees using the best-fit nucleotide substitution 
model (TVM+Gamma+Invariant sites) determined by Modeltest 3.7 (Posada 
& Crandall 1998; Posada 1998). Bootstrapping with 1000 replicates was 
undertaken to assess the robustness of the phylogenetic trees. All the analyses 
were performed in the PAUP package (Swofford 2002). 
9.2.2.2 Phylogeographic/BaTS analysis 
        BaTS software (http://evolve.zoo.ox.ac.uk/Evolve/BaTS.html) (Parker et 
al. 2008) was used to assess the degree to which the phylogeny of the viruses 
was related with the phenotypic traits. The analysis was undertaken to 
determine the spatial dynamics of IAV infection in the localized university 
community of NUS. For the spatial component there were two categories: the 
location of the residence (‘On-campus’ or ‘Off-campus’) and faculty (‘Life 
Science’: Science, Nursing and Medicine faculties or ‘Non-Life Science’: 
Engineering, Business, Design and Environment, Computing, Arts and Social 
Science). The other factors that were analysed for phylogenetic clustering 
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were age (<25 or >25); gender (Male or Female); Singaporean (Yes or No). 
The BaTS program has a pre-requisite of Bayesian analysis as it uses the tree 
file with posterior probabilities that is generated in the BEAST v1.8 software 
(Drummond & Rambaut 2007). The Bayesian analysis was performed using 
Bayesian Markov Chain Monte Carlo (MCMC) method with GTR+I+G 
substitution model along with estimated relaxed (uncorrelated lognormal) 
molecular clock. The analyses were performed with a time-aware Gaussian 
Markov Random Field Bayesian Skyride coalescent tree, prior to the 
UPGMA-derived starting tree. All model parameters were given with 
relatively uninformative prior (default setting), except a uniform prior 
distribution for the mean substitution rate with initial value of 0.005 
substitution per site per year and lower/upper limits of 0.0/1.0. Analysis was 
performed with length of MCMC chain of 50 million and sampled at every 
5000th generation. The analysis generated a total of 10000 samples for 
parameter estimates. Ten percent burn-in was applied for the analysis. This 
provided with a posterior set of trees (PSTs) which were then used to 
investigate each of the phenotypic traits listed earlier. Each trait was analysed 
as a binary character annotated into the posterior set of trees from the Beast 
analysis using the BaTS program. Two statistics (a) Association index (AI) 
(Wang et al. 2001) and (b) Parsimony score (PS) (Fitch 1971) were calculated 
to determine the phylogeny and trait association. These two statistics 
determine the strength of phylogenetic clustering by place of isolation. A p 
value of 0.05 was considered statistically significant which means that the 
clustering was in fact associated with the trait under analysis and was not 
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9.3.1 Part A 
        There were 31 ‘shared strains’ and 20 ‘non-shared strains’ suggesting at 
least some degree of transmission on campus and a limited amount of 
introductions.  The 31 in the shared group were all pH1N1/09 strain sequences 
which could be further sub-divided into 4 clusters with 100% identical aa 
patterns (Figure 9-1). Cluster A had 24 strains, clusters B and C had three 
strains each, and cluster D had two strains (Figure 9-1). The non-shared group 
had 9 distinct pandemic H1N1 2009 strains and 11 distinct seasonal influenza 
strains (sH1N1 and H3N2) (Figure 9-2). Residence at a student hostel was 
identified as a risk factor for having a shared strain (Table 9.1). 
Table 9.1: Association of Epidemiological factors with transmission of 
influenza 
P value of <0.05 was statistically significant (shown in red) 
Epidemiological factor Odds Ratio (95% CI) p-value 
On-campus vs Off-campus 
residence  
4.2 (1.2-14.9) 0.02 
Age <25 vs Age >25 years 2.3 (0.6-8.9) 0.22 
Gender 0.8 (0.2-2.7) 0.74 
Life Sciences vs Non-life 
sciences 
1.7 (0.5-5.9) 0.41 





Figure 9-1: Neighbor-Joining tree for 31 ‘shared strains’ based on amino acid 
sequences of Hemagglutinin (HA) of pH1N1/09 viruses. Four distinct clusters 
identified are shown in different colors and the name of the strain is followed 
by the day and month of sample collection. Green color strains belong to 
cluster A, blue color strains belong to cluster B, red color strains belong to 
cluster C and grey color strains belong to cluster D. The analysis were 
conducted in Mega 6. The bar at the bottom indicates the number of amino 










Figure 9-2: Neighbor-joining trees for ‘non-shared strains’ based on amino 
acid sequences of Hemagglutinin (HA) of influenza virus subtypes H3N2 (A), 
sH1N1 (B) and pandemic H1N1/09 (C)  detected on Singapore university 
campus. The analyses were conducted in Mega 6. The bar at the bottom 
indicates the number of amino acid substitutions per site. The strain name is 





9.3.2 Part B 
       Phylogenetic analysis presented in chapter 6 showed that both clade VI 
and VII pH1N1/09 viruses were co-circulating on campus during the first 
pandemic wave in Singapore from July to August at NUS campus. It is 
possible that all the earlier clades might have been displaced by clade VI and 
clade VII viruses. From the phylogenetic tree (Figure 9-3), five well-supported 
clusters (boot strap value >70) of pH1N1/09 viruses from the university 
students and staff can be seen. Clustering of pH1N1/09 suggests that there was 
some kind of intra-university/on campus transmission going on. The clusters 
were assigned names from A to E as shown in figure 9-3. All the clusters (A, 
C, D and E) comprised three virus strains each, except one cluster (B) which 
had two strains. Of the 5 clusters, only cluster E had the three clade VI virus 
strains while the rest had clade VII viruses. Apart from clustered viruses, there 
were singleton viruses which may suggest independent viral introduction 
events. The phylogeny of the pH1N1/09 viruses was then correlated with the 
epidemiological characteristics. The location of residence was compared 
amongst the various strains in each cluster. In 3 of the clusters: C, D and E, all 
the member strains were isolated from students staying on campus. This 
suggests possible intra-university transmission of influenza. However, in the 
other 3 clusters: A and B, both on-campus and off-campus strains clustered 
together. Universities represent a semi-closed setting and are themselves a 
small community where the student interaction/mixing may happen at various 
places like hostels, classrooms, canteens or while using the various university 
facilities. A closer look into the clusters with the aid of integrated phylogenetic  
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and epidemiological data provided more insights into the transmission 
dynamics on campus.  Cluster D contained three strains from students who 
reported sick on the same day, were from the same hostel and even the same 
faculty which provides strong evidence of intra campus transmission. 
Furthermore, one strain was isolated from a student who reported contact 
history with a sick neighbour in Malaysia. It is quite possible that he acquired 
infection in Malaysia and then spread it to other fellow students on campus. 
However, in cluster E, the first strain (according to the date of collection) 
A/Singapore/395/2009 was isolated from a student from non-life science 
faculty and from a different hostel than the other two strains 
A/Singapore/410/2009 and A/Singapore/419/2009. These 2 strains were 
isolated from students from life science faculty, who shared the same hostel 
and reported sick on the same day. This suggests the strain the student with 
A/Singapore/395/2009 strain may have infected the students with strains  
A/Singapore/410/2009 or A/Singapore/419/2009 on campus but at a location 
other than hostel and classroom e.g. library, canteen or while using hostel 
facilities, suggesting some kind of spatial mixing on campus. Interestingly, 
there were some students who reported sick on the same day or one day apart 
and were from the same hostel and even same faculty but did not share highly 
similar strains. 
           To further strengthen the analysis and to clear the ambiguity associated 
with phylogenetic analysis, another test of phylogeny-trait associations was 
conducted using the BaTS software. Two statistics, AI and PS scores, were 
calculated for various demographic characteristics to explore the strength of 
clustering. The Scores are shown in table 9.2.  
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      The phylogeography of the viruses was analysed employing two 
characteristics: residence location and faculty. The residence location was 
annotated as ‘On-campus’ or ‘Off-campus’ and faculty was annotated as Life 
Science or Non-Life Science as explained in the text earlier on. The results 
showed that there was in fact some degree of clustering according to residence 
and this was not merely due to chance (AI P=0.009; PS P=0.04). There was 
also evidence of clustering with faculty (AI P=0.02; PS P=0.05). 
 
Table 9.2: Results of phylogeny trait association for pandemic 2009 viruses 




Statistic                       Value (95% CI) 
    
      Observed                           Null 
P value 















































AI- Association index; PS-Parsimony score; P value <0.05 was statistically significant, Life Science- Medicine, 





Figure 9-3: Maximum Likelihood phylogenetic tree of 34 concatenated genomes of pH1N1/09 viruses from NUS campus. Strain name is 
followed by residence status and week of isolation. On-campus sequences are in red font and Off-campus sequences are in black font. Clusters 




       There are studies elaborating on the laboratory methods used for 
determining the linkages of influenza and other viruses. In particular, Holmes 
et al., (Rambaut & Holmes 2009) used computerized analyses ‘Bayesian’ 
(BEAST) of genomic sequencing data to compare viruses from across the 
world. Cauchumez et al., have published models describing transmission in 
families but have not validated their findings using molecular epidemiological 
methods (Cauchemez et al. 2009). There are epidemiological transmission 
studies (Uchida et al. 2012; Ali et al. 2013), but these are not supported by 
molecular data. There have been comprehensive epidemiologic studies from 
Singapore (Mukherjee et al. 2010) on the pandemic influenza pH1N1/09 
describing the national epidemiology of this novel virus. There has been a 
study which correlated clinical information with phylogenetic analysis of 
Singaporean sequences in the post-pandemic period but utilized sequencing of 
HA gene only (Maurer-Stroh et al. 2010). Similarly, there have been studies of 
influenza epidemiology (Aiello 2010) in semi-closed settings such as campus 
dormitories but these have not included molecular epidemiology or 
phlygeography. An outbreak report was published about a school outbreak but 
again without molecular epidemiology (Lessler et al. 2009).  
          This study was undertaken on NUS campus to understand the spatial 
dynamics of spread and transmission of IAVs. Universities represent a setting 
of a semi-closed community, but not many studies are available on the study 
of phylogeography in university setting. However, there are some data 
available on the study of influenza outbreaks in university populations but 
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without phylogeoraphy (Pons et al. 1980; Okoror et al. 2011; Mitchell et al. 
2014). Outbreak studies can determine attack rates well, but are not suitable to 
understand transmission dynamics which are critical in planning the response 
to future pandemics.  
          In this chapter, two separate analyses to study the transmission 
dynamics of IAVs were conducted. The first analysis was based on the 
percentage of aa identity of the HA protein sequences: ‘Shared’ & ‘Non-
shared’ strains. Shared strains outnumbered non-shared strains, and all the 
shared strains were pH1N1/09. Residence at hostel was identified as 
independent risk factor for having a shared strain. Clustering of identical 
strains in subjects staying on campus in hostels suggests that influenza 
transmission occurred on campus. While planning control strategies for 
influenza epidemics or mitigation strategies for pandemics, this demographic 
risk factor needs to be taken into consideration.  
          The second analysis using concatenated whole genome approach was 
undertaken to determine the molecular epidemiology of influenza. The 
concatenation may provide more concrete phylogenetic evidence than the 
single gene approach in understanding the complex microevolution of IAVs as 
genetic drift occurs in internal genes as well due to the error prone nature of 
low fidelity RNA polymerase and the aspect of reassortment was also taken 
into account. The phylogenetic analysis showed some evidence of clustering 
of highly similar sequences suggesting intra-campus transmission. 
Furthermore, the phylogeographic analysis also confirmed the evidence of 
clustering based on the residence and faculty of the students (both the statistics 
169 
 
AI and PS were statistically significant). Although a larger dataset is required 
to strongly substantiate the conclusion, this study still gives a good evidence of 
association of phylogeny with geography in a localized community of NUS. 
On the contrary, another study by Holmes et al., found no association between 
phylogeny and residence using 57 complete genomes of viruses on campus on 
the University of California, San Diego (Holmes et al. 2011). Smoking status 
was also found to be associated with clustering. However, other demographic 
characteristics analysed in this study such as age, gender, or nationality status 
were not found to be associated with clustering.  
 
9.5 Conclusions 
       Phylogenetic data showed evidence of well-supported geographical 
clustering of highly similar pandemic 2009 H1N1 influenza virus sequences 
with the majority from on-campus students suggesting some degree of intra-
campus transmission. Furthermore, phylogeographic analysis strengthened the 
evidence of geographical clustering by providing statistically significant 
association of residence and faculty with clustering. Integration of molecular, 
epidemiological and statistical methods can better help public health 
authorities to identify foci of transmission in localized communities such as 
universities. Identification of transmission hot spots can lead to more targeted 
intervention strategies such as closures of the university or campus-based 




Chapter 10: Conclusions and future work 
  In this chapter, key findings of the overall research work undertaken, 
conclusions and possible future work are presented. 
10.1 Viral etiology of ILI on NUS campus, 2007-09 
         The viral etiology of ILI in 500 students and staff was determined and a 
total of 9 viruses were tested in the nasopharyngeal swabs using real-time PCR 
assays. At least one viral agent was identified in 65% of cases of ILI. 
Influenza virus (32.8%) was identified as the main causative agent followed 
by adenovirus (32.4%), rhinovirus (10.6%), enterovirus (7%), coronavirus 
(3.4%), parainfluenza virus (1.4%), respiratory syncytial virus (1.4%) and 
human metapneumovirus (1%). Co-infections were detected in 21% of cases. 
Influenza virus predominance was expected, but adenovirus detection in such 
a huge proportion was revealed for the first time in a university cohort. There 
are not many studies with adenovirus predominance in ILI in adults in a 
university setting. Although the Singapore MOH conducts surveillance in the 
general community population, this should be supplemented with surveillance 
information from other localized communities, such as universities. This may 
provide a broader picture of the etiology of ILI so that the clinicians and 
policy makers will be better guided to take decisions on control and prevention 
of ILIs.  
Future work: In this study, bacterial agents were not tested at the time of 
writing. Future work may involve testing for the bacterial agents for 
comprehensive characterization of the etiology of ILI. The role of adenovirus 
as a respiratory pathogen also needs to be better defined in the local context. 
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10.2 Clinical characteristics of study population 
        Among subjects with ILI, those diagnosed with influenza had 
significantly higher incidence of fever, cough, chills, running nose and aches. 
Influenza vaccination should be recommended in those living on-campus 
because the infection increases morbidity in young adults. Although vaccine 
mismatch may be a problem but that too is usually for one subtype of virus 
and the trivalent/quadrivalent vaccine is still effective against other types and 
subtypes. 
Future work: As this study was predominantly an influenza study, clinical 
characteristics of other agents responsible for ILI were not analysed. Future 
work may involve determining the clinical characteristics of other viral agents 
responsible for ILI. 
10.3 Comparison between PCR and culture to detect influenza 
        The overall sensitivity difference for IAV detection using RT-PCR versus 
viral isolation was 50%; for total seasonal influenza was 61%; and for 
pandemic 2009 influenza was 33%. This shows that RT-PCR was superior to 
viral isolation techniques in detecting both seasonal and pandemic influenza. 
Furthermore, the results from this study also show that seasonal influenza A 
was even more readily detected by molecular-based than viral isolation 
methods compared with pandemic 2009 influenza A infection. This may 
probably be due to difficulty in culturing the seasonal IAV or higher 




10.4 Genetic characterization of influenza viruses circulating on campus 
      Circulating seasonal IAVs were genetically diverse from the contemporary 
vaccine strain recommended for the same season. They matched well with the 
vaccine strain of the upcoming influenza season. This suggests that good 
surveillance activities using molecular surveillance can identify these genetic 
changes and can aid in vaccine composition recommendation and in clinical 
management of patients. Additionally, the results highlight that phylogenetic 
analysis alone may not be the best approach for elucidation of evolutionary 
dynamics of IAVs. To better understand these dynamically changing viruses, 
sequence data should be correlated with epidemiological data. 
Future work: In this study, the influenza virus strains sequenced were from 
‘mild’ cases and it would be interesting to compare the sequence data and 
clinical data with the data from the strains that cause ‘severe’ infections 
especially strains from hospitalized patients. This will provide insights into the 
determination of markers of virulence of IAVs. 
10.5 Prediction of glycosylation sites 
      In this study, potential glycosylation sites were predicted on HA and NA 
protein molecules of seasonal and 2009 pandemic IAVs circulating on NUS 
campus. In influenza H3N2 strains sequenced in this study, the potential 
predicted glycosylation sites in HA were at same position and in same 
numbers in the A/Brisbane/10/2007 vaccine strain. However, the 
contemporary vaccine strain A/Wisconsin/67/2005 had same number of sites 
with one positional conversion. In influenza sH1N1 strains sequenced in this 
173 
 
study 9 potential glycosylation sites were predicted in the HA: 4 in the head 
and 5 in the stalk region. The pH1N1/09 viruses isolated in this study, have the 
same glycosylation pattern as the 1918 pandemic virus i.e. Asn (104) as others 
have reported. 
Future work: The advantage of using sequencing data and performing 
genotyping assays is that they are faster and are not confounded by the 
mutations introduced during passaging in cultures. However, they have a 
limitation that they are only predictive of glycosylation and are not 
confirmatory. Functional assays would be of great interest and future work 
may involve performing glycan assays on some representative strains to 
confirm the glycosylation sites. This may have provide insights into the 
transmissibility of the virus as to why some strains are transmissible and 
others are not and instead have a dead end.  
10.6 Drug Resistance monitoring 
     The results show no evidence of oseltamivir resistance and very high 
prevalence of adamantane resistance on university campus from 2007-09. The 
data reflect low use of NAIs in Singapore vis-å-vis Western Europe and Japan 
where widespread use of NAIS has led to significant resistance (Thorlund et 
al. 2011). Limited data on drug resistance are available from Singapore from 
2007 to early phase of pandemic 2009 (till first epidemic wave). The results 
may help fill the current gaps in the data availability and may serve as baseline 
reference for the healthcare practitioners in Singapore. Furthermore, 
emergence of drug resistant mutants de novo sans drug selection pressure 
underscores the importance of continued drug resistance monitoring 
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worldwide and especially in SEA which is believed to be the epicentre for the 
emergence of new variants of influenza virus. 
Future work: Phenotypic assays for determining drug resistance were not 
performed. In fact, a comprehensive surveillance activity should involve both 
phenotypic and genotypic assays as they both complement each other. 
Genotypic assays cannot predict the neuraminidase inhibitor susceptibility of 
uncharacterized gene mutations and phenotypic assays cannot alone accurately 
ascribe the resistance effect to a particular strain which carries low proportion 
of drug-resistant mutants in its mixed wild-type/mutant population (Nguyen et 
al. 2012).  Future work may involve performing phenotypic assays on some 
representative strains to determine the complete drug resistance profile of the 
influenza strains. 
10.7 Molecular epidemiology of influenza 
        Phylogenetic information was correlated with the epidemiological 
information to better understand the transmission dynamics of influenza on 
campus. The analysis was conducted in two parts. In the first analysis only HA 
gene sequence information was used, and was conducted on both seasonal and 
pandemic 2009 influenza viruses. Residence at hostel was identified as the risk 
factor for transmission of influenza. In the second analysis, whole genome 
information of pandemic 2009 virus was used to understand the 
phylogeography of IAV. The results showed that the location in the form of 
residence or faculty was a risk factor for the transmission of influenza. This 
suggests the adoption of targeted intervention measures, in such a situation, 
including possible closure of the universities (Uchida et al. 2011), quarantine 
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or cancellation of lectures may be considered especially in case of an 
impending pandemic to mitigate the effects of the pandemic.  
10.8 Overall conclusions 
     University populations may serve as important sentinel sites for 
surveillance of influenza and should be routinely monitored along with general 
community and other localized communities, such as schools, military 
populations and hospitalized patients. Hospitalized cases are usually moderate 
to severe cases and potential severity markers may just be a founder effect 
rather than a true association (Lee et al. 2010b). To validate these results, the 
severe cases data needs to be compared with mild cases. Furthermore, unlike 
the military population, the university population offers an advantage to study 
local epidemiology as well as imported cases as university students have a 
good mix of both local and overseas students. Integration of molecular, 
epidemiological and statistical methods may help public authorities to identify 
foci of transmission in localized communities. Targeted prevention strategies 
(vaccination) and intervention strategies in cases of impending pandemic 
(university or campus-based quarantine) may be deployed if there is sufficient 
evidence of intra-campus transmission. Although vaccine mismatch is a 
problem with influenza vaccine, it is usually to one type/subtype and the 
vaccine is still effective against the other types/subtypes included in the 
vaccine. An integrated surveillance approach may help to better understand the 
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APPENDIX I: GenBank accession numbers of strains sequenced in this study 
Strain 
 
PB2 PB1 PA HA NP NA MP NS 
A/Singapore/20J/2007 KP223195 KP223215 KP223234 KF856946 KF836407 KF856948 KF836401 KF836391 
A/Singapore/23J/2007 KP223196 KP223216 KP223235 KF856947 KP223180 KF856949 KF836403 KF836393 
A/Singapore/24D/2007 KP223197 KP223217 KP223236 KP223140 KP223181 KP223145 KP223164 KP223151 
A/Singapore/30L/2007 KP223198 KP223218 KP223237 KP223141 KP223182 KF856950 KF836404 KF836395 
A/Singapore/44T/2007 KP223199 KP223219 KP223238 KP223142 KP223183 KP223146 KP223165 KP223152 
A/Singapore/49O/2007 KP223200 KP223220 KP223239 KF533063 KF836410 KF856951 KF836405 KF836397 
A/Singapore/86D/2007 KP223201 KP223221 KP223240 KP223143 KP223184 KP223147 KP223166 KP223153 
A/Singapore/89Z/2007 KP223202 KP223222 KP223241 KP223144 KP223185 KP223148 KP223167 KP223154 
A/Singapore/106L/2007 KP223203 KP288290 KP223242 KF533064 KP223186 KP223149 KP223168 KP223155 
A/Singapore/115C/2007 KP223204 KP223223 KP223243 KF533062 KP223187 KP223150 KP223169 KP223156 
A/Singapore/25Z/2007 KP223205 KP223224 KP223244 KF533050 KF836409 KF533056 KP223170 KF836394 
A/Singapore/53C/2007 KP223206 KP223225 KP223245 KP223132 KF836411 KP223136 KP223171 KP223157 
A/Singapore/64K/2007 KP223207 KP223226 KP223246 KF533051 KP223188 KF533057 KP223172 KP223158 
A/Singapore/68Q/2007 KP223208 KP223227 KP223247 KF533052 KP223189 KF533058 KP223173 KP223159 
A/Singapore/78L/2007 KP223209 KP223228 KP223248 KF533053 KP223190 KF533059 KP223174 KP223160 
A/Singapore/87Z/2007 KP223210 KP223229 KP223248 KF533054 KP223191 KF533060 KP223175 KP223161 
A/Singapore/103C/2007 KP223211 KP223230 KP223250 KP223133 KP223192 KP223137 KP223176 KP223162 
A/Singapore/105L/2007 KP223212 KP223231 KP223251 KP223134 KP223193 KP223138 KP223177 KF836399 
A/Singapore/139N/2007 KP223213 KP223232 KP223252 KF533055 KF836413 KF533061 KP223178 KF836400 
A/Singapore/238T/2007 KP223214 KP223233 KP223253 KP223135 KP223194 KP223139 KP223179 KP223163 
A/Singapore/376Y/2009 KP222548 KP222582 KP222616 KF667880 KP222650 KF695073 KP222667 KP222706 
A/Singapore/384P/2009 KP222549 KP222583 KP222617 KF6677881 KP222651 KF695074 KP222668 KP222707 
A/Singapore/385K/2009 KP222550 KP222584 KP222618 KF6677882 KP222652 KF695075 KP222669 KP222708 
A/Singapore/386T/2009 KP222551 KP222585 KP222619 KF6677883 KP222653 KF695076 KP222670 KP222709 
A/Singapore/390T/2009 KP222552 KP222586 KP222620 KF6677884 KP222654 KF695077 KP222671 KP222710 
A/Singapore/392N/2009 KP222553 KP222587 KP222621 KF6677885 KP222655 KF695078 KP222672 KP222711 
A/Singapore/394T/2009 KP222554 KP222588 KP222622 KF6677886 KP222656 KF695079 KP222673 KP222712 
A/Singapore/395T/2009 KP222555 KP222589 KP222623 KF6677887 KP222657 KF695080 KP222674 KP222713 
A/Singapore/405S/2009 KP222556 KP222590 KP222624 KF6677890 KP222658 KF695083 KP222675 KP222714 









PB2 PB1 PA HA NP NA MP NS 
A/Singapore/410W/2009 KP222558 KP222592 KP222626 KF667892 KF09407 KF695085 KP222677 KP222716 
A/Singapore/413Y/2009 KP222559 KP222593 KP222627 KF667893 KP222660 KF695086 KP222678 KP222717 
A/Singapore/416C/2009 KP222560 KP222594 KP222628 KF667894 KF09408 KF695087 KP222679 KP222718 
A/Singapore/417C/2009 - - - KF667895 - - - - 
A/Singapore/418W/2009 KP222561 KP222595 KP222629 KF667896 KF09409 KF695088 KP222680 KP222719 
A/Singapore/419B/2009 KP222562 KP222596 KP222630 KF667897 KF09410 KF695089 KP222681 KP222720 
A/Singapore/420T/2009 KP222563 KP222597 KP222631 KF667898 KP222661 KF695090 KP222682 KP222721 
A/Singapore/425H/2009 - - - KF667899 - - KP222683 - 
A/Singapore/426N/2009 KP222564 KP222598 KP222632 KF667900 KF09411 KF695091 KP222684 KP222722 
A/Singapore/427O/2009 - - - KF667901 - - - - 
A/Singapore/437Y/2009 KP222565 KP222599 KP222633 KF667902 KP222662 KF695092 KP222686 KP222723 
A/Singapore/440F/2009 KP222566 KP222600 KP222634 KF667903 KF09412 KF695093 KP222687 KP222724 
A/Singapore/441T/2009 KP222567 KP222601 KP222635 KF667904 KF09413 KF695094 KP222688 KP222725 
A/Singapore/443N/2009 KP222568 KP222602 KP222636 KF667905 KF09414 KF695095 KP222689 KP222726 
A/Singapore/444W/2009 KP222569 KP222603 KP222637 KF667906 KP222663 KF695096 KP222690 KP222727 
A/Singapore/448D/2009 KP222570 KP222604 KP222638 KF667907 KF09415 KF695097 KP222691 KP222728 
A/Singapore/463B/2009 KP222571 KP222605 KP222639 KF667908 KP222664 KF695098 KP222692 KP222729 
A/Singapore/464L/2009 KP222572 KP222606 KP222640 KF667909 KF09416 KF695099 KP222693 KP222730 
A/Singapore/468H/2009 KP222573 KP222607 KP222641 KF667910 KF09417 KF695100 KP222694 KP222731 
A/Singapore/469O/2009 - - - KF667911 - - KP222695 - 
A/Singapore/480Y/2009 KP222574 KP222608 KP222642 KF667912 KF09418 KF695101 KP222696 KP222732 
A/Singapore/482H/2009 - - - KF667913 KF09419 KF695102 KP222697 - 
A/Singapore/483A/2009 KP222575 KP222609 KP222643 KF667914 KF09420 KF695103 KP222698 KP222733 
A/Singapore/484S/2009 - - - KF667915 - - KP222699 - 
A/Singapore/491H/2009 KP222576 KP222610 KP222644 KF667916 KP222665 KF695104 KP222700 KP222734 
A/Singapore/495W/2009 KP222577 KP222611 KP222645 KF667917 KF09421 KF695105 KP222701 KP222735 
A/Singapore/496T/2009 KP222578 KP222612 KP222646 KF667918 KF09422 KF695106 KP222702 KP222736 
A/Singapore/501L/2009 KP222579 KP222613 KP222647 KF667919 KF09423 KF695107 KP222703 KP222737 
A/Singapore/502J/2009 KP222580 KP222614 KP222648 KF667920 KP222666 KF695108 KP222704 KP222738 
A/Singapore/506T/2009 
 
KP222581 KP222615 KP222649 KF667921 KF09424 KF695109 KP222705 KP222739 
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Abstract
Background: Southeast Asia is believed to be a potential locus for the emergence of novel influenza strains, and therefore
accurate sentinel surveillance in the region is critical. Limited information exists on sentinel surveillance of influenza-like
illness (ILI) in young adults in Singapore in a University campus setting. The objective of the present study was to determine
the proportion of ILI caused by influenza A and B viruses in a university cohort in Singapore.
Methodology/Principal Findings: We conducted a prospective surveillance study from May through October 2007, at the
National University of Singapore (NUS). Basic demographic information and nasopharyngeal swabs were collected from
students and staff with ILI. Reverse-transcriptase PCR (RT-PCR) and viral isolation were employed to detect influenza viruses.
Sequencing of hemagglutinin (HA) and neuraminidase (NA) genes of some representative isolates was also performed.
Overall proportions of influenza A and B virus infections were 47/266 (18%) and 9/266 (3%) respectively. The predominant
subtype was A/H3N2 (55%) and the rest were A/H1N1 (45%). The overall sensitivity difference for detection of influenza A
viruses using RT-PCR and viral isolation was 53%. Phylogenetic analyses of HA and NA gene sequences of Singapore strains
showed identities higher than 98% within both the genes. The strains were more similar to strains included in the WHO
vaccine recommendation for the following year (2008). Genetic markers of oseltamivir resistance were not detected in any
of the sequenced Singapore isolates.
Conclusions/Significance: HA and NA gene sequences of Singapore strains were similar to vaccine strains for the upcoming
influenza season. No drug resistance was found. Sentinel surveillance on university campuses should make use of molecular
methods to better detect emerging and re-emerging influenza viral threats.
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Introduction
Influenza virus is a major cause of morbidity and mortality
worldwide. Influenza viruses are evolutionary dynamic viruses
with high mutation rate [1]. Accurate detection and further
subtyping of influenza A viruses is important for epidemiologic
surveillance [2]. Many respiratory pathogens can present with
‘‘influenza-like’’ symptoms. Thus, infections caused by other
respiratory pathogens may occasionally be difficult to distinguish
from actual influenza infection on the basis of clinical features
alone [3]. Therefore, accurate laboratory diagnosis is important in
managing influenza virus infection. Most importantly, accurate
laboratory diagnosis helps implement appropriate infection control
strategies for individual as well as public health responses to
further outbreaks [4,5]. The superiority of molecular assays over
conventional methods for diagnosis of respiratory viral infections
in various populations is well established [6–8]. Viral isolation,
however, provides an isolate of viable virus that can be used for
comprehensive characterization of viruses.
Molecular characterization of circulating influenza A virus
strains is essential for the selection of an optimal vaccine
composition [2], to understand transmission characteristics and
for monitoring drug resistance.
Neuraminidase inhibitors (NAIs), Oseltamivir and Zanamivir,
interfere with the release of progeny viruses from the host cell and
thus halt the spread of the virus [9]. The recent emergence of
resistance to NAIs has necessitated a strong surveillance system to
monitor resistance trends.
Influenza infection is a major cause of morbidity in young adults
in Singapore with estimates of the economic impact of influenza
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including more than 3 million doctor visits and 2 million lost days
of work [10]. Influenza in Singapore does not have well defined
seasonality [11,12] and tends to occur all year around. Relatively
closed populations, such as, students living on campus, in
dormitories or military personnel in camps have been proposed
as sentinel sites for surveillance of novel influenza. The proportion
of influenza-like illness (ILI) in young adults in Singapore due to
actual influenza virus infection has only recently been defined in a
military setting [13]. Military populations may not be the best for
surveillance of ILI as they only interact within their localized
community. University students, on the other hand, may be better
than the military populations because local students reflect local
community epidemiology as well as the many overseas students
who may introduce new strains from their home country across
the borders. In fact, in 1968, one of the best characterizations of
the influenza pandemic was among students and staff of the then
University of Singapore attending the University Health Centre
(UHC) [14]. The potential for student health centre acting as
sentinel surveillance site has not been thoroughly explored since
then in the tropics and elsewhere.
We conducted a comprehensive prospective surveillance study
in a university cohort to determine the proportion of ILI actually
caused by influenza A and B viruses. The relative performances of
reverse transcription-PCR (RT-PCR) and viral isolation for the
detection of influenza A viruses were evaluated in parallel. We also
carried out molecular characterization of some isolates to try to
understand the molecular epidemiology of influenza in a semi-
closed setting of a university by sequencing hemagglutinin (HA)
and neuraminindase (NA) genes of influenza A/H3N2 and A/
H1N1 viruses and by plotting phylogenetic trees. Genetic markers




The majority of students and staff from the National University
of Singapore (NUS) seek medical attention at the UHC.
Individuals meeting the case definition for ILI of fever with
respiratory symptom [15] were invited to participate in the study.
Sample and Data Collection
After consenting, two nasopharyngeal swabs were collected
from each participant by a trained research-assistant and placed in
Copan’s Universal Transport media (Copan Diagnostics Inc.,
Murrieta, California). The samples were processed immediately or
stored at –80uC until use. Basic demographic information was also
collected.
Ethics Statement
The study was approved by the NUS Institutional Review
Board (IRB). The NUS-IRB reference number is 06-156 and
approval number is NUS-282. Written informed consent was
obtained from the participants before sample collection.
Viral Isolation
Clinical samples (200 ml) were inoculated into 9 to 11-day-old
embryonated chicken eggs [16] and incubated at 35uC for 3 days.
Subsequently, the eggs were chilled at 4˚C overnight or for 4 hours
before harvesting. The allantoic fluid was harvested and inoculat-
ed into Madin-Darby Canine Kidney (MDCK, American Type
Culture Collection ATCC, CCL-34, Rockville, MD, USA) cells
grown on 12 mm coverslips. The coverslips were sterilized by
dipping in 70% ethanol and flaming. Maintenance media
comprising of Dulbecco’s Modified Eagle’s Medium (DMEM;
Gibco BRL, Grand Island, NY, USA), L-1-tosylamido-2-pheny-
lethyl chloromethyl ketone -Trypsin, bovine serum albumin,
100 U/ml of penicillin and 100 mg/ml of streptomycin was added
[17]. The infection was carried out at 37uC in the presence of
CO2. The cells were examined daily and harvested when extensive
cytopathic effects (CPE) were observed. Seven days post-infection,
the cells were fixed in 3% paraformaldehyde and processed for
immunofluorescence assay.
Immunofluorescent Antibody Staining (IFA)
The coverslips were treated with 0.1% saponin (Sigma, USA)
and stained with monoclonal antibody against influenza A virus
nucleoprotein antigen (Millipore, Bioscience Research Reagents,
Temecula, CA) followed by fluorescein isothiocyanate-labeled goat
anti-mouse immunoglobulin G (Millipore, Bioscience Research
Reagents, Temecula, CA). The virus-infected cells were examined
with a fluorescent microscope (OLYMPUS BX51). A scoring
system was used for the intensity of bright apple green fluorescent
nuclei. If more than 80% of the cells showed fluorescence, the slide
was scored 3+; if 40–80% showed fluorescence, the slide was
scored 2+; if 5–40% showed fluorescence, the slide was scored 1+;
and if less than 5% showed fluorescence slide was considered
negative.
Multiplex End-point RT-PCR and Pyrosequencing
Total nucleic acids were extracted from viral transport media
(VTM) samples using the RNeasy minikit (Qiagen, Inc., Valencia,
CA, USA) following manufacturer’s instructions. Molecular
diagnostics with primers targeting influenza A and B virus matrix
(M) gene were performed, followed by a specific probe confirma-
tion using Luminex xMAP-based assay (Luminex, Austin, TX,
USA) as previously described [18]. The end-products were
subjected to pyrosequencing, and the subtypes determined from
the DNA sequences.
Phylogenetic Analysis
Samples were randomly selected for sequencing from each
month of the study period. Viral RNAs (vRNAs) were extracted
from infected allantoic fluid of embryonated chicken eggs or VTM
samples, using RNeasy mini kit (Qiagen Inc., Valencia, CA, USA)
following manufacturer’s directions. Reverse Transcription (RT)
of the vRNAs was performed with SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen Corporation, CA,
USA), using the Uni12 primer (59AGCRAAAGCAGG39) [18].
PCR amplification of full-length HA and NA genes was carried
out using HiFi PlatTaq kit (Invitrogen) and primers as described
by Hoffman et al [19]. The PCR products were purified using
QIAquick Gel Extraction Kit (Qiagen Inc. Valencia, CA, USA)
and sequenced with primers [19–21] listed in Table 1. Sequencing
was performed with ABI Prism Big Dye Terminator (Applied
Biosystems, Foster City, CA, USA). Raw sequence data were
assembled and edited using SeqMan (DNASTAR, Lasergene
Version 7, Madison USA). Nucleotide sequences of HA and NA
genes were compared with each other, with vaccine strains and
with other published 2007 sequences from GenBank (http://www-
ncbi-nlm-nih-gov.libproxy1.nus.edu.sg/genomes/FLU/FLU.html)
using Megalign (DNASTAR, Lasergene Version 7) by the Clustal
W algorithm. For H3N2 subtype A/Winsconsin/67/2005 and A/
Brisbane/10/2007 and for H1N1 subtype A/New Caledonia/20/
1999, A/Solomon Islands/3/2006 and A/Brisbane/59/2007 were
used. Percent (%) sequence homology was calculated for each of the
full-length gene. Phylogenetic trees were constructed using the
neighbor-joining method, with bootstrap analysis performed on
Influenza Surveillance in a University Cohort
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1000 replicates. Phylogenetic trees were viewed with TreeExplorer
(v2.12,http://evolgen.biol.metro-u.ac.jp/TE/TE_man.html).
Determination of influenza virus infection
PCR positivity was determined as previously described [18] and
culture positivity was determined by scoring IFA results. Samples
that tested positive by either RT-PCR or viral isolation or both,
were regarded as true positive for influenza A virus infection. Only
RT-PCR was used for testing influenza B virus.
Statistical Analysis
Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) were calculated using standard
formulas.
Nucleotide Sequence Accession Numbers
The sequenced Singapore isolates were deposited in GenBank
and were assigned accession numbers from KF533050 to
KF533066 and KF856946 to KF856951.
Results
General Findings
From May 2007 through October 2007, a total of 266 subjects
participated in the study. There was no sample collection in June
2007 and July 2007 as the university was closed for vacations. One
hundred and thirty-five (51%) males and one hundred and thirty-
one (49%) females provided samples. The ages of the subjects
ranged from 18 years to 60 years with a median of 23 years. Of the
total of 266 subjects, 208 (78%) were students and 58/266 (22%)
were staff. Amongst the 266 subjects, the proportion of Singapor-
eans was 146/266 and of non-Singaporeans was 120/266.
Laboratory Analysis
Overall, 18% (47/266) of samples tested positive for the
presence of influenza A virus and 3% (9/266) for influenza B
virus. Eighteen percent of the samples were positive for influenza
A virus by RT-PCR and 8% by viral isolation method (Table 2).
In our study, 25 out of 47samples detected by RT-PCR were not
detected by viral isolation but all samples positive by viral isolation
were also positive by RT-PCR. Figure 1 shows the epidemiological
curve describing influenza A virus infections detected employing
RT-PCR and viral isolation. The peak in influenza A infection was
observed in May. The predominant subtype was influenza A/
H3N2 (55%) and the rest were A/H1N1 (45%).
The overall sensitivity for RT-PCR was 100% (95% Confidence
Interval; CI, 91–100%) whereas for viral isolation was 47% (95%
CI, 32–62%).The sensitivity difference between RT-PCR and
viral isolation method was 53%. The specificity and positive
predictive value for each of the methods was 100%. The negative
predictive values for RT-PCR and viral isolation were 100% and
90% respectively.
Phylogenetic Analysis
Overall there were 22 sequences of influenza A virus
successfully sequenced in this study (6 HA and 6 NA genes of
A/H3N2 viruses; 5 HA and 5 NA genes of A/H1N1 viruses).
HA and NA diversity of seasonal influenza A/H3N2
viruses in Singapore, 2007. The analysis of HA (Figure 2A)
and NA gene (Figure 2B) of A/H3N2 viruses showed that the
Singapore isolates shared .98% homology with vaccine strain of
2008-09 (A/Brisbane/10/2007). Percentage identity within the
Singapore strains ranged from 98.20-99.88%. Notably, the
genotype of the Singapore strains was different from the vaccine
Table 1. Primer sets for sequencing HA and NA genes.
Serotype Fragment Forward Primer (59- 39) Reverse Primer (59- 39)
Size
(bp)
























































*R = A/G, Y = C/T, M= A/C, N = A/C/G/T.
doi:10.1371/journal.pone.0088345.t001
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strain of 2007-08 (A/Winsconsin/67/2005) indicating antigenic
drift.
HA and NA diversity of seasonal influenza A/H1N1
viruses in Singapore, 2007. The analysis of HA (Figure 2C)
and NA genes (Figure 2D) of A/H1N1 viruses showed that the
identity percentages within the genes sequences of Singapore
strains ranged from 99.20-99.88%. Out of the three vaccine strains
chosen for analysis, the Singapore strains showed greater similarity
to vaccine strain of 2008-09 (A/Brisbane/59/2007).
NAI Resistance
Deduced aminoacid sequences of NA genes of the Singapore
strains were screened using MultAlin [22] for the genetic markers
of oseltamivir resistance. These were H274Y/H275Y mutation
and other substitution mutations like A/H3N2 (E41G, E119V/G/
D, Q136K, D151A/V/N, R152K, V165I, I222R/Q, Q226H,
G248R, K249E, D251G, H274N, R292K, and N294S) and A/
H1N1 (D79G, H126N, Q136K, Y155H, S247G, G248R, and
I266V). The sequenced Singapore strains did not harbor any of
the genetic markers of resistance to oseltamivir (Figure 3).
Discussion
ILI surveillance is important for influenza preparedness plans
globally. While there is huge body of literature on the proportion
of ILI due to actual influenza infection in temperate regions
[23,24], its knowledge remains limited in the tropics. There are
only a few studies on university students in tropical and subtropical
settings. There is a study that assessed ILI in university students
presenting to university health clinic in Florida, USA [23]. The
study, however, was done on a small cohort of 60 participants and
influenza infection was confirmed in 63% of participants. Another
study with same number of participants was conducted in 2002 in
San Francisco [24] and influenza was detected in 20% of students,
which is similar to our findings.
In our prospective study of 266 students and staff with ILI, we
found an 18% positive rate for influenza A virus. This is slightly
lower than the positive rate for influenza A virus of 24% found in a
military study in Singapore using molecular-based diagnostics
[13]. The peak in influenza A infection was observed in May. May
is the traditional influenza peak season in Singapore [11]. It is also
the examination season in the NUS and students are perceived to
be at a higher risk of upper respiratory tract infections. In general,
we found RT-PCR superior than viral isolation. The lower
sensitivity of viral isolation may be attributable to inactivation of
virus during transportation to laboratory [25]. Overall, there was a
53% sensitivity difference between RT-PCR and viral isolation in
detecting influenza A virus. A sensitivity difference of 9–40% for
detection of seasonal influenza A virus has been reported [9,26–
29]. We found a slightly wider sensitivity gap of 53% for seasonal
influenza A probably because of the difficulty in culturing the
Table 2. Number (%) of samples positive for influenza A virus
infection by RT-PCR and viral isolation (shown in bold).
Diagnostic method Influenza A virus infection
Present1 Absent2
Detected by RT-PCR 47 (1     ) 0
Not detected by RT-PCR 0 219 (82%)
Detected by viral isolation 22 (    ) 0
Not detected by viral
isolation
25 (9%) 219 (82%)
1Present means sample was positive for influenza A infection by either or both
the methods.
2Absent means sample was negative for influenza A infection by both
methods.
doi:10.1371/journal.pone.0088345.t002
Figure 1. Monthly distribution of total number of samples and influenza A positive samples detected by RT-PCR and viral isolation
during the study period.
doi:10.1371/journal.pone.0088345.g001
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Figure 2. Phylogenetic trees of Seasonal influenza viruses circulating in a university cohort in Singapore, 2007. The phylogenetic trees
of (A) 6 HA and (B) 6 (NA) genes of A/H3N2 viruses; (C) 5 HA and (D) 5 NA genes of A/H1N1 viruses with WHO vaccine strains and other 2007
sequences from GenBank constructed using neighbor-joining method. Bootstrap values 90 and over are shown. Singapore isolates are in bold and
vaccine strains in rectangles.
doi:10.1371/journal.pone.0088345.g002
Figure 3. Influenza A Neuraminidase (NA) protein sequence Analysis for Oseltamivir Resistance. (A) The consensus sequence of
neuraminidase (N1) gene from residues 251 to 300. Substitution of amino acid Histidine (H) to Tyrosine (Y) at position 275 in N1 gene (shown in bold)
and at position 274 in N2 gene confers resistance to oseltamivir. Protein sequences of (B) N1 and (C) N2 genes of Singapore isolates.
doi:10.1371/journal.pone.0088345.g003
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circulating A/H3N2 strains. This may be attributable to different
replication capacity of each strain of influenza A virus during viral
isolation. RT-PCR on the other hand is not affected by variations
in growth characteristics. The predominant subtype was A/H3N2
and this finding is in agreement with another study done in
Singapore [30] and with the national surveillance data published
by the Ministry of Health, Singapore [31].
The phylogenetic analyses shows that, both the HA and the NA
genes of sequenced influenza A/H3N2 and A/H1N1 viruses
clustered with WHO recommended vaccine strains of the
upcoming influenza season. This suggests that surveillance of
influenza viruses is essential for optimal vaccine composition.
Furthermore, majority of the Singapore strains that we sequenced
were closely related to each other by sequence analysis, this
suggests that the majority of influenza was localized. This has
implications for the response to future pandemics. In such cases,
closure of large institutions may be an important and useful
strategy. The data are limited, however, and further research is
needed to validate this. During the 2007–2008 influenza season,
oseltamivir resistance among influenza A /H1N1 viruses increased
significantly for the first time worldwide [32]. Genetic markers of
oseltamivir resistance, however, were not detected in the
sequenced Singapore isolates.
Our study has a few limitations. We collected data from a single
university so our results cannot be generalized to the general
population. Also, we did not test for other respiratory pathogens.
Our analyses were conducted on only 22 sequences and this
highlights that sequencing a few isolates is not sufficient to capture
the epidemiology of cohort studies. Nevertheless, since a limited
amount of research exists on ILI surveillance in young adults in
Singapore, to our knowledge only one study in a military
population has been published and none in a college setting in
recent years, our study provides the baseline surveillance data for
the proportion of influenza viruses in young adults with ILI in a
university setting. We were also able to identify strains that were
closely related to strains that subsequently became dominant
globally among those circulating in staff and students at our
university.
Conclusions
Populations such as university campuses are useful sentinel sites
and should be routinely monitored together with military
campuses, childcare centers and other similar cohorts. Surveil-
lance and control of influenza in large tropical institutions may be
an important and useful strategy in containing the next pandemic.
Our results also show that seasonal influenza A is more readily
detected by molecular-based than by viral isolation methods. This
further suggests that sentinel surveillance should make use of
molecular-based methods to better detect emerging and re-
emerging influenza viral threats.
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Southeast Asia is a potential locus for the emergence of novel influenza strains. However,
information on influenza within the region is limited.
Objectives
This study was to determine the proportion of influenza-like illness (ILI) caused by influenza
A and B viruses in a university cohort in Singapore, identify important distinctive clinical fea-
tures of influenza infection and potential factors associated with influenza infection com-
pared with other causes of ILI.
Methodology
A surveillance study was conducted from 2007 to 2009, at the University Health and Well-
ness Centre, National University of Singapore (NUS). Basic demographic information and
nasopharyngeal swabs were collected from consenting students and staff with ILI, with In-
fluenza A and B identified by both culture and molecular methods.
Results
Proportions of influenza A and B virus infections in subjects with ILI were 153/500 (30.6%)
and 11/500 (2.2%) respectively. The predominant subtype was A/H1N1, including both the
seasonal strain (20/153) and the pandemic strain (72/153). The clinical symptom of fever
was more common in subjects with laboratory confirmed influenza than other ILIs. On-cam-
pus hostel residence and being a student (compared with staff) were associated with in-
creased risk of laboratory confirmed influenza A/H1N1 2009 infection.
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Conclusions
This study provides a baseline prevalence of influenza infection within young adults in Sin-
gapore in a university setting. Potential risk factors, such as hostel residence, were identi-
fied, allowing for more targeted infection control measures in the event of a future
influenza pandemic.
Introduction
The influenza virus is a major cause of morbidity and mortality worldwide. In Singapore, it
causes significant economic impact, estimated to include more than 3 million doctor visits and
2 million lost days of work [1]. Singapore does not have a well-defined influenza seasonality,
and influenza infection tends to occur throughout the year. [2–3]
Many respiratory pathogens can present with “influenza-like” symptoms. Infections caused
by other respiratory pathogens may present similarly to influenza infections, making it difficult
to distinguish them clinically [4]. Hence, accurate detection and subtyping of influenza virus are
important for epidemiologic surveillance [5], while aiding infection control and management
for the individual and public health responses to influenza outbreaks and pandemics [6–7].
Transmission of influenza-like illnesses (ILIs) has been historically known to occur more
easily in relatively closed populations such as campus accommodations, dormitories or military
camps. Recently, a study in Singapore defined the proportion of influenza-like illnesses in a
military setting due to actual laboratory confirmed influenza infection in 2010 [8]. However,
there has not been a similar study done in civilian populations in recent years. University stu-
dents may have an advantage for surveillance as local students reflect local community epide-
miology while overseas students studying in Singapore may introduce new strains from their
home country. This was evidenced in 1968, where good characterization of the 1968 influenza
pandemic was obtained from students and staff of the National University of Singapore attend-
ing the University Health Centre (UHC) [9]. The potential for a student health centre acting as
sentinel surveillance site has not been thoroughly explored since then in Singapore or other
Southeast Asian cities to our knowledge.
It has been postulated that those living within hostels, being a relatively closed community
with close contact, have a higher risk of influenza transmission. Similarly, individuals clustered
in academic centers or schools within the campus that are located close together in physical lo-
cation may be at higher risk of influenza transmission from their fellow staff or students.
We conducted a prospective surveillance study in a university cohort to determine the pro-
portion of ILI actually caused by influenza A and B viruses [10] and to better understand the
risk factors for laboratory confirmed influenza virus infection in this cohort.
Materials and Methods
The methods for this study have previously been described in a descriptive analysis and molec-
ular characterization of viruses circulating on campus [10]. The study details are as below.
Study Population
Students and staff from the National University of Singapore (NUS) seek medical attention at
the UHC. Individuals meeting the case definition for ILI of fever with respiratory symptoms
[11] were invited to participate in the study.
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Ethics Statement
The study was approved by the NUS Institutional Review Board (IRB). The NUS-IRB reference
number is 06–156 and approval number is NUS-282. Written informed consent was obtained
from all the participants before sample and data collection. Students were generally aged be-
tween 17 to 25 and considered under NUS-IRB to be able to give consent without
parental participation.
Sample and Data Collection
Individuals had two nasopharyngeal swabs collected by a trained research assistant. Viruses
were subsequently isolated using two different culturing methods and two different molecular
methods including inoculation in embryonated chicken eggs, followed by Madin-Darby Ca-
nine Kidney (MDCK, American Type Culture Collection ATCC, CCL-34, Rockville, MD,
USA) cells; immunofluorescence assay for influenza A virus antigens and multiplex End-point
RT-PCR and pyrosequencing to obtain influenza subtypes. Basic demographic and clinical in-
formation were also collected.
Table 1. Characteristics of Study Population.










Never smoked 436 87.2




Not stated * 3
Campus
Life Science (Science/Nursing/Medicine) 134 27.86
Non-life science (Engineering/Computing/Finance) 347 72.14
Not stated * 19
Domicile
Hostel 216 44.17
Non hostel 273 55.83
No valid address stated * 11
Data is n (%)
* Not included within analysis
doi:10.1371/journal.pone.0119485.t001
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Statistical Analysis
Data were analysed with STATA 12th Edition, to obtain confidence intervals and prevalence
rate ratios. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value
(NPV) were calculated using standard formulas. Individuals with incomplete or invalid data of
the variable being analyzed were excluded from the respective analyses. Bonferroni correction
was used to account for multiple comparisons.
Results
A total of 500 subjects' data were analyzed. Characteristics of the study population are summa-
rized in table 1. Gender was approximately equal, 48% female (240/500) and 52% male (260/
500). The age of the subjects ranged from 17 years to 70 years with a median of 22 years. Over-
all, 30.6% (153/500) tested positive for the presence of influenza A virus and 2.2% (11/500) for
influenza B virus as previously described [10]. The predominant subtype was influenza A/
H1N1. The Singapore seasonal A/H1N1 made up 20 of the 92 cases (21.7%) of A/H1N1 with
the remaining 72 being pandemic A/H1N1. 6 samples of Influenza were not typeable. The de-
tails are summarized in table 2.
The distribution of Influenza was clustered across different time periods (Fig. 1) although
there were gaps in the collection of data during the university vacations. Influenza B was isolat-
ed more often in early 2007. Subtype A/H3N2 was noted across the entire time period of sam-
pling. The pandemic strain of A/H1N1 was isolated only in the later half of 2009 as would
be expected.
Of the seven symptoms of ILI elicited, five were noted to have a significant association with
laboratory confirmed influenza infection overall: muscle aches (odds ratio of 1.613), cough
(1.425), stuffy or runny nose (1.327), chills (1.510) and fever (2.357). Only fever (3.255) was
noted to be significantly associated in laboratory confirmed 2009 pandemic H1N1. The posi-
tive and negative predictive values of each symptom are summarized in table 3.
Amongst the 500 subjects, 216 (44.17%) lived on campus in hostels at time of presentation
and 273 did not. 11 did not provide a valid address or hostel location. Comparison between
those living in hostels and not was not significant (p = 0.070) for overall influenza positivity
disregarding type or subtype. However, on campus hostel residence was a significant risk factor
for Influenza A infection (OR 1.31 [1.00–1.71], p = 0.043) and in particular for pandemic influ-
enza A H1N1 2009 (OR 1.96 [1.25–3.08],p = 0.002).
Of the total of 500 subjects, 400 (80.4%) were students. 3 did not state their occupation. Stu-
dents and staff with ILI had similar rates of laboratory confirmed influenza positivity (p =
0.662). However, students had a significantly larger proportion testing positive for pandemic
Influenza A H1N1 2009 (OR 4.12 [1.54–11.0], p = 0.001).
Study subjects were also divided according to faculties they were involved with based on the
geographical distribution of the different schools and faculties on campus; the life science part
Table 2. Number (%) of Subjects positive for Inﬂuenza Virus Infection.
Inﬂuenza A 153 30.6
Seasonal H1N1 20 4
Pandemic H1N1 72 14.4
A / H3 N2 55 11
A / Not typeable 6 1.2
Inﬂuenza B 11 2.2
doi:10.1371/journal.pone.0119485.t002
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of campus namely, Medicine, Science and Nursing. Students from the non-life science part of
campus were from Engineering, Business, Arts and Computing. A total of 481 subjects were
able to be identified according to this categorisation. There was no association between the dif-
ferent parts of campus and the influenza types and subtypes detected.
Study subjects were classified according to their nationality into Singaporean (50.2%) and
non-Singaporean (49.8%) groups. Nationality was used as a surrogate for travel history, given
that the vast majority of overseas students at the university returned to their home countries
during university vacations. Comparison between the two groups also showed no significant
difference in influenza positivity. The results are summarized in table 4.
Discussion
Influenza surveillance is important for influenza preparedness plans worldwide. Influenza-like
illnesses (ILI) due to laboratory-confirmed influenza virus infections have been well studied
within the temperate regions, but there are only a few studies on university students in tropical
and subtropical settings. In Florida, USA, a cohort study was done on participants presenting
to the university health clinic for ILIs [12]. The study was limited by small number of 60 partic-
ipants with influenza infection confirmed in 63% of participants. Another study with the same
number of participants was conducted in 2002 in temperate San Francisco [13] and influenza
was detected in 20% of students, which is similar to our findings (32.8%). We also found a
30.6% positive rate for influenza A virus. This is similar to the positive rate for influenza A
Fig 1. Influenza Distribution According to Time.
doi:10.1371/journal.pone.0119485.g001
Table 3. Symptom distribution in subjects and prevalence rate ratios with predictive values.
Symptom Number (%) OR of Inﬂuenza (95% CI) PPV NPV
Fever 280 (56.0) 2.36 (1.74–3.20) 0.43 0.81
Chills 214 (42.8) 1.51 (1.18–1.94) 0.4 0.73
Aches 246 (49.2) 1.61 (1.24–2.09) 0.4 0.74
Stuffy or runny nose 280 (56.0) 1.33 (1.02–1.73) 0.36 0.72
Sore throat 325 (65.0) 1.26 (0.96–1.67) 0.35 0.72
Cough 252 (50.4) 1.43 (1.10–1.84) 0.38 0.72
Hoarse voice 216 (43.2) 1.22 (0.95–1.57) 0.36 0.7
OR: Odds Ratio, PPV: Positive Predictive Value, NPV: Negative Predictive Value
doi:10.1371/journal.pone.0119485.t003
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virus of 24% found in a military study in Singapore [8]. The above studies [12,13] highlight the
possibility of universities acting as influenza sentinel sites, using studies similar to ours.
We found that overall, influenza does appear significantly more commonly in students liv-
ing on campus within hostels, especially for the pandemic strain of subtype A/H1N1 2009.
This bears out the hypothesis that influenza will be higher in close contact areas like hostels es-
pecially for novel strains of influenza. In many temperate countries, meningococcal vaccination
is recommended for students living in dormitories on campus, as a preventive measure against
infections that spread easily in close contact, closed communities such as hostels. Influenza is
one such pathogen.




























>25 years 0.900 0.841 1.103 0.247 1.892 0.662 1.892
(0.658–1.225) (0.602–1.176) (0.410–2.971) (0.102–0.600) (1.137–3.146) (0.078–5.610) (0.564–6.349)
Gender
Female 0.729 0.738 0.464 0.689 0.902 1.083 0.619
(0.563–0.944) (0.563–0.968) (0.181–1.189) (0.444–1.070) (0.547–1.490) (0.221–5.316) (0.184–2.088)
Occupation
Student 1.075 1.175 0.565 4.123 0.591 - 0.424
(0.774–1.493) (0.821–1.683) (0.223–1.435) (1.542–11.02) (0.345–1.012) (0.127–1.421)
Nationality
Singaporean 0.857 0.815 1.488 0.793 0.661 0.992 1.737
(0.666–1.102) (0.624–1.063) (0.619–3.578) (0.516–1.221) (0.397–1.102) (0.202–4.868) (0.515–5.856)
Domicile
Hostel 1.264 1.316 0.583 1.966 1.053 1.263 0.722
(0.981–1.629) (1.007–1.718) (0.226–1.509) (1.254–3.081) (0.639–1.736) (0.258–6.200) (0.214–2.435)
Symptoms
Fever 2.357 2.463 0.786 3.255 3.143 1.571 1.375
(1.735–3.202) (1.779–3.410) (0.333–1.854) (1.866–5.677) (1.663–5.941) (0.290–8.501) (0.408–4.637)
Chills 1.510 1.504 1.336 1.264 2.339 0.267 1.604
(1.176–1.940) (1.155–1.957) (0.566–3.153) (0.825–1.937) (1.390–3.934) (0.315–2.271) (0.496–5.185)
Muscle Aches 1.613 1.625 0.845 1.531 2.753 0.516 1.239
(1.244–2.093) (1.250–2.164) (0.356–2.003) (0.989–2.370) (1.562–4.854) (0.095–2.793) (0.383–4.007)
Stuffy / Runny nose 1.327 1.400 3.143 1.100 1.615 0.786 0.655
(1.020–1.726) (1.059–1.851) (1.066–9.267) (0.713–1.698) (0.946–2.757) (0.160–3.855) (0.202–2.117)
Sore throat 1.264 1.253 1.615 0.897 1.929 1.077 1.436
(0.956–1.671) (0.935–1.678) (0.597–4.370) (0.578–1.394) (1.045–3.562) (0.199–5.821) (0.386–5.344)
Cough 1.425 1.406 1.476 1.230 1.722 0.984 1.722
(1.102–1.843) (1.073–1.842) (0.614–3.549) (0.800–1.892) (1.023–2.899) (0.201–4.829) (0.511–5.810)
Hoarse voice 1.222 1.264 1.972 0.887 1.972 0.263 0.751
(0.952–1.569) (0.972–1.645) (0.821–4.740) (0.573–1.372) (1.185–3.283) (0.031–2.234) (0.223–2.534)
Campus
Non-Life-science 0.861 0.858 1.004 0.807 0.818 1.931 0.901
(0.653–1.134) (0.642–1.147) (0.365–2.762) (0.506–1.288) (0.476–1.405) (0.228–16.37) (0.236–3.433)
doi:10.1371/journal.pone.0119485.t004
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In Singapore, only high-risk groups such as the elderly, the very young (below 5), healthcare
workers, or those with reduced immunity have definite recommendations for influenza vacci-
nation. Perhaps even in tropical countries, influenza vaccination should be recommended for
students who live on campus in hostels as influenza can spread even amongst healthy young
adults in such close proximity.
There was no significant difference in laboratory confirmed influenza between the life sci-
ences and the other campuses, suggesting that physical location of classes may not be an im-
portant factor for on campus transmission. This may be due to the high movement and mixing
of students and staff across faculties at closed ventilation areas such as libraries, canteens,
sports facilities and lecture halls.
Being a student as compared to being a staff or faculty member appeared to be a risk factor
only for the pandemic strain, as proportions of infected students and non-students were not
significantly different for other types and subtypes of influenza virus infections. This could be
due to older staff members having some degree of immunity to the H1N1 2009 strain or per-
haps to a higher degree of close contact among students compared to staff when the H1N1
2009 emerged. There were also smaller numbers of other strains in this cohort which may have
led to missing an association for the other strains and subtypes.
Certain clinical symptoms were identified as being more commonly associated with labora-
tory confirmed influenza: fever, chills, aches and cough. These are commonly used in case defi-
nitions [14–21]. The current practice in Singapore, especially at the primary care level, is to
diagnose based primarily on symptoms. Similarly, in the event of an influenza epidemic, case
definitions are based primarily on symptoms. Hence, knowing whether symptoms are signifi-
cant predictors of influenza positivity is of clinical significance. However, for pandemic influ-
enza 2009, only fever was identified as being significant in distinguishing influenza from other
ILI. This highlights the importance of a high index of suspicion for influenza diagnosis clinical-
ly even for those with relatively atypical presentations.
Our study had some important limitations. Data collected were from a single university, so
generalization to other similar institutions would be difficult although the National University
of Singapore does have a very high proportion of students from the region compared with
most institutions worldwide.
The study also did not include students or staff who were clinically asymptomatic but may
have been positive for influenza. Similarly, the study also did not take into account individuals
who did not seek medical treatment or sought treatment outside of the UHC although anec-
dotally, the majority of ill staff and students do seek medical attention at the UHC.
Sampling was also affected by the university academic calendar. The majority of the samples
were obtained during term periods, while few or no samples were obtained during university
vacation periods. This was possibly due to a much smaller population on campus and thus
smaller numbers seeking medical attention at the university health centre.
Sample sizes for type Influenza B and subtypes A/H3N2, seasonal A/H1N1 and those unable
to be typed were also small, making any subgroup analyses for these subtypes and
strains difficult.
Conclusions
This study highlights the inadequacy of clinical diagnosis of influenza based on symptoms
alone. In addition, we found a high concentration of laboratory confirmed influenza in stu-
dents living on campus in hostels. Perhaps influenza vaccination should be recommended for
students living in hostels. Given the diverse student body, the University can also act as a
Influenza Characterization in University Cohort
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sentinel site for surveillance and control of influenza in large tropical institutions. This may be
an important and useful strategy in containing the next pandemic.
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